Publications

Publications from OUS - Department of Nephrology Rikshospitalet (Div SIMT)

865 publications found

Publications 2023

1. Birkeland KI, Meling S, Alsnes IV, Svensson E, Gullestad L, Jenssen TG (2023)
   New international recommendations for type 2 diabetes - consequences for treatment practice in Norway?
   Tidsskr Nor Laegeforen, 143 (3)
   DOI 10.4045/tidsskr.22.0672, PubMed 36811420
2. Drevland OM, Robertsen I, Theie Gustavsen M, Kveim HK, Herberg Hovd M, Midtvedt K, Åsberg A (2023)
   Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients
   Transplant Direct, 9 (3), e1448
   DOI 10.1097/TXD.0000000000001448, PubMed 36875939
3. Grossi AA, Sever MS, Hellemans R, Mariat C, Crespo M, Watschinger B, Peruzzi L, Demir E, Velioglu A, Gandolfini I, Oniscu GC, Hilbrands L, Mjoen G (2023)
   The 3-Step Model of informed consent for living kidney donation: a proposal on behalf of the DESCaRTES Working Group of the European Renal Association
   Nephrol Dial Transplant (in press)
   DOI 10.1093/ndt/gfad022, PubMed 36702535
4. Helgeson ES, Vempati S, Palzer EF, Mjoen G, Haugen AJ, Matas AJ (2023)
   Development and Validation of a Hypertension Risk Calculator for Living Kidney Donors
   Transplantation (in press)
   DOI 10.1097/TP.0000000000004505, PubMed 36727726
5. Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2023)
   Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
   NPJ Vaccines, 8 (1), 4
   DOI 10.1038/s41541-023-00600-6, PubMed 36697432
6. Tronstad C, Amini M, Olesen E, Qvigstad E, Pabst O, Martinsen T, Abie SM, Martinsen ØG, Hisdal J, Jenssen TG, Kalvøy H (2023)
   Diabetic Foot Assessment using Skin Impedance in a Custom Made Sensor-sock
   J Electr Bioimpedance, 13 (1), 136-142
   DOI 10.2478/joeb-2022-0019, PubMed 36694878
7. Verde L, Lucà S, Cernea S, Sulu C, Yumuk VD, Jenssen TG, Savastano S, Sarno G, Colao A, Barrea L, Muscogiuri G (2023)
   The Fat Kidney
   Curr Obes Rep (in press)
   DOI 10.1007/s13679-023-00500-9, PubMed 36933154

Publications 2022

1. Andreassen RM, Kronborg JB, Schirmer H, Mathiesen EB, Melsom T, Eriksen BO, Jenssen TG, Solbu MD (2022)
   Urinary orosomucoid is associated with diastolic dysfunction and carotid arteriopathy in the general population. Cross-sectional data from the Tromsø study
   Scand Cardiovasc J, 56 (1), 148-156
   DOI 10.1080/14017431.2022.2079714, PubMed 35652526
2. Azulay N, Olsen RB, Nielsen CS, Stubhaug A, Jenssen TG, Schirmer H, Frigessi A, Rosseland LA, Tronstad C (2022)
   Reduced heart rate variability is related to the number of metabolic syndrome components and manifest diabetes in the sixth Tromsø study 2007-2008
   Sci Rep, 12 (1), 11998
   DOI 10.1038/s41598-022-15824-0, PubMed 35835836
3. Berger S, Bjark TH, Midtvedt K, Andersen R (2022)
   Regression of a venous malformation during angiotensin-converting enzyme inhibitor treatment for hypertension
   J Vasc Surg Cases Innov Tech, 8 (4), 657-659
   DOI 10.1016/j.jvscit.2022.09.004, PubMed 36262918
4. Bredewold OW, Chan J, Svensson M, Bruchfeld A, de Fijter JW, Furuland H, Grinyo JM, Hartmann A, Holdaas H, Hellberg O, Jardine A, Mjörnstedt L, Skov K, Smerud KT, Soveri I, Sørensen SS, Zonneveld AV, Fellström B (2022)
   Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial
   Kidney Med, 5 (1), 100574
   DOI 10.1016/j.xkme.2022.100574, PubMed 36593877
5. Budde K, Rostaing L, Maggiore U, Piotti G, Surace D, Geraci S, Procaccianti C, Nicolini G, Witzke O, Kamar N, Albano L, Büchler M, Pascual J, Gutiérrez-Dalmau A, Kuypers D, Wekerle T, Głyda M, Carmellini M, Tisone G, Midtvedt K, Wennberg L, Grinyó JM (2022)
   Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe
   Transpl Int, 35, 10225
   DOI 10.3389/ti.2021.10225, PubMed 36017158
6. Chan J, Svensson M, Tannæs TM, Waldum-Grevbo B, Jenssen T, Eide IA (2022)
   Associations of Serum Uromodulin and Urinary Epidermal Growth Factor with Measured Glomerular Filtration Rate and Interstitial Fibrosis in Kidney Transplantation
   Am J Nephrol, 53 (2-3), 108-117
   DOI 10.1159/000521757, PubMed 35104815
7. Dahle DO, Skauby M, Langberg CW, Brabrand K, Wessel N, Midtvedt K (2022)
   Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review
   Transplantation, 106 (1), e52-e63
   DOI 10.1097/TP.0000000000003762, PubMed 33741842
8. Gandolfini I, Crespo M, Hellemans R, Maggiore U, Mariat C, Mjoen G, Oniscu GC, Peruzzi L, Sever MS, Watschinger B, Hilbrands L (2022)
   Issues regarding COVID-19 in kidney transplantation in the ERA of the Omicron variant: a commentary by the ERA Descartes Working Group
   Nephrol Dial Transplant, 37 (10), 1824-1829
   DOI 10.1093/ndt/gfac203, PubMed 35746885
9. Haugen AJ, Hallan S, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisæter AV, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2022)
   Increased risk of ischaemic heart disease after kidney donation
   Nephrol Dial Transplant, 37 (5), 928-936
   DOI 10.1093/ndt/gfab054, PubMed 33624826
10. Heldal TF, Åsberg A, Ueland T, Reisaeter AV, Pischke SE, Mollnes TE, Aukrust P, Hartmann A, Heldal K, Jenssen T (2022)
    Inflammation in the early phase after kidney transplantation is associated with increased long-term all-cause mortality
    Am J Transplant, 22 (8), 2016-2027
    DOI 10.1111/ajt.17047, PubMed 35352462
11. Huijben JA, Kramer A, Kerschbaum J, de Meester J, Collart F, Arévalo OLR, Helve J, Lassalle M, Palsson R, Ten Dam M, Casula A, Methven S, Ortiz A, Ferraro PM, Segelmark M, Mingo PU, Arici M, Reisæter AV, Stendahl M, Stel VS, Jager KJ (2022)
    Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA Registry study
    Nephrol Dial Transplant (in press)
    DOI 10.1093/ndt/gfac165, PubMed 35974693
12. Khan SA, Åsberg A, Jenssen TG (2022)
    Anticoagulation and safety of renal transplant biopsy
    Clin Transplant, 36 (8), e14715
    DOI 10.1111/ctr.14715, PubMed 35594153
13. Kindem IA, Bjerre A, Hammarstrøm C, Naper C, Midtvedt K, Åsberg A (2022)
    Kidney-transplanted Adolescents-Nonadherence and Graft Outcomes During the Transition Phase: A Nationwide Analysis, 2000-2020
    Transplantation (in press)
    DOI 10.1097/TP.0000000000004431, PubMed 36476728
14. Kjøsen G, Horneland R, Nordheim E, Aandahl EM, Line PD, Rydenfelt K, Jenssen TG, Tønnessen TI, Haugaa H (2022)
    Validating the US pancreas donor risk index in a Norwegian population, a retrospective observational study
    Scand J Gastroenterol, 57 (3), 345-351
    DOI 10.1080/00365521.2021.2012590, PubMed 35130456
15. Krogstad V, Elgstøen KBP, Johnsen LF, Hartmann A, Mørkrid L, Åsberg A (2022)
    High Plasma Oxalate Levels Early After Kidney Transplantation Are Associated With Impaired Long-Term Outcomes
    Transpl Int, 35, 10240
    DOI 10.3389/ti.2022.10240, PubMed 35368646
16. Kurnikowski A, Nordheim E, Schwaiger E, Krenn S, Harreiter J, Kautzky-Willer A, Leutner M, Werzowa J, Tura A, Budde K, Eller K, Pascual J, Krebs M, Jenssen TG, Hecking M (2022)
    Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: A 2-year diagnostic accuracy study of participants from a randomized controlled trial
    Am J Transplant, 22 (12), 2880-2891
    DOI 10.1111/ajt.17187, PubMed 36047565
17. Lindahl JP, Barlinn R, Abrahamsen IW, Spetalen S, Midtvedt K, Jenssen T (2022)
    Case Report: Pure Red Cell Aplasia Caused by Refractory Parvovirus B19 Infection After Pancreas Transplantation Alone
    Front Med (Lausanne), 9, 849783
    DOI 10.3389/fmed.2022.849783, PubMed 35372384
18. Mariat C, Mjøen G, Watschinger B, Sever MS, Crespo M, Peruzzi L, Oniscu GC, Abramowicz D, Hilbrands L, Maggiore U (2022)
    Assessment of pre-donation glomerular filtration rate: going back to basics
    Nephrol Dial Transplant, 37 (3), 430-437
    DOI 10.1093/ndt/gfab259, PubMed 34519827
19. Melsom T, Norvik JV, Enoksen IT, Stefansson V, Mathisen UD, Fuskevåg OM, Jenssen TG, Solbu MD, Eriksen BO (2022)
    Sex Differences in Age-Related Loss of Kidney Function
    J Am Soc Nephrol, 33 (10), 1891-1902
    DOI 10.1681/ASN.2022030323, PubMed 35977806
20. Midtvedt K, Vaage JT, Heldal K, Munthe LA, Lund-Johansen F, Åsberg A (2022)
    Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response
    Am J Transplant, 22 (11), 2704-2706
    DOI 10.1111/ajt.17091, PubMed 35533010
21. Nordheim E, Raki M, Midtvedt K (2022)
    Case Report: Let Us Not Forget the Treatment That Some Patients Have Received-The Brief 50-Year History of a Kidney Transplant Survivor
    Front Med (Lausanne), 9, 906925
    DOI 10.3389/fmed.2022.906925, PubMed 35685423
22. Pippias M, Skinner L, Noordzij M, Reisaeter AV, Abramowicz D, Stel VS, Jager KJ (2022)
    Pregnancy after living kidney donation, a systematic review of the available evidence, and a review of the current guidance
    Am J Transplant, 22 (10), 2360-2380
    DOI 10.1111/ajt.17122, PubMed 35716049
23. Rossignol P, Duarte K, Bresso E, A Å, Devignes MD, Eriksson N, Girerd N, Glerup R, Jardine AG, Holdaas H, Lamiral Z, Leroy C, Massy Z, März W, Krämer B, Wu PH, Schmieder R, Soveri I, Christensen JH, Svensson M, Zannad F, Fellström B (2022)
    NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients
    Eur Heart J Open, 2 (6), oeac069
    DOI 10.1093/ehjopen/oeac069, PubMed 36600882
24. Rønning M, Hjellvik V, Sakshaug S, Blix HS, Midtvedt K, Reisæter AV, Holdaas H, Åsberg A (2022)
    Use of Statins in Kidney Transplant Recipients in Norway
    Int J Environ Res Public Health, 19 (3)
    DOI 10.3390/ijerph19031370, PubMed 35162389
25. Saeed M, Stene LC, Reisæter AV, Jenssen TG, Tell GS, Tapia G, Joner G, Skrivarhaug T (2022)
    End-stage renal disease: incidence and prediction by coronary heart disease, and educational level. Follow-up from diagnosis of childhood-onset type 1 diabetes throughout Norway 1973-2017
    Ann Epidemiol, 76, 181-187
    DOI 10.1016/j.annepidem.2022.03.015, PubMed 35398254
26. Svistounov D, Solbu MD, Jenssen TG, Mathisen UD, Hansen T, Elgstøen KBP, Zykova SN (2022)
    Development of quantitative assay for simultaneous measurement of purine metabolites and creatinine in biobanked urine by liquid chromatography-tandem mass spectrometry
    Scand J Clin Lab Invest, 82 (1), 37-49
    DOI 10.1080/00365513.2021.2015799, PubMed 35048747
27. Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2022)
    Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
    NPJ Vaccines, 7 (1), 174
    DOI 10.1038/s41541-022-00586-7, PubMed 36585405
28. Tronstad C, Pabst O, Amini M, Kleggetveit IP, Elvebakk O, Martinsen OG, Jenssen TG, Hisdal J, Berg TJ, Qvigstad E (2022)
    Development of a prototype toe sensor for detection of diabetic peripheral small fiber neuropathy
    Annu Int Conf IEEE Eng Med Biol Soc, 2022, 99-104
    DOI 10.1109/EMBC48229.2022.9871101, PubMed 36086669
29. Tsarpali V, Midtvedt K, Lønning K, Bernklev T, Åsberg A, Fawad H, von der Lippe N, Reisæter AV, Røysland K, Heldal K (2022)
    A Comorbidity Index and Pretransplant Physical Status Predict Survival in Older Kidney Transplant Recipients: A National Prospective Study
    Transplant Direct, 8 (4), e1307
    DOI 10.1097/TXD.0000000000001307, PubMed 35350108
30. Tsarpali V, Midtvedt K, Lønning K, Bernklev T, Åsberg A, von der Lippe N, Reisæter AV, Heldal K (2022)
    Poor Physical Function Trajectory Predicts Impaired Patient Survival in Older Recipients of Deceased Donor Kidneys: A Prospective Cohort Study
    Transplant Direct, 8 (11), e1374
    DOI 10.1097/TXD.0000000000001374, PubMed 36245999
31. Vart P, Jager KJ, Arnol M, Duivenvoorden R, Franssen CFM, Groeneveld M, Hemmelder MH, Lepeytre F, Malfait T, Midtvedt K, Mitra S, Facundo C, Noordzij M, Reina CC, Safak S, Toapanta N, Hilbrands LB, Gansevoort RT (2022)
    COVID-19 Pandemic Waves and Mortality Among Patients on Kidney Replacement Therapy
    Kidney Int Rep, 7 (9), 2091-2096
    DOI 10.1016/j.ekir.2022.06.007, PubMed 35757188
32. Weinreich I, Bengtsson M, Lauronen J, Naper C, Lokk K, Helanterä I, Andrésdóttir MB, Sørensen SS, Wennberg L, Reisaeter AV, Møller B, Koefoed-Nielsen P (2022)
    Scandiatransplant acceptable mismatch program-10 years with an effective strategy for transplanting highly sensitized patients
    Am J Transplant, 22 (12), 2869-2879
    DOI 10.1111/ajt.17182, PubMed 36030513

Publications 2021

1. Andersen MH, Urstad KH, Larsen MH, Henrichsen GF, Engebretsen E, Ødemark J, Stenehjem AE, Reisaeter AV, Nordlie A, Wahl AK (2021)
   Intervening on health literacy by knowledge translation processes in kidney transplantation: A feasibility study
   J Ren Care, 48 (1), 60-68
   DOI 10.1111/jorc.12379, PubMed 34053202
2. Aubert O, Yoo D, Zielinski D, Cozzi E, Cardillo M, Dürr M, Domínguez-Gil B, Coll E, Da Silva MI, Sallinen V, Lemström K, Midtvedt K, Ulloa C, Immer F, Weissenbacher A, Vallant N, Basic-Jukic N, Tanabe K, Papatheodoridis G, Menoudakou G, Torres M, Soratti C, Hansen Krogh D, Lefaucheur C, Ferreira G et al. (2021)
   COVID-19 pandemic and worldwide organ transplantation: a population-based study
   Lancet Public Health, 6 (10), e709-e719
   DOI 10.1016/S2468-2667(21)00200-0, PubMed 34474014
3. Bjørkto MH, Barratt-Due A, Nordøy I, Dörje C, Galteland E, Lind A, Hilli A, Aukrust P, Mjøen G (2021)
   The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
   BMC Infect Dis, 21 (1), 137
   DOI 10.1186/s12879-021-05789-2, PubMed 33526010
4. Bleskestad KB, Nordheim E, Lindahl JP, Midtvedt K, Pihlstrøm HK, Horneland R, Lee S, Åsberg A, Jenssen TG, Birkeland KI (2021)
   Insulin secretion and action after pancreas transplantation. A retrospective single-center study
   Scand J Clin Lab Invest, 81 (5), 365-370
   DOI 10.1080/00365513.2021.1926535, PubMed 34075856
5. Blom KB, Åsberg A, Sjaastad I, Kalleberg KT, Søraas A, Midtvedt K, Birkeland JA (2021)
   Kidney Transplant Recipient Behavior During the Early COVID-19 Pandemic: A National Survey Study in Norway
   Kidney Med, 4 (2), 100389
   DOI 10.1016/j.xkme.2021.09.006, PubMed 34805967
6. Chan J, Eide IA, Tannæs TM, Waldum-Grevbo B, Jenssen T, Svensson M (2021)
   Marine n-3 Polyunsaturated Fatty Acids and Cellular Senescence Markers in Incident Kidney Transplant Recipients: The Omega-3 Fatty Acids in Renal Transplantation (ORENTRA) Randomized Clinical Trial
   Kidney Med, 3 (6), 1041-1049
   DOI 10.1016/j.xkme.2021.07.010, PubMed 34939013
7. Dahle DO, Mjøen G (2021)
   Hypertensive Living Kidney Donor Candidates: What's the Risk?
   Kidney Int Rep, 6 (5), 1208-1210
   DOI 10.1016/j.ekir.2021.03.891, PubMed 34015066
8. Delanaye P, Gaillard F, van der Weijden J, Mjøen G, Ferhman-Ekholm I, Dubourg L, Ebert N, Schaeffner E, Åkerfeldt T, Goffin K, Couzi L, Garrouste C, Rostaing L, Courbebaisse M, Legendre C, Hourmant M, Kamar N, Cavalier E, Weekers L, Bouquegneau A, de Borst MH, Mariat C, Pottel H, van Londen M (2021)
   Age-adapted percentiles of measured glomerular filtration in healthy individuals: extrapolation to living kidney donors over 65 years
   Clin Chem Lab Med, 60 (3), 401-407
   DOI 10.1515/cclm-2021-1011, PubMed 34670031
9. Deyab G, Reine TM, Vuong TT, Jenssen T, Hjeltnes G, Agewall S, Mikkelsen K, Førre Ø, Fagerland MW, Kolset SO, Hollan I (2021)
   Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
   PLoS One, 16 (7), e0253247
   DOI 10.1371/journal.pone.0253247, PubMed 34242246
10. Engvig A, Wyller TB, Skovlund E, Ahmed MV, Hall TS, Rockwood K, Njaastad AM, Neerland BE (2021)
    Association between clinical frailty, illness severity and post-discharge survival: a prospective cohort study of older medical inpatients in Norway
    Eur Geriatr Med, 13 (2), 453-461
    DOI 10.1007/s41999-021-00555-8, PubMed 34417977
11. Gjerde A, Skrunes R, Reisæter AV, Marti HP, Vikse BE (2021)
    Familial Contributions to the Association Between Low Birth Weight and Risk of CKD in Adult Life
    Kidney Int Rep, 6 (8), 2151-2158
    DOI 10.1016/j.ekir.2021.05.032, PubMed 34386664
12. Haugen AJ, Mjøen G (2021)
    Living donation - any news on the donor?
    Curr Opin Organ Transplant, 26 (1), 85-90
    DOI 10.1097/MOT.0000000000000830, PubMed 33278148
13. Heldal K, Åsberg A, Abedini S, Jenssen TG, Reisæter AV, Bergan S, Hartmann A (2021)
    [Estimated glomerular filtration rate as a measurement of kidney function]
    Tidsskr Nor Laegeforen, 141 (1)
    DOI 10.4045/tidsskr.21.0501, PubMed 35026092
14. Helve J, Kramer A, Abad Diez JM, Aresté-Fosalba N, Arici M, Cases A, Collart F, Heaf J, De Meester J, Nordio M, Palsson R, Pobes A, Rydell H, Reisæter AV, Massy ZA, Jager KJ, Finne P (2021)
    Effect of comorbidities on survival in patients >80 years of age at onset of renal replacement therapy: data from the ERA-EDTA Registry
    Nephrol Dial Transplant, 36 (4), 688-694
    DOI 10.1093/ndt/gfaa278, PubMed 33537775
15. Jenssen T, Kristensen B, Uglenes I, Larsen LS, Allgot B (2021)
    Primary healthcare teams with a diabetes nurse is a solution
    Tidsskr Nor Laegeforen, 141 (5)
    DOI 10.4045/tidsskr.20.0999, PubMed 33754683
16. Jenssen TG (2021)
    Efficacy and safety of Sodium-Glucose-Transporter-2 inhibitors in kidney transplant patients
    Curr Opin Nephrol Hypertens, 30 (6), 577-583
    DOI 10.1097/MNH.0000000000000749, PubMed 34507336
17. Jørgensen HS, Eide IA, Jenssen T, Åsberg A, Bollerslev J, Godang K, Hartmann A, Schmidt EB, Svensson M (2021)
    Marine n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Kidney Transplant Recipients: A Randomized, Placebo-Controlled Trial
    Nutrients, 13 (7)
    DOI 10.3390/nu13072361, PubMed 34371870
18. Kjøsen G, Rydenfelt K, Horneland R, Aandahl EM, Line PD, Dorenberg E, Berstad AE, Brabrand K, Hagen G, Pischke SE, Bergmann GB, Nordheim E, Jenssen TG, Tønnessen TI, Haugaa H (2021)
    Early detection of complications in pancreas transplants by microdialysis catheters, an observational feasibility study
    PLoS One, 16 (3), e0247615
    DOI 10.1371/journal.pone.0247615, PubMed 33705460
19. Langberg NE, Jenssen TG, Haugen AJ, Mjøen G, Birkeland KI, Åsberg A, Hartmann A, Dahle DO (2021)
    Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
    Transplant Direct, 8 (1), e1262
    DOI 10.1097/TXD.0000000000001262, PubMed 34912949
20. Melsom T, Norvik JV, Enoksen IT, Stefansson V, Rismo R, Jenssen T, Solbu MD, Eriksen BO (2021)
    Association of High-Density Lipoprotein Cholesterol With GFR Decline in a General Nondiabetic Population
    Kidney Int Rep, 6 (8), 2084-2094
    DOI 10.1016/j.ekir.2021.05.007, PubMed 34386657
21. Midtvedt K, Onsøien MO, Åsberg A (2021)
    Posttransplant Hypertension Matters!
    Transplantation, 105 (10), e150
    DOI 10.1097/TP.0000000000003831, PubMed 34591816
22. Midtvedt K, Tran T, Parker K, Marti HP, Stenehjem AE, Gøransson LG, Mørkve Soldal K, Madsen C, Smedbråten J, Vaage EB, Lund-Johansen F, Åsberg A (2021)
    Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up!
    Transplantation, 105 (8), e80-e81
    DOI 10.1097/TP.0000000000003856, PubMed 34132229
23. Mitra S, Jayanti A, Vart P, Coca A, Gallieni M, Øvrehus MA, Midtvedt K, Abd ElHafeez S, Gandolfini I, Büttner S, Franssen CFM, Hemmelder MH, ERACODA Collaborators (2021)
    Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis
    Nephrol Dial Transplant, 36 (12), 2308-2320
    DOI 10.1093/ndt/gfab196, PubMed 34129039
24. Mjøen G, Maggiore U, Kessaris N, Kimenai D, Watschinger B, Mariat C, Sever MS, Crespo M, Peruzzi L, Spasovski G, Sørensen SS, Heemann U, Pascual J, Viklicky O, Courtney AE, Hadaya K, Wagner L, Nistor I, Hadjianastassiou V, Durlik M, Helanterä I, Oberbauer R, Oniscu G, Hilbrands L, Abramowicz D (2021)
    Long-term risks after kidney donation: how do we inform potential donors? A survey from DESCARTES and EKITA transplantation working groups
    Nephrol Dial Transplant, 36 (9), 1742-1753
    DOI 10.1093/ndt/gfab035, PubMed 33585931
25. Nordheim E, Geir Jenssen T (2021)
    Chronic kidney disease in patients with diabetes mellitus
    Endocr Connect, 10 (5), R151-R159
    DOI 10.1530/EC-21-0097, PubMed 33830068
26. Nordheim E, Lindahl JP, Carlsen RK, Åsberg A, Birkeland KI, Horneland R, Boye B, Scholz H, Jenssen TG (2021)
    Patient selection for islet or solid organ pancreas transplantation: experiences from a multidisciplinary outpatient-clinic approach
    Endocr Connect, 10 (2), 230-239
    DOI 10.1530/EC-20-0519, PubMed 33544090
27. Onsøien MO, Midtvedt K, Reisæter AV, Aasarød K, Waldum-Grevbo B, Vikse BE, Eriksen BO, Åsberg A (2021)
    Blood Pressure Treatment in Kidney Transplant Recipients-Can We Improve?
    Transplant Direct, 7 (4), e688
    DOI 10.1097/TXD.0000000000001142, PubMed 33786373
28. Pihlstrøm HK, Weedon-Fekjær MS, Bjerkely BL, von der Lippe C, Ørstavik K, Mathisen P, Heimdal K, Jenssen TG, Dahle DO, Solberg OK, Sigurdardottir S (2021)
    Health-related quality of life in Norwegian adults with Fabry disease: Disease severity, pain, fatigue and psychological distress
    JIMD Rep, 62 (1), 56-69
    DOI 10.1002/jmd2.12240, PubMed 34765399
29. Pippias M, Stel VS, Arnol M, Bemelman F, Berger SP, Buturovic Ponikvar JB, Kramar R, Magaz Á, Nordio M, Peters-Sengers H, Reisæter AV, Sørensen SS, Massy ZA, Jager KJ (2021)
    Temporal trends in the quality of deceased donor kidneys and kidney transplant outcomes in Europe: an analysis by the ERA-EDTA Registry
    Nephrol Dial Transplant, 37 (1), 175-186
    DOI 10.1093/ndt/gfab156, PubMed 33848355
30. Robertsen I, Åsberg A, Jenssen TG, Gence B, Tore Vethe N, Midtvedt K, Svensson MHS, Eide IA (2021)
    Increased systemic exposure of once-daily tacrolimus in renal transplant recipients on marine omega-3 fatty acid supplementation
    Transpl Int, 34 (7), 1322-1324
    DOI 10.1111/tri.13917, PubMed 33991364
31. Salib M, Girerd S, Girerd N, März W, Scharnagl H, Massy ZA, Leroy C, Duarte K, Holdaas H, Jardine AG, Schmieder RE, Fellström B, López-Andrés N, Rossignol P, Zannad F (2021)
    Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial
    Clin Res Cardiol, 111 (6), 614-626
    DOI 10.1007/s00392-021-01898-9, PubMed 34170371
32. Sigurdardottir S, Bjerkely B, Jenssen TG, Mathisen P, von der Lippe C, Ørstavik K, Heimdal K, Dahle DO, Weedon-Fekjær MS, Solberg O, Pihlstrøm HK (2021)
    The impact of demographic and clinical characteristics on the trajectories of health-related quality of life among patients with Fabry disease
    Orphanet J Rare Dis, 16 (1), 427
    DOI 10.1186/s13023-021-02066-y, PubMed 34641933
33. Tsarpali V, Midtvedt K, Lønning K, Bernklev T, Lippe NV, Reisæter AV, Brunborg C, Heldal K (2021)
    Health-Related Quality of Life in Older Kidney Transplant Recipients: A National Cohort Study of Short- and Longer-Term Outcomes
    Kidney Med, 3 (6), 974-983.e1
    DOI 10.1016/j.xkme.2021.05.007, PubMed 34939006
34. Witczak BJ, Pischke SE, Reisæter AV, Midtvedt K, Ludviksen JK, Heldal K, Jenssen T, Hartmann A, Åsberg A, Mollnes TE (2021)
    Elevated Terminal C5b-9 Complement Complex 10 Weeks Post Kidney Transplantation Was Associated With Reduced Long-Term Patient and Kidney Graft Survival
    Front Immunol, 12, 738927
    DOI 10.3389/fimmu.2021.738927, PubMed 34759922

Publications 2020

1. Abd ElHafeez S, Noordzij M, Kramer A, Bell S, Savoye E, Abad Diez JM, Lundgren T, Reisaeter AV, Kerschbaum J, Santiuste de Pablos C, Ortiz F, Collart F, Palsson R, Arici M, Heaf JG, Massy ZA, Jager KJ (2020)
   The association of living donor source with patient and graft survival among kidney transplant recipients in the ERA-EDTA Registry - a retrospective study
   Transpl Int, 34 (1), 76-86
   DOI 10.1111/tri.13759, PubMed 33022814
2. Benoni H, Eloranta S, Dahle DO, Svensson MHS, Nordin A, Carstens J, Mjøen G, Helanterä I, Hellström V, Enblad G, Pukkala E, Sørensen SS, Lempinen M, Smedby KE (2020)
   Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study
   Transpl Int, 33 (12), 1700-1710
   DOI 10.1111/tri.13734, PubMed 32896035
3. Bjerre A, Mjøen G, Line PD, Naper C, Reisaeter AV, Åsberg A (2020)
   Five decades with grandparent donors: The Norwegian strategy and experience
   Pediatr Transplant, 24 (6), e13751
   DOI 10.1111/petr.13751, PubMed 32485019
4. Chan J, Svensson M, Jenssen T, Schmidt EB, Eide IA (2020)
   Marine n-3 fatty acid consumption in a Norwegian renal transplant cohort: Comparison of a food frequency questionnaire with plasma phospholipid marine n-3 levels
   PLoS One, 15 (12), e0244089
   DOI 10.1371/journal.pone.0244089, PubMed 33332416
5. Chandra A, Midtvedt K, Åsberg A, Eide IA (2020)
   The Authors' Reply: Placental Pathology in Pregnancies After Kidney Transplantation
   Transplantation, 104 (7), e216
   DOI 10.1097/TP.0000000000003120, PubMed 32569005
6. Dahle DO, Mjoen G (2020)
   The Salutary Blood Pressure of a Solitary Kidney
   Am J Hypertens, 33 (3), 218-219
   DOI 10.1093/ajh/hpaa004, PubMed 31907513
7. de Gonzalo-Calvo D, Martínez-Camblor P, Bär C, Duarte K, Girerd N, Fellström B, Schmieder RE, Jardine AG, Massy ZA, Holdaas H, Rossignol P, Zannad F, Thum T (2020)
   Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids
   Theranostics, 10 (19), 8665-8676
   DOI 10.7150/thno.46123, PubMed 32754270
8. Eriksen BO, Palsson R, Ebert N, Melsom T, van der Giet M, Gudnason V, Indridason OS, Inker LA, Jenssen TG, Levey AS, Solbu MD, Tighiouart H, Schaeffner E (2020)
   GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts
   J Am Soc Nephrol, 31 (7), 1602-1615
   DOI 10.1681/ASN.2020020151, PubMed 32499396
9. Flemmen HØ, Simonsen CS, Berg-Hansen P, Moen SM, Kersten H, Heldal K, Celius EG (2020)
   Prevalence of multiple sclerosis in rural and urban districts in Telemark county, Norway
   Mult Scler Relat Disord, 45, 102352
   DOI 10.1016/j.msard.2020.102352, PubMed 32707528
10. Gjerde A, Lillås BS, Marti HP, Reisæter AV, Vikse BE (2020)
    Intrauterine growth restriction, preterm birth and risk of end-stage renal disease during the first 50 years of life
    Nephrol Dial Transplant, 35 (7), 1157-1163
    DOI 10.1093/ndt/gfaa001, PubMed 32040151
11. Gjerde A, Reisæter AV, Skrunes R, Marti HP, Vikse BE (2020)
    Intrauterine Growth Restriction and Risk of Diverse Forms of Kidney Disease during the First 50 Years of Life
    Clin J Am Soc Nephrol, 15 (10), 1413-1423
    DOI 10.2215/CJN.04080320, PubMed 32816833
12. Gustavsen MT, Midtvedt K, Robertsen I, Woillard JB, Debord J, Klaasen RA, Vethe NT, Bergan S, Åsberg A (2020)
    Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients
    Clin Transl Sci, 13 (6), 1327-1335
    DOI 10.1111/cts.12833, PubMed 32652886
13. Gustavsen MT, Midtvedt K, Vethe NT, Robertsen I, Bergan S, Åsberg A (2020)
    Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling
    Ther Drug Monit, 42 (3), 407-414
    DOI 10.1097/FTD.0000000000000697, PubMed 31479042
14. Haller MC, Wallisch C, Mjøen G, Holdaas H, Dunkler D, Heinze G, Oberbauer R (2020)
    Predicting donor, recipient and graft survival in living donor kidney transplantation to inform pretransplant counselling: the donor and recipient linked iPREDICTLIVING tool - a retrospective study
    Transpl Int, 33 (7), 729-739
    DOI 10.1111/tri.13580, PubMed 31970822
15. Haugen AJ, Hallan S, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2020)
    Increased long-term risk for hypertension in kidney donors - a retrospective cohort study
    Transpl Int, 33 (5), 536-543
    DOI 10.1111/tri.13576, PubMed 31958170
16. Hecking M, Sharif A, Eller K, Jenssen T (2020)
    Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics
    Transpl Int, 34 (1), 27-48
    DOI 10.1111/tri.13783, PubMed 33135259
17. Klaasen RA, Bergan S, Bremer S, Hole K, Nordahl CB, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2020)
    Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation
    Br J Clin Pharmacol, 86 (6), 1100-1112
    DOI 10.1111/bcp.14218, PubMed 31925806
18. Lorentzen EM, Henriksen S, Kaur A, Kro GB, Hammarström C, Hirsch HH, Midtvedt K, Rinaldo CH (2020)
    Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor
    Virol J, 17 (1), 5
    DOI 10.1186/s12985-019-1275-9, PubMed 31924245
19. Luis-Lima S, Mas-Sanmartin C, Rodríguez-Rodríguez AE, Porrini E, Ortiz A, Gaspari F, Diaz-Martin L, Åsberg A, Jenssen T, Jiménez-Sosa A, Martinez-Ros P, Gonzalez-Bulnes A (2020)
    A Simplified Iohexol-Based Method to Measure Renal Function in Sheep Models of Renal Disease
    Biology (Basel), 9 (9)
    DOI 10.3390/biology9090259, PubMed 32878167
20. Maggiore U, Abramowicz D, Crespo M, Mariat C, Mjoen G, Peruzzi L, Sever MS, Oniscu GC, Hilbrands L, Watschinger B (2020)
    How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion
    Nephrol Dial Transplant, 35 (6), 899-904
    DOI 10.1093/ndt/gfaa130, PubMed 32441741
21. Nordheim E, Dahle DO, Halden T, Birkeland KI, Åsberg A, Hartmann A, Horneland R, Jenssen TG (2020)
    Endothelial function after pancreas transplantation-A single-center observational study
    Clin Transplant, 34 (3), e13815
    DOI 10.1111/ctr.13815, PubMed 32027399
22. Pihlstrøm HK, Ueland T, Michelsen AE, Aukrust P, Gatti F, Hammarström C, Kasprzycka M, Wang J, Haraldsen G, Mjøen G, Dahle DO, Midtvedt K, Eide IA, Hartmann A, Holdaas H (2020)
    Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients
    PLoS One, 15 (12), e0243759
    DOI 10.1371/journal.pone.0243759, PubMed 33326471

Publications 2019

1. Antlanger M, Noordzij M, van de Luijtgaarden M, Carrero JJ, Palsson R, Finne P, Hemmelder MH, Aresté-Fosalba N, Reisæter AV, Cases A, Traynor JP, Kramar R, Massy Z, Jager KJ, Hecking M, ERA-EDTA Registry (2019)
   Sex Differences in Kidney Replacement Therapy Initiation and Maintenance
   Clin J Am Soc Nephrol, 14 (11), 1616-1625
   DOI 10.2215/CJN.04400419, PubMed 31649071
2. Berstad AE, Brabrand K, Horneland R, Syversveen T, Haugaa H, Jenssen TG, Foss A (2019)
   Microbubble contrast-enhanced ultrasound in the vascular evaluation after pancreas transplantation: a single-center experience
   Acta Radiol, 60 (10), 1224-1231
   DOI 10.1177/0284185119828190, PubMed 30754980
3. Bhopal A, Wium C, Reisaeter AV, Bhala N, Kumar B (2019)
   Organ donation for migrants and ethnic minorities
   Tidsskr. Nor. Laegeforen., 139 (13), 1234-1235
4. Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2019)
   Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
   Blood Press, 29 (2), 123-134
   DOI 10.1080/08037051.2019.1684817, PubMed 31718316
5. Boardman NT, Falck AT, Lund T, Chu X, Martin-Armas M, Norvik JV, Jenssen TG, Ytrehus K (2019)
   Human concentrations of uric acid scavenges adaptive and maladaptive reactive oxygen species in isolated rat hearts subjected to ischemic stress
   Can J Physiol Pharmacol, 98 (3), 139-146
   DOI 10.1139/cjpp-2019-0024, PubMed 31518503
6. Brovold H, Lund T, Svistounov D, Solbu MD, Jenssen TG, Ytrehus K, Zykova SN (2019)
   Crystallized but not soluble uric acid elicits pro-inflammatory response in short-term whole blood cultures from healthy men
   Sci Rep, 9 (1), 10513
   DOI 10.1038/s41598-019-46935-w, PubMed 31324844
7. Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O et al. (2019)
   Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
   Ther Drug Monit, 41 (3), 261-307
   DOI 10.1097/FTD.0000000000000640, PubMed 31045868
8. Chandra A, Midtvedt K, Åsberg A, Eide IA (2019)
   Immunosuppression and Reproductive Health After Kidney Transplantation
   Transplantation, 103 (11), e325-e333
   DOI 10.1097/TP.0000000000002903, PubMed 31397802
9. Eide IA, Rashidi F, Lønning K, Oldereid NB, Reisæter AV, Åsberg A, Midtvedt K (2019)
   Contraceptive Choices and Counseling in Norwegian Female Renal Transplant Recipients
   Transplant Proc, 51 (2), 470-474
   DOI 10.1016/j.transproceed.2019.01.068, PubMed 30879570
10. Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Frøslie KF, Godang K, Kalvøy H, Martinsen ØG, Gulseth HL (2019)
    Author Correction: Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
    Sci Rep, 9 (1), 6347
    DOI 10.1038/s41598-019-42218-6, PubMed 30988313
11. Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Gulseth HL, Kalvøy H, Høgetveit JO, Martinsen ØG (2019)
    A multiparameter model for non-invasive detection of hypoglycemia
    Physiol Meas, 40 (8), 085004
    DOI 10.1088/1361-6579/ab3676, PubMed 31357185
12. Girerd S, Girerd N, Frimat L, Holdaas H, Jardine AG, Schmieder RE, Fellström B, Settembre N, Malikov S, Rossignol P, Zannad F (2019)
    Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial
    Clin Kidney J, 13 (1), 116-122
    DOI 10.1093/ckj/sfz048, PubMed 32082562
13. Gustavsen MT, Midtvedt K, Lønning K, Jacobsen T, Reisaeter AV, De Geest S, Andersen MH, Hartmann A, Åsberg A (2019)
    Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial
    Transpl Int, 32 (6), 614-625
    DOI 10.1111/tri.13412, PubMed 30770608
14. Halden TAS, Kvitne KE, Midtvedt K, Rajakumar L, Robertsen I, Brox J, Bollerslev J, Hartmann A, Åsberg A, Jenssen T (2019)
    Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus
    Diabetes Care, 42 (6), 1067-1074
    DOI 10.2337/dc19-0093, PubMed 30862658
15. Haugen AJ, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2019)
    Long-term risk for kidney donors with hypertension at donation - a retrospective cohort study
    Transpl Int, 32 (9), 960-964
    DOI 10.1111/tri.13443, PubMed 30983060
16. Heldal K, Midtvedt K, Lønning K, Iversen T, Hernæs KH, Tsarpali V, Reisæter AV, Bernklev T (2019)
    Kidney transplantation: an attractive and cost-effective alternative for older patients? A cost-utility study
    Clin Kidney J, 12 (6), 888-894
    DOI 10.1093/ckj/sfz018, PubMed 31807304
17. Holdaas H (2019)
    People in Transplantation
    Transplantation, 103 (8), 1529-1531
    DOI 10.1097/TP.0000000000002658, PubMed 31348435
18. Jenssen T, Hartmann A (2019)
    Post-transplant diabetes mellitus in patients with solid organ transplants
    Nat Rev Endocrinol, 15 (3), 172-188
    DOI 10.1038/s41574-018-0137-7, PubMed 30622369
19. Jenssen TG (2019)
    Prediabetes after kidney transplantation-a reason to worry?
    Kidney Int, 96 (6), 1280-1282
    DOI 10.1016/j.kint.2019.08.008, PubMed 31759487
20. Klaasen RA, Egeland EJ, Chan J, Midtvedt K, Svensson M, Bolstad N, Fellström B, Holdaas H, Åsberg A, Bergan S, Vethe NT, Warren DJ (2019)
    A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients
    Ther Drug Monit, 41 (1), 11-18
    DOI 10.1097/FTD.0000000000000580, PubMed 30633722
21. Legendre C, Viebahn R, Crespo M, Dor F, Gustafsson B, Samuel U, Karam V, Binet I, Aberg F, De Geest S, Moes DJAR, Tonshoff B, Oppenheimer F, Asberg A, Halleck F, Loupy A, Suesal C (2019)
    Beyond Survival in Solid Organ Transplantation: A Summary of Expert Presentations from the Sandoz 6th Standalone Transplantation Meeting, 2018
    Transplantation, 103 (9 Suppl 1), S1-S13
    DOI 10.1097/TP.0000000000002846, PubMed 31449167
22. Lilleberg HS, Cichosz SL, Svensson M, Christensen JH, Fleischer J, Eide I, Jenssen T (2019)
    The Effect of Marine n-3 Polyunsaturated Fatty Acids on Heart Rate Variability in Renal Transplant Recipients: A Randomized Controlled Trial
    Nutrients, 11 (12)
    DOI 10.3390/nu11122847, PubMed 31757095
23. Melsom T, Nair V, Schei J, Mariani L, Stefansson VTN, Harder JL, Jenssen TG, Solbu MD, Norvik JV, Looker H, Knowler WC, Kretzler M, Nelson RG, Eriksen BO (2019)
    Correlation Between Baseline GFR and Subsequent Change in GFR in Norwegian Adults Without Diabetes and in Pima Indians
    Am J Kidney Dis, 73 (6), 777-785
    DOI 10.1053/j.ajkd.2018.11.011, PubMed 30704883
24. Midtvedt K, Robertsen I, Asberg A (2019)
    Generic drugs - not as similar as we think?
    Tidsskr. Nor. Laegeforen., 139 (18), 1722
25. Mjoen G, Reisæter A, Hartmann A, Dahle DO, Holdaas H (2019)
    Regarding age-calibrated glomerular filtration rate
    Kidney Int, 95 (1), 234-235
    DOI 10.1016/j.kint.2018.10.003, PubMed 30606421
26. Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD, Heaf JG, Hemmelder MH, Martínez-Castelao A, de Meester J, Palsson R, Prischl FC, Segelmark M, Traynor JP, Santamaria R, Reisaeter AV, Massy ZA, Jager KJ (2019)
    International comparison of trends in patients commencing renal replacement therapy by primary renal disease
    Nephrology (Carlton), 24 (10), 1064-1076
    DOI 10.1111/nep.13531, PubMed 30456883
27. Thorsen IS, Bleskestad IH, Åsberg A, Hartmann A, Skadberg Ø, Brede C, Ueland T, Pasch A, Reisaeter AV, Gøransson LG (2019)
    Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study
    Clin Transplant, 33 (5), e13517
    DOI 10.1111/ctr.13517, PubMed 30844090
28. Tunbridge M, Holdaas H, Jardine AG (2019)
    Pulse Pressure: A Risk Factor for Renal Transplant Failure or a Useful Therapeutic Target?
    Transplantation, 103 (4), 662-663
    DOI 10.1097/TP.0000000000002441, PubMed 30188414
29. Ussif AM, Åsberg A, Halden TAS, Nordheim E, Hartmann A, Jenssen T (2019)
    Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation
    BMC Nephrol, 20 (1), 12
    DOI 10.1186/s12882-018-1171-3, PubMed 30630438
30. Vethe NT, Gustavsen MT, Midtvedt K, Lauritsen ME, Andersen AM, Åsberg A, Bergan S (2019)
    Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients
    Ther Drug Monit, 41 (5), 607-614
    DOI 10.1097/FTD.0000000000000655, PubMed 31584926
31. von Zur-Mühlen B, Lundgren T, Bayman L, Berne C, Bridges N, Eggerman T, Foss A, Goldstein J, Jenssen T, Jorns C, Morrison Y, Rydén M, Schwieger T, Tufveson G, Nilsson B, Korsgren O (2019)
    Open Randomized Multicenter Study to Evaluate Safety and Efficacy of Low Molecular Weight Sulfated Dextran in Islet Transplantation
    Transplantation, 103 (3), 630-637
    DOI 10.1097/TP.0000000000002425, PubMed 30211831
32. Åsberg A, Bjerre A, Almaas R, Luis-Lima S, Robertsen I, Salvador CL, Porrini E, Schwartz GJ, Hartmann A, Bergan S (2019)
    Measured GFR by Utilizing Population Pharmacokinetic Methods to Determine Iohexol Clearance
    Kidney Int Rep, 5 (2), 189-198
    DOI 10.1016/j.ekir.2019.11.012, PubMed 32043033
33. Aasebø W, Svensson M, Jenssen T, Eide IA (2019)
    Marine n-3 Polyunsaturated Fatty Acid Supplementation and Quality of Life After Kidney Transplant
    Transplant Proc, 51 (2), 466-469
    DOI 10.1016/j.transproceed.2019.01.067, PubMed 30879569

Publications 2018

1. Abedini S, Gøransson L, Cockburn E, Kilany S, Holdaas H (2018)
   Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study
   Transplant Direct, 4 (2), e338
   DOI 10.1097/TXD.0000000000000755, PubMed 29464199
2. Ceretta ML, Noordzij M, Luxardo R, De Meester J, Abad Diez JM, Finne P, Heaf JG, Couchoud C, Kramar R, Collart F, Cases A, Palsson R, Reisæter AV, Rydell H, Massy ZA, Jager KJ, Kramer A (2018)
   Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA Registry
   Nephrol Dial Transplant, 33 (10), 1794-1804
   DOI 10.1093/ndt/gfx355, PubMed 29361126
3. Chandra A, Svensson M, Åsberg A, Schmidt EB, Bjerve KS, Jenssen T, Hartmann A, Ueland T, Eide IA (2018)
   Trans-fatty Acids and Survival in Renal Transplantation
   J Ren Nutr, 29 (3), 169-180
   DOI 10.1053/j.jrn.2018.08.003, PubMed 30309780
4. Egeland EJ, Reisaeter AV, Robertsen I, Midtvedt K, Strøm EH, Holdaas H, Hartmann A, Åsberg A (2018)
   High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study
   Transpl Int, 32 (3), 257-269
   DOI 10.1111/tri.13356, PubMed 30252957
5. Eide IA, Reinholt FP, Jenssen T, Hartmann A, Schmidt EB, Åsberg A, Bergan S, Brabrand K, Svensson M (2018)
   Effects of marine n-3 fatty acid supplementation in renal transplantation: A randomized controlled trial
   Am J Transplant, 19 (3), 790-800
   DOI 10.1111/ajt.15080, PubMed 30125457
6. Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Frøslie KF, Godang K, Kalvøy H, Martinsen ØG, Gulseth HL (2018)
   Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
   Sci Rep, 8 (1), 14722
   DOI 10.1038/s41598-018-33189-1, PubMed 30283093
7. Eriksen BO, Småbrekke S, Jenssen TG, Mathisen UD, Norvik JV, Schei J, Schirmer H, Solbu MD, Stefansson VTN, Melsom T (2018)
   Office and Ambulatory Heart Rate as Predictors of Age-Related Kidney Function Decline
   Hypertension, 72 (3), 594-601
   DOI 10.1161/HYPERTENSIONAHA.118.11594, PubMed 30354758
8. Foss S, Nordheim E, Sørensen DW, Syversen TB, Midtvedt K, Åsberg A, Dahl T, Bakkan PA, Foss AE, Geiran OR, Fiane AE, Line PD (2018)
   First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion
   Transplant Direct, 4 (7), e366
   DOI 10.1097/TXD.0000000000000802, PubMed 30046656
9. García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Reisaeter AV, Seron D (2018)
   Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantation
   Clin Transplant, 32 (3), e13196
   DOI 10.1111/ctr.13196, PubMed 29380890
10. Heldal K, Midtvedt K, Hartmann A, Reisaeter AV, Heldal TF, Bergan S, Salvador CL, Åsberg A (2018)
    Estimated glomerular filtration rate in stable older kidney transplant recipients-are present algorithms valid? A national cross-sectional cohort study
    Transpl Int, 31 (6), 629-638
    DOI 10.1111/tri.13137, PubMed 29453878
11. Heldal TF, Ueland T, Jenssen T, Hartmann A, Reisaeter AV, Aukrust P, Michelsen A, Åsberg A (2018)
    Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study
    Transpl Int, 31 (5), 510-519
    DOI 10.1111/tri.13116, PubMed 29341300
12. Hruskova Z, Pippias M, Stel VS, Abad-Díez JM, Benítez Sánchez M, Caskey FJ, Collart F, De Meester J, Finne P, Heaf JG, Magaz A, Palsson R, Reisæter AV, Salama AD, Segelmark M, Traynor JP, Massy ZA, Jager KJ, Tesar V (2018)
    Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry
    Am J Kidney Dis, 73 (2), 184-193
    DOI 10.1053/j.ajkd.2018.05.016, PubMed 30122544
13. Klaasen RA, Bergan S, Bremer S, Daleq L, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2018)
    Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney Transplantation
    Ther Drug Monit, 40 (5), 558-566
    DOI 10.1097/FTD.0000000000000539, PubMed 30086087
14. Lønning K, Heldal K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisæter AV, Line PD, Hartmann A, Midtvedt K (2018)
    Improved Health-Related Quality of Life in Older Kidney Recipients 1 Year After Transplantation
    Transplant Direct, 4 (4), e351
    DOI 10.1097/TXD.0000000000000770, PubMed 29707622
15. Lønning K, Midtvedt K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisaeter AV, Line PD, Hartmann A, Heldal K (2018)
    Changes in health-related quality of life in older candidates waiting for kidney transplantation
    Nephrology (Carlton), 23 (10), 948-956
    DOI 10.1111/nep.13117, PubMed 28734131
16. Lønning K, Midtvedt K, Heldal K, Andersen MH (2018)
    Older kidney transplantation candidates' expectations of improvement in life and health following kidney transplantation: semistructured interviews with enlisted dialysis patients aged 65 years and older
    BMJ Open, 8 (6), e021275
    DOI 10.1136/bmjopen-2017-021275, PubMed 29934388
17. Mafham MM, Staplin N, Emberson J, Haynes R, Herrington W, Reith C, Wanner C, Walker R, Cass A, Levin A, Fellström B, Jiang L, Holdaas H, Kasiske B, Wheeler DC, Landray MJ, Baigent C, SHARP Collaborative Group (2018)
    Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection
    Nephrol Dial Transplant, 33 (2), 257-264
    DOI 10.1093/ndt/gfw396, PubMed 28088776
18. Majak GB, Reisæter AV, Weedon-Fekjær H, Henriksen T, Michelsen TM (2018)
    The Effect of Pregnancy on the Long-term Risk of Graft Loss, Cardiovascular Disease, and Death in Kidney Transplanted Women in Norway: A Retrospective Cohort Study
    Transplantation, 102 (9), e391-e396
    DOI 10.1097/TP.0000000000002167, PubMed 29528968
19. Melsom T, Solbu MD, Schei J, Stefansson VTN, Norvik JV, Jenssen TG, Wilsgaard T, Eriksen BO (2018)
    Mild Albuminuria Is a Risk Factor for Faster GFR Decline in the Nondiabetic Population
    Kidney Int Rep, 3 (4), 817-824
    DOI 10.1016/j.ekir.2018.01.015, PubMed 29989017
20. Mjoen G, Holdaas H (2018)
    Mid- and Long-Term Health Risks in Living Kidney Donors
    Ann Intern Med, 169 (4), 265
    DOI 10.7326/L18-0340, PubMed 30128523
21. Nordheim E, Birkeland KI, Åsberg A, Hartmann A, Horneland R, Jenssen T (2018)
    Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational study
    Eur J Endocrinol, 179 (4), 251-259
    DOI 10.1530/EJE-18-0360, PubMed 30299895
22. Nordheim E, Horneland R, Aandahl EM, Grzyb K, Aabakken L, Paulsen V, Midtvedt K, Hartmann A, Jenssen T (2018)
    Pancreas transplant rejection episodes are not revealed by biopsies of the donor duodenum in a prospective study with paired biopsies
    Am J Transplant, 18 (5), 1256-1261
    DOI 10.1111/ajt.14658, PubMed 29316221
23. Pedersen HL, Horvei KD, Thiyagarajan D, Norby GE, Seredkina N, Moroni G, Eilertsen GØ, Holdaas H, Strøm EH, Bakland G, Meroni PL, Rekvig OP (2018)
    Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression
    J Pathol Clin Res, 4 (3), 193-203
    DOI 10.1002/cjp2.99, PubMed 29624903
24. Pihlstrøm HK, Mjøen G, Mucha S, Franke A, Jardine A, Fellström B, Dahle DO, Holdaas H, Melum E (2018)
    Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients
    Am J Transplant, 19 (5), 1444-1451
    DOI 10.1111/ajt.15191, PubMed 30457209
25. Pippias M, Stel VS, Kramer A, Abad Diez JM, Aresté-Fosalba N, Ayav C, Buturovic J, Caskey FJ, Collart F, Couchoud C, De Meester J, Heaf JG, Helanterä I, Hemmelder MH, Kostopoulou M, Noordzij M, Pascual J, Palsson R, Reisaeter AV, Traynor JP, Massy Z, Jager KJ (2018)
    Access to kidney transplantation in European adults aged 75-84 years and related outcomes: an analysis of the European Renal Association-European Dialysis and Transplant Association Registry
    Transpl Int, 31 (5), 540-553
    DOI 10.1111/tri.13125, PubMed 29383764
26. Skaare H, Svensson M, Jenssen T, Åsberg A, Schmidt EB, Chandra A, Ueland T, Mollnes TE, Hartmann A, Eide IA (2018)
    Plasma n-6 Polyunsaturated Fatty Acid Levels and Survival in Renal Transplantation
    J Ren Nutr, 28 (5), 333-339
    DOI 10.1053/j.jrn.2018.02.008, PubMed 29703632
27. Solbu MD, Kolset SO, Jenssen TG, Wilsgaard T, Løchen ML, Mathiesen EB, Melsom T, Eriksen BO, Reine TM (2018)
    Gender differences in the association of syndecan-4 with myocardial infarction: The population-based Tromsø Study
    Atherosclerosis, 278, 166-173
    DOI 10.1016/j.atherosclerosis.2018.08.005, PubMed 30278359
28. Solbu MD, Mjøen G, Mark PB, Holdaas H, Fellström B, Schmieder RE, Zannad F, Herrington WG, Jardine AG (2018)
    Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study
    Nephrol Dial Transplant, 33 (1), 102-112
    DOI 10.1093/ndt/gfw360, PubMed 27798199
29. Stefansson VTN, Schei J, Solbu MD, Jenssen TG, Melsom T, Eriksen BO (2018)
    Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population
    Kidney Int, 93 (5), 1183-1190
    DOI 10.1016/j.kint.2017.11.012, PubMed 29395334
30. Tronstad C, Elvebakk O, Staal OM, Kalvøy H, Høgetveit JO, Jenssen TG, Birkeland KI, Martinsen ØG (2018)
    Non-invasive prediction of blood glucose trends during hypoglycemia
    Anal Chim Acta, 1052, 37-48
    DOI 10.1016/j.aca.2018.12.009, PubMed 30685040
31. Urstad KH, Wahl AK, Engebretsen E, Larsen MH, Vidnes TK, Stenwig AGK, Simensen ØW, Nordli A, Reisaeter AV, Andersen MH (2018)
    Implementation of a new patient education programme for renal transplant recipients
    J Ren Care, 44 (2), 106-114
    DOI 10.1111/jorc.12236, PubMed 29460501
32. Ussif A, Pihlstrøm H, Pasch A, Holdaas H, Hartmann A, Smerud K, Åsberg A (2018)
    Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
    BMC Nephrol, 19 (1), 212
    DOI 10.1186/s12882-018-1000-8, PubMed 30134956
33. von Düring ME, Jenssen T, Bollerslev J, Godang K, Hartmann A, Åsberg A (2018)
    Arterial stiffness is associated with visceral fat mass in kidney transplanted patients-A nationwide cohort study
    Clin Transplant, 32 (8), e13341
    DOI 10.1111/ctr.13341, PubMed 29957825

Publications 2017

1. Bethel MA, Hyland KA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Levitt NS, McMurray JJV, Boutati E, Thomas L, Sun JL, Haffner SM, NAVIGATOR Study Group (2017)
   Updated risk factors should be used to predict development of diabetes
   J Diabetes Complications, 31 (5), 859-863
   DOI 10.1016/j.jdiacomp.2017.02.012, PubMed 28319004
2. Bremer S, Vethe NT, Skauby M, Kasbo M, Johansson ED, Midtvedt K, Bergan S (2017)
   NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation
   Br J Clin Pharmacol, 83 (11), 2494-2502
   DOI 10.1111/bcp.13367, PubMed 28686294
3. Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reisæter AV, Mjøen G, Pihlstrøm HK, Næss H, Holdaas H (2017)
   Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients
   Transplantation, 101 (10), 2599-2605
   DOI 10.1097/TP.0000000000001659, PubMed 28207636
4. de Fijter JW, Holdaas H, Øyen O, Sanders JS, Sundar S, Bemelman FJ, Sommerer C, Pascual J, Avihingsanon Y, Pongskul C, Oppenheimer F, Toselli L, Russ G, Wang Z, Lopez P, Kochuparampil J, Cruzado JM, van der Giet M, ELEVATE Study Group (2017)
   Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial
   Am J Transplant, 17 (7), 1853-1867
   DOI 10.1111/ajt.14186, PubMed 28027625
5. Dupont L, Eide IA, Hartmann A, Christensen JH, Åsberg A, Jenssen T, Krarup H, Svensson M (2017)
   Haptoglobin 2-2 Genotype, Patient, and Graft Survival in Renal Transplant Recipients
   Prog Transplant, 27 (4), 386-391
   DOI 10.1177/1526924817732020, PubMed 29187131
6. Egeland EJ, Robertsen I, Hermann M, Midtvedt K, Størset E, Gustavsen MT, Reisæter AV, Klaasen R, Bergan S, Holdaas H, Hartmann A, Åsberg A (2017)
   High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation
   Transplantation, 101 (8), e273-e279
   DOI 10.1097/TP.0000000000001796, PubMed 28452920
7. Eide IA, Dörje C, Svensson M, Jenssen T, Hammarstrøm C, Scott H, Bjerve KS, Christensen JH, Schmidt EB, Hartmann A, Åsberg A, Reisæter AV, Reinholt FP (2017)
   Development of Kidney Transplant Fibrosis Is Inversely Associated With Plasma Marine Fatty Acid Level
   J Ren Nutr, 28 (2), 118-124
   DOI 10.1053/j.jrn.2017.09.001, PubMed 29146138
8. Eide IA, Halden TAS, Hartmann A, Dahle DO, Åsberg A, Jenssen T (2017)
   Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival
   Transplantation, 101 (6), 1282-1289
   DOI 10.1097/TP.0000000000001259, PubMed 27362306
9. Eriksen BO, Stefansson VT, Jenssen TG, Mathisen UD, Schei J, Solbu MD, Wilsgaard T, Melsom T (2017)
   Blood pressure and age-related GFR decline in the general population
   BMC Nephrol, 18 (1), 77
   DOI 10.1186/s12882-017-0496-7, PubMed 28245797
10. Eriksen BO, Stefansson VTN, Jenssen TG, Mathisen UD, Schei J, Solbu MD, Wilsgaard T, Melsom T (2017)
    High Ambulatory Arterial Stiffness Index Is an Independent Risk Factor for Rapid Age-Related Glomerular Filtration Rate Decline in the General Middle-Aged Population
    Hypertension, 69 (4), 651-659
    DOI 10.1161/HYPERTENSIONAHA.117.09020, PubMed 28223468
11. García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV (2017)
    Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies
    Transplantation, 101 (6), 1410-1415
    DOI 10.1097/TP.0000000000001216, PubMed 27163535
12. Heldal K, Hartmann A, Lønning K, Leivestad T, Reisæter AV, Line PD, Holdaas H, Midtvedt K (2017)
    Should patients older than 65 years be offered a second kidney transplant?
    BMC Nephrol, 18 (1), 13
    DOI 10.1186/s12882-016-0426-0, PubMed 28077080
13. Holdaas H, de Fijter JW, Cruzado JM, Massari P, Nashan B, Kanellis J, Witzke O, Gutierrez-Dalmau A, Turkmen A, Wang Z, Lopez P, Bernhardt P, Kochuparampil J, van der Giet M, Murbraech K, ELEVATE Study Group (2017)
    Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study
    Transplantation, 101 (10), 2612-2620
    DOI 10.1097/TP.0000000000001739, PubMed 28333860
14. Holdaas H, Mjøen G, Jardine AG (2017)
    Belatacept: Where the BENEFITS Outweigh the Risk
    Am J Kidney Dis, 69 (5), 561-563
    DOI 10.1053/j.ajkd.2017.02.007, PubMed 28434523
15. Hole K, Størset E, Olastuen A, Haslemo T, Kro GB, Midtvedt K, Åsberg A, Molden E (2017)
    Recovery of CYP3A Phenotype after Kidney Transplantation
    Drug Metab Dispos, 45 (12), 1260-1265
    DOI 10.1124/dmd.117.078030, PubMed 28928137
16. Jenssen T, Hartmann A, Birkeland KI (2017)
    Long-term diabetes complications after pancreas transplantation
    Curr Opin Organ Transplant, 22 (4), 382-388
    DOI 10.1097/MOT.0000000000000436, PubMed 28598888
17. Koefoed-Nielsen P, Weinreich I, Bengtsson M, Lauronen J, Naper C, Gäbel M, Sørensen SS, Wennberg L, Reisaeter AV, Møller BK, Nordic Kidney group and the Tissue Typing group in Scandiatransplant (2017)
    Scandiatransplant acceptable mismatch program (STAMP) a bridge to transplanting highly immunized patients
    HLA, 90 (1), 17-24
    DOI 10.1111/tan.13046, PubMed 28449350
18. Lindahl JP, Horneland R, Nordheim E, Hartmann A, Aandahl EM, Grzyb K, Haugaa H, Kjøsen G, Åsberg A, Jenssen T (2017)
    Outcomes in Pancreas Transplantation With Exocrine Drainage Through a Duodenoduodenostomy Versus Duodenojejunostomy
    Am J Transplant, 18 (1), 154-162
    DOI 10.1111/ajt.14420, PubMed 28696022
19. Lindahl JP, Massey RJ, Hartmann A, Aakhus S, Endresen K, Günther A, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2017)
    Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation
    Transplantation, 101 (6), 1261-1267
    DOI 10.1097/TP.0000000000001274, PubMed 27467687
20. Majak GB, Reisæter AV, Zucknick M, Lorentzen B, Vangen S, Henriksen T, Michelsen TM (2017)
    Preeclampsia in kidney transplanted women; Outcomes and a simple prognostic risk score system
    PLoS One, 12 (3), e0173420
    DOI 10.1371/journal.pone.0173420, PubMed 28319175
21. Meyer KB, Hartmann A, Mjøen G, Andersen MH (2017)
    Relationships Between Clinical, Self-Reported, and Donation Specific Outcomes: A Prospective Follow-up Study 10 Years After Kidney Donation
    Ann Transplant, 22, 148-155
    DOI 10.12659/aot.902330, PubMed 28321111
22. Midtvedt K, Bergan S, Reisæter AV, Vikse BE, Åsberg A (2017)
    Exposure to Mycophenolate and Fatherhood
    Transplantation, 101 (7), e214-e217
    DOI 10.1097/TP.0000000000001747, PubMed 28346297
23. Midtvedt K, Åsberg A (2017)
    Mycophenolate Acid and Balancing the Risk for Male Allograft Recipients
    Transplantation, 101 (1), e39
    DOI 10.1097/TP.0000000000001509, PubMed 27748704
24. Mjøen G, Holdaas H (2017)
    Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors"
    Kidney Int, 91 (5), 1256
    DOI 10.1016/j.kint.2017.01.034, PubMed 28407879
25. Mjøen G, Holdaas H (2017)
    Long term risk of mortality after living kidney donation
    BMJ, 357, j1770
    DOI 10.1136/bmj.j1770, PubMed 28442509
26. Norby GE, Mjøen G, Bjørneklett R, Vikse BE, Holdaas H, Svarstad E, Aasarød K (2017)
    Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry
    Lupus, 26 (8), 881-885
    DOI 10.1177/0961203316686700, PubMed 28059018
27. Norvik JV, Schirmer H, Ytrehus K, Jenssen TG, Zykova SN, Eggen AE, Eriksen BO, Solbu MD (2017)
    Low adiponectin is associated with diastolic dysfunction in women: a cross-sectional study from the Tromsø Study
    BMC Cardiovasc Disord, 17 (1), 79
    DOI 10.1186/s12872-017-0509-2, PubMed 28292262
28. Norvik JV, Schirmer H, Ytrehus K, Storhaug HM, Jenssen TG, Eriksen BO, Mathiesen EB, Løchen ML, Wilsgaard T, Solbu MD (2017)
    Uric acid predicts mortality and ischaemic stroke in subjects with diastolic dysfunction: the Tromsø Study 1994-2013
    ESC Heart Fail, 4 (2), 154-161
    DOI 10.1002/ehf2.12134, PubMed 28451452
29. Pihlstrøm HK, Gatti F, Hammarström C, Eide IA, Kasprzycka M, Wang J, Haraldsen G, Svensson MHS, Midtvedt K, Mjøen G, Dahle DO, Hartmann A, Holdaas H (2017)
    Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
    Transpl Int, 30 (8), 827-840
    DOI 10.1111/tri.12973, PubMed 28436117
30. Pippias M, Jager KJ, Caskey F, Casula A, Erlandsson H, Finne P, Heaf J, Heinze G, Hoitsma A, Kramar R, Lempinen M, Magaz A, Midtvedt K, Mumford LL, Pascual J, Prütz KG, Sørensen SS, Traynor JP, Massy ZA, Ravanan R, Stel VS (2017)
    Kidney transplant outcomes from older deceased donors: a paired kidney analysis by the European Renal Association-European Dialysis and Transplant Association Registry
    Transpl Int, 31 (7), 708-719
    DOI 10.1111/tri.13103, PubMed 29210108
31. Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU (2017)
    Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection
    PLoS Pathog, 13 (4), e1006299
    DOI 10.1371/journal.ppat.1006299, PubMed 28406982
32. Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU (2017)
    Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection
    PLoS Pathog, 13 (5), e1006386
    DOI 10.1371/journal.ppat.1006386, PubMed 28489893
33. Salvador CL, Hartmann A, Åsberg A, Bergan S, Rowe AD, Mørkrid L (2017)
    Estimating Glomerular Filtration Rate in Kidney Transplant Recipients: Comparing a Novel Equation With Commonly Used Equations in this Population
    Transplant Direct, 3 (12), e332
    DOI 10.1097/TXD.0000000000000742, PubMed 29536033
34. Schei J, Fuskevåg OM, Stefansson VTN, Solbu MD, Jenssen TG, Eriksen BO, Melsom T (2017)
    Urinary Markers of Oxidative Stress Are Associated With Albuminuria But Not GFR Decline
    Kidney Int Rep, 3 (3), 573-582
    DOI 10.1016/j.ekir.2017.11.020, PubMed 29854964
35. Smerud KT, Åsberg A, Kile H, Pasch A, Dahle DO, Bollerslev J, Godang K, Hartmann A (2017)
    A rapid and sustained improvement of calcification propensity score (serum T₅₀ ) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate
    Clin Transplant, 31 (12)
    DOI 10.1111/ctr.13131, PubMed 28972673
36. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
    The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation
    Br J Clin Pharmacol, 83 (7), 1457-1465
    DOI 10.1111/bcp.13248, PubMed 28146606
37. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
    Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'
    Br J Clin Pharmacol, 83 (6), 1357-1358
    DOI 10.1111/bcp.13276, PubMed 28374426
38. Torres IB, Reisaeter AV, Moreso F, Âsberg A, Vidal M, Garcia-Carro C, Midtvedt K, Reinholt FP, Scott H, Castellà E, Salcedo M, Dörje C, Sellarés J, Azancot MA, Perello M, Holdaas H, Serón D (2017)
    Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants
    Transpl Int, 30 (11), 1119-1131
    DOI 10.1111/tri.13002, PubMed 28667664
39. van den Brand JAJG, Pippias M, Stel VS, Caskey FJ, Collart F, Finne P, Heaf J, Jais JP, Kramar R, Massy ZA, De Meester J, Traynor JP, Reisæter AV, Wetzels JFM, Jager KJ (2017)
    Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry
    Nephrol Dial Transplant, 32 (2), 348-355
    DOI 10.1093/ndt/gfw392, PubMed 28031344
40. Vivier PH, Augdal TA, Avni FE, Bacchetta J, Beetz R, Bjerre AK, Blickman J, Cochat P, Coppo R, Damasio B, Darge K, El-Ghoneimi A, Hoebeke P, Läckgren G, Leclair MD, Lobo ML, Manzoni G, Marks SD, Mattioli G, Mentzel HJ, Mouriquand P, Nevéus T, Ntoulia A, Ording-Muller LS, Oswald J et al. (2017)
    Standardization of pediatric uroradiological terms: a multidisciplinary European glossary
    Pediatr Radiol, 48 (2), 291-303
    DOI 10.1007/s00247-017-4006-7, PubMed 29138893
41. Vivier PH, Augdal TA, Avni FE, Bacchetta J, Beetz R, Bjerre AK, Blickman J, Cochat P, Coppo R, Damasio B, Darge K, El-Ghoneimi A, Hoebeke P, Läckgren G, Leclair MD, Lobo ML, Manzoni G, Marks SD, Mattioli G, Mentzel HJ, Mouriquand P, Nevéus T, Ntoulia A, Ording-Muller LS, Oswald J et al. (2017)
    Standardization of pediatric uroradiological terms: A multidisciplinary European glossary
    J Pediatr Urol, 13 (6), 641-650
    DOI 10.1016/j.jpurol.2017.05.026, PubMed 29174378
42. Wagner S, Apetrii M, Massy ZA, Kleber ME, Delgado GE, Scharnagel H, März W, Metzger M, Rossignol P, Jardine A, Holdaas H, Fellström B, Schmieder R, Stengel B, Zannad F, on behalf AURORA study group and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) network (2017)
    Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis
    Free Radic Res, 51 (1), 14-23
    DOI 10.1080/10715762.2016.1241878, PubMed 27667446
43. Åsberg A, Robertsen I, Midtvedt K (2017)
    How to Report and Interpret Bioequivalence Data in Solid Organ Transplant Recipients
    Transplantation, 101 (11), e347
    DOI 10.1097/TP.0000000000001894, PubMed 28787310

Publications 2016

1. Cholesterol Treatment Trialists' (CTT) Collaboration, Herrington WG, Emberson J, Mihaylova B, Blackwell L, Reith C, Solbu MD, Mark PB, Fellström B, Jardine AG, Wanner C, Holdaas H, Fulcher J, Haynes R, Landray MJ, Keech A, Simes J, Collins R, Baigent C (2016)
   Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
   Lancet Diabetes Endocrinol, 4 (10), 829-39
   DOI 10.1016/S2213-8587(16)30156-5, PubMed 27477773
2. Dörje C, Reisaeter AV, Dahle DO, Mjøen G, Midtvedt K, Holdaas H, Flaa-Johnsen L, Syversveen T, Hartmann A, Jenssen T, Scott H, Reinholt FP (2016)
   Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant
   Clin Transplant, 30 (7), 802-9
   DOI 10.1111/ctr.12753, PubMed 27101801
3. Eide IA, Dahle DO, Svensson M, Hartmann A, Åsberg A, Bjerve KS, Christensen JH, Schmidt EB, Lauritsen ME, Lund K, Jenssen T (2016)
   Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipients
   Eur J Clin Nutr, 70 (7), 824-30
   DOI 10.1038/ejcn.2016.14, PubMed 26931669
4. Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisaeter AV, Jenssen T (2016)
   Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria
   Transpl Int, 29 (5), 568-78
   DOI 10.1111/tri.12757, PubMed 26875590
5. Eide IA, Åsberg A, Svensson M, Ueland T, Mollnes TE, Hartmann A, Bjerve KS, Michelsen A, Aukrust P, Christensen JH, Schmidt EB, Jenssen T (2016)
   Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant Recipients
   J Ren Nutr, 27 (3), 161-168
   DOI 10.1053/j.jrn.2016.09.008, PubMed 27838193
6. Eriksen BO, Stefansson VTN, Jenssen TG, Mathisen UD, Schei J, Solbu MD, Wilsgaard T, Melsom T (2016)
   Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population
   Kidney Int, 90 (2), 404-410
   DOI 10.1016/j.kint.2016.03.021, PubMed 27188503
7. Gagnum V, Stene LC, Jenssen TG, Berteussen LM, Sandvik L, Joner G, Njølstad PR, Skrivarhaug T (2016)
   Causes of death in childhood-onset Type 1 diabetes: long-term follow-up
   Diabet Med, 34 (1), 56-63
   DOI 10.1111/dme.13114, PubMed 26996105
8. Halden TA, Egeland EJ, Åsberg A, Hartmann A, Midtvedt K, Khiabani HZ, Holst JJ, Knop FK, Hornum M, Feldt-Rasmussen B, Jenssen T (2016)
   GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes
   Diabetes Care, 39 (4), 617-24
   DOI 10.2337/dc15-2383, PubMed 26908914
9. Holdaas H, De Simone P, Zuckermann A (2016)
   Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
   J Transplant, 2016, 4369574
   DOI 10.1155/2016/4369574, PubMed 27807479
10. Jørgensen HS, Eide IA, Hartmann A, Åsberg A, Christensen JH, Schmidt EB, Godang K, Bollerslev J, Svensson M (2016)
    Plasma n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Renal Transplant Recipients
    J Ren Nutr, 26 (3), 196-203
    DOI 10.1053/j.jrn.2015.11.007, PubMed 26776249
11. Kolseth IB, Reine TM, Parker K, Sudworth A, Witczak BJ, Jenssen TG, Kolset SO (2016)
    Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy
    J Diabetes Complications, 31 (1), 245-252
    DOI 10.1016/j.jdiacomp.2016.06.029, PubMed 27452162
12. Lønning K, Midtvedt K, Leivestad T, Reisæter AV, Line PD, Hartmann A, Heldal K (2016)
    Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
    Transplantation, 100 (12), 2705-2709
    DOI 10.1097/TP.0000000000001363, PubMed 27861296
13. Majak GB, Sandven I, Lorentzen B, Vangen S, Reisaeter AV, Henriksen T, Michelsen TM (2016)
    Pregnancy outcomes following maternal kidney transplantation: a national cohort study
    Acta Obstet Gynecol Scand, 95 (10), 1153-61
    DOI 10.1111/aogs.12937, PubMed 27288648
14. Melsom T, Stefansson V, Schei J, Solbu M, Jenssen T, Wilsgaard T, Eriksen BO (2016)
    Association of Increasing GFR with Change in Albuminuria in the General Population
    Clin J Am Soc Nephrol, 11 (12), 2186-2194
    DOI 10.2215/CJN.04940516, PubMed 27683625
15. Meyer K, Wahl AK, Bjørk IT, Wisløff T, Hartmann A, Andersen MH (2016)
    Long-term, self-reported health outcomes in kidney donors
    BMC Nephrol, 17, 8
    DOI 10.1186/s12882-016-0221-y, PubMed 26754798
16. Miroslawska AK, Gjessing PF, Solbu MD, Fuskevåg OM, Jenssen TG, Steigen TK (2016)
    Renal Denervation for Resistant Hypertension Fails to Improve Insulin Resistance as Assessed by Hyperinsulinemic-Euglycemic Step Clamp
    Diabetes, 65 (8), 2164-8
    DOI 10.2337/db16-0205, PubMed 27246911
17. Mjoen G, Reisaeter AV, Dahle DO (2016)
    HLA Mismatch and Allograft Survival
    Transplantation, 100 (9), e52
    DOI 10.1097/TP.0000000000001366, PubMed 27399204
18. Mjøen G, Holdaas H (2016)
    Regarding long-term outcome after kidney donation
    Transpl Int, 29 (3), 381
    DOI 10.1111/tri.12717, PubMed 26563683
19. Mjøen G, Holdaas H (2016)
    Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate
    N Engl J Med, 374 (21), 2094
    DOI 10.1056/NEJMc1603007, PubMed 27223156
20. Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2016)
    Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
    Nephrol Dial Transplant, 31 (1), 170
    DOI 10.1093/ndt/gfv397, PubMed 26740671
21. Nordheim E, Dahle DO, Syse IM, Åsberg A, Reisæter AV, Hartmann A (2016)
    Resolution of Calciphylaxis After Urgent Kidney Transplantation in 3 Patients With End-Stage Kidney Failure
    Transplant Direct, 2 (11), e113
    DOI 10.1097/TXD.0000000000000627, PubMed 27826606
22. Norvik JV, Storhaug HM, Ytrehus K, Jenssen TG, Zykova SN, Eriksen BO, Solbu MD (2016)
    Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study
    BMC Cardiovasc Disord, 16, 85
    DOI 10.1186/s12872-016-0265-8, PubMed 27165776
23. Pihlstrøm HK, Mjøen G, Mucha S, Haraldsen G, Franke A, Jardine A, Fellström B, Holdaas H, Melum E (2016)
    Single Nucleotide Polymorphisms and Long-Term Clinical Outcome in Renal Transplant Patients: A Validation Study
    Am J Transplant, 17 (2), 528-533
    DOI 10.1111/ajt.13995, PubMed 27483393
24. Pippias M, Stel VS, Aresté-Fosalba N, Couchoud C, Fernandez-Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Pálsson R, Ravani P, Segelmark M, Traynor JP, Reisæter AV, Caskey FJ, Jager KJ (2016)
    Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry
    Transplantation, 100 (9), 1955-62
    DOI 10.1097/TP.0000000000000962, PubMed 26588008
25. Reine TM, Jenssen TG, Kolset SO (2016)
    Glucosamine exposure reduces proteoglycan synthesis in primary human endothelial cells in vitro
    Food Nutr Res, 60, 32615
    DOI 10.3402/fnr.v60.32615, PubMed 27667774
26. Schive SW, Foss A, Sahraoui A, Kloster-Jensen K, Hafsahl G, Kvalheim G, Lundgren T, von Zur-Mühlen B, Felldin M, Rafael E, Lempinen M, Korsgren O, Jenssen TG, Mishra V, Scholz H (2016)
    Cost and clinical outcome of islet transplantation in Norway 2010-2015
    Clin Transplant, 31 (1)
    DOI 10.1111/ctr.12871, PubMed 27862341
27. Skrunes R, Svarstad E, Reisæter AV, Marti HP, Vikse BE (2016)
    End Stage Renal Disease Predicts Increased Risk of Death in First Degree Relatives in the Norwegian Population
    PLoS One, 11 (11), e0165026
    DOI 10.1371/journal.pone.0165026, PubMed 27828975
28. Smedbråten J, Mjøen G, Hartmann A, Åsberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
    Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
    BMC Nephrol, 17 (1), 148
    DOI 10.1186/s12882-016-0373-9, PubMed 27760523
29. Smedbråten J, Sagedal S, Åsberg A, Hartmann A, Rollag H, Mjøen G, Fagerland MW, Hansen SW, Mollnes TE, Thiel S (2016)
    Collectin Liver 1 and Collectin Kidney 1 of the Lectin Complement Pathway Are Associated With Mortality After Kidney Transplantation
    Am J Transplant, 17 (1), 265-271
    DOI 10.1111/ajt.13933, PubMed 27341702
30. Solbu MD, Norvik JV, Storhaug HM, Eriksen BO, Melsom T, Eggen AE, Zykova SN, Kronborg JB, Jenssen TG (2016)
    The Association Between Adiponectin, Serum Uric Acid and Urinary Markers of Renal Damage in the General Population: Cross-Sectional Data from the Tromsø Study
    Kidney Blood Press Res, 41 (5), 623-634
    DOI 10.1159/000447931, PubMed 27622764
31. Stefansson VT, Schei J, Jenssen TG, Melsom T, Eriksen BO (2016)
    Central obesity associates with renal hyperfiltration in the non-diabetic general population: a cross-sectional study
    BMC Nephrol, 17 (1), 172
    DOI 10.1186/s12882-016-0386-4, PubMed 27832768
32. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2016)
    Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance
    Br J Clin Pharmacol, 83 (6), 1350-1352
    DOI 10.1111/bcp.13188, PubMed 28008657
33. Størset E, von Düring ME, Godang K, Bergan S, Midtvedt K, Åsberg A (2016)
    Prediction of Fat-Free Mass in Kidney Transplant Recipients
    Ther Drug Monit, 38 (4), 439-46
    DOI 10.1097/FTD.0000000000000305, PubMed 27019101
34. Størset E, Åsberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K (2016)
    Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience
    Nephrology (Carlton), 21 (10), 821-7
    DOI 10.1111/nep.12738, PubMed 26854648
35. von Düring ME, Jenssen T, Bollerslev J, Åsberg A, Godang K, Hartmann A (2016)
    Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1 year after kidney transplantation
    Clin Transplant, 31 (1)
    DOI 10.1111/ctr.12869, PubMed 27859633

Publications 2015

1. Breckenridge K, Bekker HL, Gibbons E, van der Veer SN, Abbott D, Briançon S, Cullen R, Garneata L, Jager KJ, Lønning K, Metcalfe W, Morton RL, Murtagh FE, Prutz K, Robertson S, Rychlik I, Schon S, Sharp L, Speyer E, Tentori F, Caskey FJ (2015)
   How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting
   Nephrol Dial Transplant, 30 (10), 1605-14
   DOI 10.1093/ndt/gfv209, PubMed 25982327
2. Dahle DO, Eide IA, Åsberg A, Leivestad T, Holdaas H, Jenssen TG, Fagerland MW, Pihlstrøm H, Mjøen G, Hartmann A (2015)
   Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
   Transplantation, 99 (8), 1730-7
   DOI 10.1097/TP.0000000000000660, PubMed 25757216
3. Dahle DO, Åsberg A, Hartmann A, Holdaas H, Bachtler M, Jenssen TG, Dionisi M, Pasch A (2015)
   Serum Calcification Propensity Is a Strong and Independent Determinant of Cardiac and All-Cause Mortality in Kidney Transplant Recipients
   Am J Transplant, 16 (1), 204-12
   DOI 10.1111/ajt.13443, PubMed 26375609
4. Drechsler C, Pihlstrøm H, Meinitzer A, Pilz S, Tomaschitz A, Abedini S, Fellstrom B, Jardine AG, Wanner C, März W, Holdaas H (2015)
   Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study
   Transplantation, 99 (7), 1470-6
   DOI 10.1097/TP.0000000000000568, PubMed 25675199
5. Dörje C, Mjøen G, Strøm EH, Holdaas H, Jenssen T, Øyen O, Akkök ÇA, Cvancarova M, Midtvedt K, Reisaeter AV (2015)
   One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
   Clin Transplant, 29 (3), 268-76
   DOI 10.1111/ctr.12515, PubMed 25644963
6. Egli A, Lisboa LF, O'Shea D, Asberg A, Mueller T, Emery V, Kumar D, Humar A (2015)
   Complexity of Host Micro-RNA Response to Cytomegalovirus Reactivation After Organ Transplantation
   Am J Transplant, 16 (2), 650-60
   DOI 10.1111/ajt.13464, PubMed 26460801
7. Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisæter AV, Jenssen T (2015)
   Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus
   Transplantation, 99 (3), 629-35
   DOI 10.1097/TP.0000000000000376, PubMed 25162478
8. Eide IA, Halden TA, Jenssen T (2015)
   The Authors' Reply: HbA1c Is Insensitive at Month 3 After Kidney Transplantation
   Transplantation, 99 (5), e38
   DOI 10.1097/TP.0000000000000684, PubMed 25943237
9. Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M (2015)
   The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation
   Clin J Am Soc Nephrol, 10 (7), 1246-56
   DOI 10.2215/CJN.11931214, PubMed 26063768
10. Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M (2015)
    Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survival
    Nephrol Dial Transplant, 31 (1), 160-7
    DOI 10.1093/ndt/gfv339, PubMed 26410884
11. Eriksen BO, Løchen ML, Arntzen KA, Bertelsen G, Winther Eilertsen BA, von Hanno T, Herder M, Jenssen TG, Mathisen UD, Melsom T, Njølstad I, Solbu MD, Mathiesen EB (2015)
    Estimated and Measured GFR Associate Differently with Retinal Vasculopathy in the General Population
    Nephron, 131 (3), 175-84
    DOI 10.1159/000441092, PubMed 26426198
12. Jenssen T, Hartmann A (2015)
    Emerging treatments for post-transplantation diabetes mellitus
    Nat Rev Nephrol, 11 (8), 465-77
    DOI 10.1038/nrneph.2015.59, PubMed 25917553
13. Kolseth IB, Reine TM, Vuong TT, Meen AJ, Fan Q, Jenssen TG, Grønning-Wang LM, Kolset SO (2015)
    Serglycin is part of the secretory repertoire of LPS-activated monocytes
    Immun Inflamm Dis, 3 (1), 23-31
    DOI 10.1002/iid3.47, PubMed 25866637
14. Lindahl JP, Hartmann A, Aakhus S, Endresen K, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2015)
    Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation
    Diabetologia, 59 (4), 844-52
    DOI 10.1007/s00125-015-3853-8, PubMed 26713324
15. Lisboa LF, Egli A, O'Shea D, Åsberg A, Hartmann A, Rollag H, Pang XL, Tyrrell DL, Kumar D, Humar A (2015)
    Hcmv-miR-UL22A-5p: A Biomarker in Transplantation With Broad Impact on Host Gene Expression and Potential Immunological Implications
    Am J Transplant, 15 (7), 1893-902
    DOI 10.1111/ajt.13222, PubMed 25833298
16. Meen AJ, Drevon CA, Pejler G, Jenssen TG, Olstad OK, Åbrink M, Kolset SO (2015)
    Serglycin protects against high fat diet-induced increase in serum LDL in mice
    Glycoconj J, 32 (9), 703-14
    DOI 10.1007/s10719-015-9621-7, PubMed 26391682
17. Melsom T, Fuskevåg OM, Mathisen UD, Strand H, Schei J, Jenssen T, Solbu M, Eriksen BO (2015)
    Estimated GFR is biased by non-traditional cardiovascular risk factors
    Am J Nephrol, 41 (1), 7-15
    DOI 10.1159/000371557, PubMed 25612475
18. Melsom T, Schei J, Stefansson VT, Solbu MD, Jenssen TG, Mathisen UD, Wilsgaard T, Eriksen BO (2015)
    Prediabetes and Risk of Glomerular Hyperfiltration and Albuminuria in the General Nondiabetic Population: A Prospective Cohort Study
    Am J Kidney Dis, 67 (6), 841-50
    DOI 10.1053/j.ajkd.2015.10.025, PubMed 26744126
19. Mjøen G, Holdaas H (2015)
    The authors reply:
    Kidney Int, 87 (3), 660
    DOI 10.1038/ki.2014.400, PubMed 25723634
20. Murbraech K, Massey R, Undset LH, Midtvedt K, Holdaas H, Aakhus S (2015)
    Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial
    Clin Transplant, 29 (8), 678-84
    DOI 10.1111/ctr.12565, PubMed 25982053
21. Norum J, Leivestad T, Eriksen BO, Skår S, Fagerheim A, Reisæter AV (2015)
    Regional differences in renal replacement therapy in northern Norway 2000-2012
    Int J Circumpolar Health, 74, 24298
    DOI 10.3402/ijch.v74.24298, PubMed 25672881
22. Pihlstrøm H, Dahle DO, Mjøen G, Pilz S, März W, Abedini S, Holme I, Fellström B, Jardine AG, Holdaas H (2015)
    Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism
    Transplantation, 99 (2), 351-9
    DOI 10.1097/TP.0000000000000583, PubMed 25594550
23. Reine TM, Vuong TT, Rutkovskiy A, Meen AJ, Vaage J, Jenssen TG, Kolset SO (2015)
    Serglycin in Quiescent and Proliferating Primary Endothelial Cells
    PLoS One, 10 (12), e0145584
    DOI 10.1371/journal.pone.0145584, PubMed 26694746
24. Robertsen I, Vethe NT, Midtvedt K, Falck P, Christensen H, Åsberg A (2015)
    Closer to the Site of Action: Everolimus Concentrations in Peripheral Blood Mononuclear Cells Correlate Well With Whole Blood Concentrations
    Ther Drug Monit, 37 (5), 675-80
    DOI 10.1097/FTD.0000000000000185, PubMed 25565673
25. Robertsen I, Åsberg A, Ingerø AO, Vethe NT, Bremer S, Bergan S, Midtvedt K (2015)
    Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed
    Transplantation, 99 (3), 528-32
    DOI 10.1097/TP.0000000000000384, PubMed 25148382
26. Schive SW, Scholz H, Sahraoui A, Kloster-Jensen K, Hafsahl G, Korsgren O, Foss A, Jenssen TG (2015)
    Graft function 1 year after pregnancy in an islet-transplanted patient
    Transpl Int, 28 (10), 1235-9
    DOI 10.1111/tri.12596, PubMed 25903157
27. Smedbråten YV, Sagedal S, Mjøen G, Hartmann A, Fagerland MW, Rollag H, Mollnes TE, Thiel S (2015)
    High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients
    Transplantation, 99 (4), 791-6
    DOI 10.1097/TP.0000000000000422, PubMed 25222012
28. Solbu MD, Toft I, Løchen ML, Mathiesen EB, Eriksen BO, Melsom T, Njølstad I, Wilsgaard T, Jenssen TG (2015)
    N-Acetyl-β-D-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population
    J Am Soc Nephrol, 27 (2), 533-42
    DOI 10.1681/ASN.2014100960, PubMed 26047791
29. Sriskandarajah S, Aasarød K, Skrede S, Knoop T, Reisæter AV, Bjørneklett R (2015)
    Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies
    Nephrol Dial Transplant, 30 Suppl 1 (Suppl 1), i67-75
    DOI 10.1093/ndt/gfv008, PubMed 25694535
30. Storhaug HM, Toft I, Norvik JV, Jenssen T, Eriksen BO, Melsom T, Løchen ML, Solbu MD (2015)
    Uric acid is associated with microalbuminuria and decreased glomerular filtration rate in the general population during 7 and 13 years of follow-up: The Tromsø Study
    BMC Nephrol, 16, 210
    DOI 10.1186/s12882-015-0207-1, PubMed 26651613
31. Størset E, Åsberg A, Skauby M, Neely M, Bergan S, Bremer S, Midtvedt K (2015)
    Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study
    Transplantation, 99 (10), 2158-66
    DOI 10.1097/TP.0000000000000708, PubMed 25886918
32. Ueland T, Rollag H, Hartmann A, Jardine A, Humar A, Bignamini AA, Åsberg A, Aukrust P (2015)
    Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients
    Transplantation, 99 (1), 100-5
    DOI 10.1097/TP.0000000000000227, PubMed 24983306
33. von Düring ME, Jenssen T, Bollerslev J, Åsberg A, Godang K, Eide IA, Dahle DO, Hartmann A (2015)
    Visceral fat is better related to impaired glucose metabolism than body mass index after kidney transplantation
    Transpl Int, 28 (10), 1162-71
    DOI 10.1111/tri.12606, PubMed 25970153
34. Vuong TT, Reine TM, Sudworth A, Jenssen TG, Kolset SO (2015)
    Syndecan-4 is a major syndecan in primary human endothelial cells in vitro, modulated by inflammatory stimuli and involved in wound healing
    J Histochem Cytochem, 63 (4), 280-92
    DOI 10.1369/0022155415568995, PubMed 25575567
35. Waldum-Grevbo B, Leivestad T, Reisæter AV, Os I (2015)
    Impact of initial dialysis modality on mortality: a propensity-matched study
    BMC Nephrol, 16, 179
    DOI 10.1186/s12882-015-0175-5, PubMed 26519164
36. Zykova SN, Storhaug HM, Toft I, Chadban SJ, Jenssen TG, White SL (2015)
    Cross-sectional analysis of nutrition and serum uric acid in two Caucasian cohorts: the AusDiab Study and the Tromsø study
    Nutr J, 14, 49
    DOI 10.1186/s12937-015-0032-1, PubMed 25971955

Publications 2014

1. Apeland T, Holdaas H, Mansoor MA (2014)
   Kidney donors and kidney transplants have abnormal aminothiol redox status, and are at increased risk of oxidative stress and reduced redox buffer capacity
   Clin Biochem, 47 (6), 378-82
   DOI 10.1016/j.clinbiochem.2014.02.003, PubMed 24530370
2. Aulie HA, Selvaag AM, Günther A, Lilleby V, Molberg Ø, Hartmann A, Holdaas H, Flatø B (2014)
   Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis
   Ann Rheum Dis, 74 (8), 1515-21
   DOI 10.1136/annrheumdis-2013-204804, PubMed 24695010
3. Bleskestad IH, Bergrem H, Leivestad T, Hartmann A, Gøransson LG (2014)
   Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function
   Clin Transplant, 28 (4), 479-86
   DOI 10.1111/ctr.12341, PubMed 25649861
4. Chen Z, Bouamar R, Van Schaik RH, De Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DR, Weimar W, Hesselink DA, Van Gelder T (2014)
   Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patients
   Clin Transplant, 28 (6), 649-55
   DOI 10.1111/ctr.12346, PubMed 24579958
5. Dahle DO, Jenssen T, Holdaas H, Asberg A, Soveri I, Holme I, Mjøen G, Eide IA, Pihlstrøm H, Dörje C, Halden TA, Hartmann A (2014)
   Uric acid and clinical correlates of endothelial function in kidney transplant recipients
   Clin Transplant, 28 (10), 1167-76
   DOI 10.1111/ctr.12435, PubMed 25124959
6. Dörje C, Midtvedt K, Reisæter AV (2014)
   Analysis of predictive and preventive factors for de novo donor-specific antibodies in kidney transplant recipientsy--is nonadherence of importance?
   Transplantation, 98 (4), e31
   DOI 10.1097/TP.0000000000000330, PubMed 25243517
7. Hirsch HH, Babel N, Comoli P, Friman V, Ginevri F, Jardine A, Lautenschlager I, Legendre C, Midtvedt K, Muñoz P, Randhawa P, Rinaldo CH, Wieszek A, ESCMID Study Group of Infection in Compromised Hosts (2014)
   European perspective on human polyomavirus infection, replication and disease in solid organ transplantation
   Clin Microbiol Infect, 20 Suppl 7, 74-88
   DOI 10.1111/1469-0691.12538, PubMed 24476010
8. Holdaas H, Jardine AG (2014)
   BP targets in renal transplant recipients: too high or too low?
   J Am Soc Nephrol, 25 (7), 1371-3
   DOI 10.1681/ASN.2014020177, PubMed 24627350
9. Holdaas H, Mjoen G (2014)
   Long-term risks of kidney donation: age known
   Am J Transplant, 14 (11), 2671-2
   DOI 10.1111/ajt.12971, PubMed 25293790
10. Holdaas H, Potena L, Saliba F (2014)
    mTOR inhibitors and dyslipidemia in transplant recipients: a cause for concern?
    Transplant Rev (Orlando), 29 (2), 93-102
    DOI 10.1016/j.trre.2014.08.003, PubMed 25227328
11. Horneland R, Paulsen V, Lindahl JP, Grzyb K, Eide TJ, Lundin K, Aabakken L, Jenssen T, Aandahl EM, Foss A, Øyen O (2014)
    Pancreas transplantation with enteroanastomosis to native duodenum poses technical challenges--but offers improved endoscopic access for scheduled biopsies and therapeutic interventions
    Am J Transplant, 15 (1), 242-50
    DOI 10.1111/ajt.12953, PubMed 25394773
12. Lindahl JP, Jenssen T, Hartmann A (2014)
    Long-term outcomes after organ transplantation in diabetic end-stage renal disease
    Diabetes Res Clin Pract, 105 (1), 14-21
    DOI 10.1016/j.diabres.2014.03.004, PubMed 24698407
13. Lindahl JP, Reinholt FP, Eide IA, Hartmann A, Midtvedt K, Holdaas H, Dorg LT, Reine TM, Kolset SO, Horneland R, Øyen O, Brabrand K, Jenssen T (2014)
    In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone
    Diabetologia, 57 (11), 2357-65
    DOI 10.1007/s00125-014-3353-2, PubMed 25145544
14. Lunde I, Bremer S, Midtvedt K, Mohebi B, Dahl M, Bergan S, Åsberg A, Christensen H (2014)
    The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
    Eur J Clin Pharmacol, 70 (6), 685-93
    DOI 10.1007/s00228-014-1656-3, PubMed 24658827
15. Midtvedt K, Heldal K (2014)
    Chronic kidney disease and the aging population
    Transplantation, 97 (11), e64
    DOI 10.1097/TP.0000000000000172, PubMed 24887750
16. Mjøen G (2014)
    The author replies
    Kidney Int, 85 (6), 1469
    DOI 10.1038/ki.2014.91, PubMed 24875550
17. Mjøen G, Hallan S, Dekker FW, Holdaas H (2014)
    The authors reply
    Kidney Int, 86 (3), 650
    DOI 10.1038/ki.2014.148, PubMed 25168504
18. Mjøen G, Hallan S, Holdaas H (2014)
    The authors reply:
    Kidney Int, 85 (5), 1241-2
    DOI 10.1038/ki.2014.37, PubMed 24786884
19. Mjøen G, Holdaas H (2014)
    The authors reply
    Kidney Int, 86 (2), 447
    DOI 10.1038/ki.2014.149, PubMed 25079028
20. Mjøen G, Holdaas H (2014)
    Selecting appropriate controls for kidney donors
    Am J Transplant, 15 (1), 286
    DOI 10.1111/ajt.13016, PubMed 25363214
21. Mjörnstedt L, Schwartz Sørensen S, von Zur Mühlen B, Jespersen B, Hansen JM, Bistrup C, Andersson H, Gustafsson B, Solbu D, Holdaas H (2014)
    Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation
    Transpl Int, 28 (1), 42-51
    DOI 10.1111/tri.12437, PubMed 25176389
22. Murbraech K, Holdaas H, Massey R, Undset LH, Aakhus S (2014)
    Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients: an echocardiographic substudy of the randomized controlled CENTRAL trial
    Transplantation, 97 (2), 184-8
    DOI 10.1097/TP.0b013e3182a92728, PubMed 24092385
23. Pihlstrøm H, Mjøen G, Dahle DO, Pilz S, Midtvedt K, März W, Abedini S, Holme I, Fellström B, Jardine A, Holdaas H (2014)
    Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients
    Transplantation, 98 (11), 1219-25
    DOI 10.1097/TP.0000000000000205, PubMed 24999963
24. Reine TM, Kolseth IB, Meen AJ, Lindahl JP, Jenssen TG, Reinholt FP, Zaia J, Shao C, Hartmann A, Kolset SO (2014)
    Effects of restoring normoglycemia in type 1 diabetes on inflammatory profile and renal extracellular matrix structure after simultaneous pancreas and kidney transplantation
    Diabetes Res Clin Pract, 107 (1), 46-53
    DOI 10.1016/j.diabres.2014.10.006, PubMed 25467621
25. Reine TM, Vuong TT, Jenssen TG, Kolset SO (2014)
    Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro
    Biochim Biophys Acta, 1840 (8), 2498-505
    DOI 10.1016/j.bbagen.2014.02.002, PubMed 24513305
26. Robertsen I, Asberg A, Granseth T, Vethe NT, Akhlaghi F, Ghareeb M, Molden E, Reier-Nilsen M, Holdaas H, Midtvedt K (2014)
    More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients
    Transplantation, 97 (12), 1266-71
    DOI 10.1097/01.TP.0000443225.66960.7e, PubMed 24521776
27. Sharif A, Hecking M, de Vries AP, Porrini E, Hornum M, Rasoul-Rockenschaub S, Berlakovich G, Krebs M, Kautzky-Willer A, Schernthaner G, Marchetti P, Pacini G, Ojo A, Takahara S, Larsen JL, Budde K, Eller K, Pascual J, Jardine A, Bakker SJ, Valderhaug TG, Jenssen TG, Cohney S, Säemann MD (2014)
    Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions
    Am J Transplant, 14 (9), 1992-2000
    DOI 10.1111/ajt.12850, PubMed 25307034
28. Skrunes R, Svarstad E, Reisæter AV, Vikse BE (2014)
    Familial clustering of ESRD in the Norwegian population
    Clin J Am Soc Nephrol, 9 (10), 1692-700
    DOI 10.2215/CJN.01680214, PubMed 25092600
29. Strøm Halden TA, Åsberg A, Vik K, Hartmann A, Jenssen T (2014)
    Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation
    Nephrol Dial Transplant, 29 (4), 926-33
    DOI 10.1093/ndt/gft536, PubMed 24452849
30. Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, Åsberg A, Midtvedt K, Staatz CE (2014)
    Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
    Br J Clin Pharmacol, 78 (3), 509-23
    DOI 10.1111/bcp.12361, PubMed 25279405
31. van der Giet M, Cruzado JM, de Fijter JW, Holdaas H, Wang ZL, Speziale A, Junge G (2014)
    ELEVATE: an innovative study design to assess the efficacy, safety, and evolution of cardiovascular parameters in de novo kidney transplant recipients after early conversion from a calcineurin inhibitor to everolimus
    Open Access J. Clin. Trials, 6, 17-27
    DOI 10.2147/OAJCT.S59549
32. von der Lippe N, Waldum B, Brekke FB, Amro AA, Reisæter AV, Os I (2014)
    From dialysis to transplantation: a 5-year longitudinal study on self-reported quality of life
    BMC Nephrol, 15, 191
    DOI 10.1186/1471-2369-15-191, PubMed 25465066
33. von der Lippe N, Waldum B, Østhus TB, Reisæter AV, Os I (2014)
    Health related quality of life in patients in dialysis after renal graft loss and effect of gender
    BMC Womens Health, 14 (1), 34
    DOI 10.1186/1472-6874-14-34, PubMed 24580724

Publications 2013

1. Berdal M, Jenssen T (2013)
   No Association between Glycemia and Wound Healing in an Experimental db/db Mouse Model
   ISRN Endocrinol, 2013, 307925
   DOI 10.1155/2013/307925, PubMed 24251043
2. Bethel MA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Kahn SE, Levitt NS, McMurray JJ, Califf RM, Raptis SA, Thomas L, Sun JL, Haffner SM (2013)
   A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk
   Am J Cardiol, 112 (2), 231-7
   DOI 10.1016/j.amjcard.2013.03.019, PubMed 23608615
3. Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vårdal M, Mjøen G, Reisaeter AV, Toft I, Hartmann A (2013)
   Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients
   Clin Transplant, 28 (1), 134-40
   DOI 10.1111/ctr.12290, PubMed 24372653
4. Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjøen G, Leivestad T, Asberg A (2013)
   Endothelial dysfunction is associated with graft loss in renal transplant recipients
   Transplantation, 95 (5), 733-9
   DOI 10.1097/TP.0b013e31827d6312, PubMed 23364481
5. Dörje C, Midtvedt K, Holdaas H, Naper C, Strøm EH, Øyen O, Leivestad T, Aronsen T, Jenssen T, Flaa-Johnsen L, Lindahl JP, Hartmann A, Reisæter AV (2013)
   Early versus late acute antibody-mediated rejection in renal transplant recipients
   Transplantation, 96 (1), 79-84
   DOI 10.1097/TP.0b013e31829434d4, PubMed 23632391
6. Flechner SM, Gurkan A, Hartmann A, Legendre CM, Russ GR, Campistol JM, Schena FP, Hahn CM, Li H, Korth-Bradley JM, Tai SS, Schulman SL (2013)
   A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipients
   Transplantation, 95 (10), 1233-41
   DOI 10.1097/TP.0b013e318291a269, PubMed 23689085
7. Heldal K, Midtvedt K (2013)
   Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens
   Drugs Aging, 30 (7), 459-66
   DOI 10.1007/s40266-013-0082-z, PubMed 23609876
8. Heldal K, Thorarinsdottir S, Hartmann A, Leivestad T, Reisæter AV, Foss AE, Midtvedt K (2013)
   Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
   Transplant Res, 2 (1), 11
   DOI 10.1186/2047-1440-2-11, PubMed 23799993
9. Hornum M, Lindahl JP, von Zur-Mühlen B, Jenssen T, Feldt-Rasmussen B (2013)
   Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies
   Transpl Int, 26 (11), 1049-60
   DOI 10.1111/tri.12112, PubMed 23634804
10. Jenssen T (2013)
    [The body's own signaling system--now as treatment]
    Tidsskr Nor Laegeforen, 133 (23-24), 2447
    DOI 10.4045/tidsskr.13.1434, PubMed 24326489
11. Knoop T, Vikse BE, Svarstad E, Leh S, Reisæter AV, Bjørneklett R (2013)
    Mortality in patients with IgA nephropathy
    Am J Kidney Dis, 62 (5), 883-90
    DOI 10.1053/j.ajkd.2013.04.019, PubMed 23796906
12. Lindahl JP, Hartmann A, Horneland R, Holdaas H, Reisæter AV, Midtvedt K, Leivestad T, Oyen O, Jenssen T (2013)
    Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease
    Diabetologia, 56 (6), 1364-71
    DOI 10.1007/s00125-013-2888-y, PubMed 23549518
13. Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H (2013)
    Long-term risks for kidney donors
    Kidney Int, 86 (1), 162-7
    DOI 10.1038/ki.2013.460, PubMed 24284516
14. Pihlstrøm H, Mjøen G, März W, Olav Dahle D, Abedini S, Holme I, Fellström B, Jardine A, Pilz S, Holdaaas H (2013)
    Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients
    Clin Transplant, 28 (1), 111-9
    DOI 10.1111/ctr.12285, PubMed 24372612
15. Reine TM, Grøndahl F, Jenssen TG, Hadler-Olsen E, Prydz K, Kolset SO (2013)
    Reduced sulfation of chondroitin sulfate but not heparan sulfate in kidneys of diabetic db/db mice
    J Histochem Cytochem, 61 (8), 606-16
    DOI 10.1369/0022155413494392, PubMed 23757342
16. Reine TM, Kusche-Gullberg M, Feta A, Jenssen T, Kolset SO (2013)
    Heparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells (vol 29, pg 67, 2012)
    Glycoconjugate J., 30 (7), 733
    DOI 10.1007/s10719-013-9470-1
17. Schjelderup P, Dahle DO, Holdaas H, Mjøen G, Nordby G, Abedini S, Jardine A, Fellström B, Svensson M (2013)
    Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study
    Clin Transplant, 27 (6), E636-43
    DOI 10.1111/ctr.12220, PubMed 23991916
18. Schneider A, Jardine AG, Schneider MP, Holdaas H, Holme I, Fellstroem BC, Zannad F, Schmieder RE, AURORA Study Group (2013)
    Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study
    Am J Nephrol, 37 (2), 144-51
    DOI 10.1159/000346710, PubMed 23392089
19. Smedbråten YV, Sagedal S, Leivestad T, Mjøen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2013)
    The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
    Clin Transplant, 28 (1), 120-6
    DOI 10.1111/ctr.12288, PubMed 24351078
20. Soveri I, Snyder J, Holdaas H, Holme I, Jardine AG, L'Italien GJ, Fellström B (2013)
    The external validation of the cardiovascular risk equation for renal transplant recipients: applications to BENEFIT and BENEFIT-EXT trials
    Transplantation, 95 (1), 142-7
    DOI 10.1097/TP.0b013e31827722c9, PubMed 23192156
21. Storhaug HM, Norvik JV, Toft I, Eriksen BO, Løchen ML, Zykova S, Solbu M, White S, Chadban S, Jenssen T (2013)
    Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study
    BMC Cardiovasc Disord, 13, 115
    DOI 10.1186/1471-2261-13-115, PubMed 24330812
22. Størset E, Holford N, Midtvedt K, Bremer S, Bergan S, Åsberg A (2013)
    Importance of hematocrit for a tacrolimus target concentration strategy
    Eur J Clin Pharmacol, 70 (1), 65-77
    DOI 10.1007/s00228-013-1584-7, PubMed 24071959
23. Åsberg A, Apeland T, Reisaeter AV, Foss A, Leivestad T, Heldal K, Thorud LO, Eriksen BO, Hartmann A, NILS Study Group (2013)
    Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial
    Clin Transplant, 27 (2), E151-6
    DOI 10.1111/ctr.12076, PubMed 23351013
24. Åsberg A, Midtvedt K, van Guilder M, Størset E, Bremer S, Bergan S, Jelliffe R, Hartmann A, Neely MN (2013)
    Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
    Transpl Int, 26 (12), 1198-207
    DOI 10.1111/tri.12194, PubMed 24118301

Publications 2012

1. Bleskestad IH, Bergrem H, Hartmann A, Godang K, Gøransson LG (2012)
   Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial
   BMC Nephrol, 13, 49
   DOI 10.1186/1471-2369-13-49, PubMed 22742720
2. Brabrand K, Midtvedt K, Günther A, Marthinsen PB, Berstad AE (2012)
   Color Doppler ultrasound-guided transducer compression of post biopsy bleeding of kidney transplants
   J Clin Ultrasound, 41 (1), 26-31
   DOI 10.1002/jcu.21983, PubMed 22927091
3. Emery VC, Manuel O, Asberg A, Pang X, Kumar D, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Gahlemann CG, Humar A (2012)
   Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy
   J Clin Virol, 54 (1), 56-60
   DOI 10.1016/j.jcv.2012.01.015, PubMed 22410132
4. Feldman RD, Flack J, Howes L, Jenssen T, Reeves R, Shi H, Westergaard M, Hobbs FD, GEMINI US, GEMINI AALA, JEWEL 1 and 2 and CAPABLE investigators (2012)
   Impact of age and gender on blood pressure and low-density lipoprotein cholesterol reduction: results of a pooled analysis
   Curr Med Res Opin, 28 (9), 1421-33
   DOI 10.1185/03007995.2012.713339, PubMed 22809114
5. Friberg AS, Lundgren T, Malm H, Felldin M, Nilsson B, Jenssen T, Kyllönen L, Tufveson G, Tibell A, Korsgren O (2012)
   Transplanted functional islet mass: donor, islet preparation, and recipient factors influence early graft function in islet-after-kidney patients
   Transplantation, 93 (6), 632-8
   DOI 10.1097/TP.0b013e3182455912, PubMed 22258287
6. Gjersvik P, Helsing P, Holdaas H, Bergan S (2012)
   [Immunosuppressive drugs and the development of skin cancer after organ transplantation]
   Tidsskr Nor Laegeforen, 132 (18), 2064-8
   DOI 10.4045/tidsskr.12.0389, PubMed 23038197
7. Hartmann A, Jenssen T, Holdaas H (2012)
   Diabetes, chronic kidney disease and cancer risk
   Nephrol Dial Transplant, 27 (8), 3018-20
   DOI 10.1093/ndt/gfs175, PubMed 22734106
8. Hausken J, Klingenberg O, Mørkrid L, Rollag H, Foss A, Midtvedt K (2012)
   Elevated troponin I and NT-proBNP at the time of transplantation may predict a major adverse cardiac event in the early postoperative period after renal transplantation
   Transplantation, 94 (2), e15-6
   DOI 10.1097/TP.0b013e31825b7633, PubMed 22820562
9. Heldal K, Midtvedt K (2012)
   Doctor, should I remain on dialysis or accept the ECD kidney offered to me?
   Am J Kidney Dis, 59 (6), 748-50
   DOI 10.1053/j.ajkd.2012.03.002, PubMed 22613394
10. Holdaas H, Jardine A (2012)
    Chronic kidney disease: Do patients with CKD benefit from lipid-lowering therapy?
    Nat Rev Nephrol, 8 (12), 684-5
    DOI 10.1038/nrneph.2012.240, PubMed 23090449
11. Holdaas H, Midtvedt K, Åsberg A (2012)
    A drug safety evaluation of everolimus in kidney transplantation
    Expert Opin Drug Saf, 11 (6), 1013-22
    DOI 10.1517/14740338.2012.722993, PubMed 22954349
12. Holme I, Fellström BC, Jardine AG, Hartmann A, Holdaas H (2012)
    Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients
    Clin J Am Soc Nephrol, 8 (2), 241-7
    DOI 10.2215/CJN.03760412, PubMed 23160259
13. Kolset SO, Reinholt FP, Jenssen T (2012)
    Diabetic nephropathy and extracellular matrix
    J Histochem Cytochem, 60 (12), 976-86
    DOI 10.1369/0022155412465073, PubMed 23103723
14. Krämer BK, Klinger M, Vítko Š, Glyda M, Midtvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Ostrowski M, Senatorski G, Nordström J, Salmela K (2012)
    Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial
    Transplantation, 94 (5), 492-8
    DOI 10.1097/TP.0b013e31825c1d6c, PubMed 22858806
15. Loftheim H, Midtvedt K, Hartmann A, Reisæter AV, Falck P, Holdaas H, Jenssen T, Reubsaet L, Asberg A (2012)
    Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
    Transplant Res, 1 (1), 9
    DOI 10.1186/2047-1440-1-9, PubMed 23369437
16. Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I, Eriksen BO (2012)
    Ambulatory blood pressure is associated with measured glomerular filtration rate in the general middle-aged population
    J Hypertens, 30 (3), 497-504
    DOI 10.1097/HJH.0b013e32834f973a, PubMed 22278141
17. Melsom T, Mathisen UD, Eilertsen BA, Ingebretsen OC, Jenssen T, Njølstad I, Solbu MD, Toft I, Eriksen BO (2012)
    Physical exercise, fasting glucose, and renal hyperfiltration in the general population: the Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6)
    Clin J Am Soc Nephrol, 7 (11), 1801-10
    DOI 10.2215/CJN.02980312, PubMed 22917703
18. Mjörnstedt L, Sørensen SS, von Zur Mühlen B, Jespersen B, Hansen JM, Bistrup C, Andersson H, Gustafsson B, Undset LH, Fagertun H, Solbu D, Holdaas H (2012)
    Improved renal function after early conversion from a calcineurin inhibitor to everolimus: a randomized trial in kidney transplantation
    Am J Transplant, 12 (10), 2744-53
    DOI 10.1111/j.1600-6143.2012.04162.x, PubMed 22812414
19. Rollag H, Asberg A, Ueland T, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2012)
    Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome
    Transplantation, 94 (10), 1060-5
    DOI 10.1097/TP.0b013e31826c39de, PubMed 23104251
20. Smerud KT, Dolgos S, Olsen IC, Åsberg A, Sagedal S, Reisæter AV, Midtvedt K, Pfeffer P, Ueland T, Godang K, Bollerslev J, Hartmann A (2012)
    A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
    Am J Transplant, 12 (12), 3316-25
    DOI 10.1111/j.1600-6143.2012.04233.x, PubMed 22946930
21. Soveri I, Abedini S, Holdaas H, Jardine A, Eriksson N, Fellström B (2012)
    Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trial
    J Nephrol, 25 (2), 245-54
    DOI 10.5301/JN.2011.8450, PubMed 21725919
22. Soveri I, Holme I, Holdaas H, Budde K, Jardine AG, Fellström B (2012)
    A cardiovascular risk calculator for renal transplant recipients
    Transplantation, 94 (1), 57-62
    DOI 10.1097/TP.0b013e3182516cdc, PubMed 22683851
23. Svensson M, Jardine A, Fellström B, Holdaas H (2012)
    Prevention of cardiovascular disease after renal transplantation
    Curr Opin Organ Transplant, 17 (4), 393-400
    DOI 10.1097/MOT.0b013e3283560a3b, PubMed 22790074
24. Syversveen T, Midtvedt K, Berstad AE, Brabrand K, Strøm EH, Abildgaard A (2012)
    Tissue elasticity estimated by acoustic radiation force impulse quantification depends on the applied transducer force: an experimental study in kidney transplant patients
    Eur Radiol, 22 (10), 2130-7
    DOI 10.1007/s00330-012-2476-4, PubMed 22610533
25. Valderhaug TG, Bergrem HA, Jenssen T, Hjelmesæth J (2012)
    Comment on: Chakkera et al. Pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care 2011;34:2141-2145
    Diabetes Care, 35 (3), e26; author reply e27
    DOI 10.2337/dc11-2046, PubMed 22355029
26. Valderhaug TG, Hjelmesæth J, Jenssen T, Røislien J, Leivestad T, Hartmann A (2012)
    Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses
    Transplantation, 94 (7), 714-20
    DOI 10.1097/TP.0b013e31825f4434, PubMed 22965263
27. Vikse BE, Irgens LM, Karumanchi SA, Thadhani R, Reisæter AV, Skjærven R (2012)
    Familial factors in the association between preeclampsia and later ESRD
    Clin J Am Soc Nephrol, 7 (11), 1819-26
    DOI 10.2215/CJN.01820212, PubMed 22956264

Publications 2011

1. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V et al. (2011)
   The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
   Lancet, 377 (9784), 2181-92
   DOI 10.1016/S0140-6736(11)60739-3, PubMed 21663949
2. Berdal M, Appelbom HI, Eikrem JH, Lund A, Busund LT, Hanes R, Seljelid R, Jenssen T (2011)
   Aminated β-1,3-D-glucan has a dose-dependent effect on wound healing in diabetic db/db mice
   Wound Repair Regen, 19 (5), 579-87
   DOI 10.1111/j.1524-475X.2011.00715.x, PubMed 22092796
3. Bjørneklett R, Vikse BE, Smerud HK, Bostad L, Leivestad T, Hartmann A, Iversen BM (2011)
   Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients
   Clin Transplant, 25 (3), E356-65
   DOI 10.1111/j.1399-0012.2011.01424.x, PubMed 21651619
4. Brabrand K, Holdaas H, Gunther A, Midtvedt K (2011)
   Spontaneous regression of initially elevated peak systolic velocity in renal transplant artery
   Transpl Int, 24 (6), 555-9
   DOI 10.1111/j.1432-2277.2011.01233.x, PubMed 21332581
5. Campistol JM, de Fijter JW, Nashan B, Holdaas H, Vítko S, Legendre C (2011)
   Everolimus and long-term outcomes in renal transplantation
   Transplantation, 92 (3 Suppl), S3-26
   DOI 10.1097/TP.0b013e3182230900, PubMed 21799392
6. Carrero JJ, de Jager DJ, Verduijn M, Ravani P, De Meester J, Heaf JG, Finne P, Hoitsma AJ, Pascual J, Jarraya F, Reisaeter AV, Collart F, Dekker FW, Jager KJ (2011)
   Cardiovascular and noncardiovascular mortality among men and women starting dialysis
   Clin J Am Soc Nephrol, 6 (7), 1722-30
   DOI 10.2215/CJN.11331210, PubMed 21734088
7. Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, März W, Abedini S, Norby GE, Holme I, Fellström B, Jardine A, Holdaas H (2011)
   Inflammation-associated graft loss in renal transplant recipients
   Nephrol Dial Transplant, 26 (11), 3756-61
   DOI 10.1093/ndt/gfr163, PubMed 21511816
8. Eriksen BO, Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I (2011)
   The role of cystatin C in improving GFR estimation in the general population
   Am J Kidney Dis, 59 (1), 32-40
   DOI 10.1053/j.ajkd.2011.09.001, PubMed 22001180
9. Eriksen BO, Melsom T, Mathisen UD, Jenssen TG, Solbu MD, Toft I (2011)
   GFR normalized to total body water allows comparisons across genders and body sizes
   J Am Soc Nephrol, 22 (8), 1517-25
   DOI 10.1681/ASN.2010121321, PubMed 21784894
10. Hadler-Olsen E, Winberg JO, Reinholt FP, Larsen T, Uhlin-Hansen L, Jenssen T, Berg E, Kolset SO (2011)
    Proteases in Plasma and Kidney of db/db Mice as Markers of Diabetes-Induced Nephropathy
    ISRN Endocrinol, 2011, 832642
    DOI 10.5402/2011/832642, PubMed 22363890
11. Heldal K, Hartmann A, Leivestad T, Foss A, Midtvedt K (2011)
    Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium
    Nephrol Dial Transplant, 26 (8), 2706-11
    DOI 10.1093/ndt/gfq786, PubMed 21285131
12. Heldal K, Hartmann A, Leivestad T, Lien B, Foss AE, Midtvedt K (2011)
    Renal transplantation is also an option for patients over 70
    Tidsskr Nor Laegeforen, 131 (20), 2004-7
    DOI 10.4045/tidsskr.10.1391, PubMed 22016126
13. Holdaas H, Holme I, Schmieder RE, Jardine AG, Zannad F, Norby GE, Fellström BC, AURORA study group (2011)
    Rosuvastatin in diabetic hemodialysis patients
    J Am Soc Nephrol, 22 (7), 1335-41
    DOI 10.1681/ASN.2010090987, PubMed 21566054
14. Holdaas H, Rostaing L, Serón D, Cole E, Chapman J, Fellstrøm B, Strom EH, Jardine A, Midtvedt K, Machein U, Ulbricht B, Karpov A, O'Connell PJ, ASCERTAIN Investigators (2011)
    Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study
    Transplantation, 92 (4), 410-8
    DOI 10.1097/TP.0b013e318224c12d, PubMed 21697773
15. Holme I, Fellström BC, Jardin AG, Schmieder RE, Zannad F, Holdaas H (2011)
    Prognostic model for total mortality in patients with haemodialysis from the Assessments of Survival and Cardiovascular Events (AURORA) study
    J Intern Med, 271 (5), 463-71
    DOI 10.1111/j.1365-2796.2011.02435.x, PubMed 21812843
16. Jardine AG, Gaston RS, Fellstrom BC, Holdaas H (2011)
    Prevention of cardiovascular disease in adult recipients of kidney transplants
    Lancet, 378 (9800), 1419-27
    DOI 10.1016/S0140-6736(11)61334-2, PubMed 22000138
17. Jenssen T, Hartmann A (2011)
    Prevention and management of transplant-associated diabetes
    Expert Opin Pharmacother, 12 (17), 2641-55
    DOI 10.1517/14656566.2011.628936, PubMed 22047007
18. Lisboa LF, Asberg A, Kumar D, Pang X, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Humar A (2011)
    The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response
    Transplantation, 91 (2), 231-6
    DOI 10.1097/TP.0b013e3181ff8719, PubMed 21048530
19. Mathisen UD, Melsom T, Ingebretsen OC, Jenssen T, Njølstad I, Solbu MD, Toft I, Eriksen BO (2011)
    Estimated GFR associates with cardiovascular risk factors independently of measured GFR
    J Am Soc Nephrol, 22 (5), 927-37
    DOI 10.1681/ASN.2010050479, PubMed 21454717
20. Melsom T, Mathisen UD, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I, Eriksen BO (2011)
    Impaired fasting glucose is associated with renal hyperfiltration in the general population
    Diabetes Care, 34 (7), 1546-51
    DOI 10.2337/dc11-0235, PubMed 21593291
21. Meyer K, Bjørk IT, Eide H (2011)
    Intensive care nurses' perceptions of their professional competence in the organ donor process: a national survey
    J Adv Nurs, 68 (1), 104-15
    DOI 10.1111/j.1365-2648.2011.05721.x, PubMed 21645048
22. Midtvedt K, Holdaas H (2011)
    Belatacept: BENEFIT to the kidney?
    Am J Transplant, 11 (3), 633; author reply 634
    DOI 10.1111/j.1600-6143.2010.03411.x, PubMed 21342454
23. Midtvedt K, Jenssen T, Hartmann A, Vethe NT, Bergan S, Havnes K, Åsberg A (2011)
    No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus
    Nephrol Dial Transplant, 26 (11), 3767-72
    DOI 10.1093/ndt/gfr153, PubMed 21471328
24. Midtvedt K, Namtvedt T, Scott H, Abedini S, Rocke JC, Dørje C, Foss S, Christen U, Hagness M, Hartmann A (2011)
    Single transplanted kidneys from a 90-year-old deceased donor perform acceptably at 1 year
    Transplant Proc, 43 (5), 2107-9
    DOI 10.1016/j.transproceed.2011.01.192, PubMed 21693337
25. Mjøen G, Oyen O, Midtvedt K, Dahle DO, Norby G, Holdaas H (2011)
    Age, gender, and body mass index are associated with renal function after kidney donation
    Clin Transplant, 25 (6), E579-83
    DOI 10.1111/j.1399-0012.2011.01503.x, PubMed 21906171
26. Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2011)
    Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
    Nephrol Dial Transplant, 27 (1), 443-7
    DOI 10.1093/ndt/gfr303, PubMed 21636826
27. Mjøen G, Stavem K, Westlie L, Midtvedt K, Fauchald P, Norby G, Holdaas H (2011)
    Quality of life in kidney donors
    Am J Transplant, 11 (6), 1315-9
    DOI 10.1111/j.1600-6143.2011.03517.x, PubMed 21486387
28. Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A (2011)
    Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients
    Transplantation, 92 (2), 217-23
    DOI 10.1097/TP.0b013e31821fad25, PubMed 21685829
29. März W, Genser B, Drechsler C, Krane V, Grammer TB, Ritz E, Stojakovic T, Scharnagl H, Winkler K, Holme I, Holdaas H, Wanner C, German Diabetes and Dialysis Study Investigators (2011)
    Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis
    Clin J Am Soc Nephrol, 6 (6), 1316-25
    DOI 10.2215/CJN.09121010, PubMed 21493741
30. Norby GE, Günther A, Mjøen G, Andersen R, Dolgos S, Hartmann A, Holdaas H (2011)
    Prevalence and risk factors for coronary artery calcification following kidney transplantation for systemic lupus erythematosus
    Rheumatology (Oxford), 50 (9), 1659-64
    DOI 10.1093/rheumatology/ker186, PubMed 21624893
31. Norby GE, Leivestad T, Mjøen G, Hartmann A, Midtvedt K, Gran JT, Holdaas H (2011)
    Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation
    Arthritis Rheum, 63 (3), 733-7
    DOI 10.1002/art.30184, PubMed 21360503
32. Reine TM, Kusche-Gullberg M, Feta A, Jenssen T, Kolset SO (2011)
    Heparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells
    Glycoconj J, 29 (1), 67-76
    DOI 10.1007/s10719-011-9365-y, PubMed 22187328
33. Reisaeter AV, Foss A, Hartmann A, Leivestad T, Midtvedt K (2011)
    The kidney transplantation program in Norway since 2000
    Clin Transpl, 111-8
    PubMed 22755407
34. Sagedal S, Witczak BJ, Osnes K, Hartmann A, Os I, Eikvar L, Klingenberg O, Brosstad F (2011)
    A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8)
    Blood Purif, 32 (3), 151-5
    DOI 10.1159/000325227, PubMed 21659742
35. Svensson M, Dahle DO, Mjøen G, Weihrauch G, Scharnagl H, Dobnig H, März W, Jardine A, Fellström B, Holdaas H (2011)
    Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study
    Nephrol Dial Transplant, 27 (6), 2571-5
    DOI 10.1093/ndt/gfr694, PubMed 22172725
36. Syversveen T, Brabrand K, Midtvedt K, Strøm EH, Hartmann A, Berstad AE (2011)
    Non-invasive assessment of renal allograft fibrosis by dynamic sonographic tissue perfusion measurement
    Acta Radiol, 52 (8), 920-6
    DOI 10.1258/ar.2011.110215, PubMed 21873503
37. Syversveen T, Midtvedt K, Brabrand K, Øyen O, Foss A, Scholz T (2011)
    Prophylactic peritoneal fenestration to prevent morbidity after kidney transplantation: a randomized study
    Transplantation, 92 (2), 196-202
    DOI 10.1097/TP.0b013e318220f57b, PubMed 21597401
38. Tangeraas T, Midtvedt K, Cvancarova M, Hirth A, Fredriksen PM, Tonstad S, Isaksen GA, Bjerre A (2011)
    Cardiorespiratory fitness in young adults with a history of renal transplantation in childhood
    Pediatr Nephrol, 26 (11), 2041-9
    DOI 10.1007/s00467-011-1898-6, PubMed 21541798
39. Valderhaug TG, Hjelmesæth J, Hartmann A, Røislien J, Bergrem HA, Leivestad T, Line PD, Jenssen T (2011)
    The association of early post-transplant glucose levels with long-term mortality
    Diabetologia, 54 (6), 1341-9
    DOI 10.1007/s00125-011-2105-9, PubMed 21409415
40. Vethe NT, Midtvedt K, Asberg A, Amundsen R, Bergan S (2011)
    [Drug interactions and immunosuppression in organ transplant recipients]
    Tidsskr Nor Laegeforen, 131 (20), 2000-3
    DOI 10.4045/tidsskr.11.0138, PubMed 22016125
41. Øfjord ES, Skag A, Helberg S, Aarskog D, Risberg K, Jacobsen T, Nasrala S, Bakken S, Syversen U, Jenssen T (2011)
    Medicinal prevention of pre-diabetes--no purpose?
    Tidsskr Nor Laegeforen, 131 (15), 1418-9
    DOI 10.4045/tidsskr.10.1459, PubMed 21844941

Publications 2010

1. Abedini S, Meinitzer A, Holme I, März W, Weihrauch G, Fellstrøm B, Jardine A, Holdaas H (2010)
   Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients
   Kidney Int, 77 (1), 44-50
   DOI 10.1038/ki.2009.382, PubMed 19847152
2. Asberg A, Falck P, Undset LH, Dørje C, Holdaas H, Hartmann A, Midtvedt K (2010)
   Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot study
   Ther Drug Monit, 32 (2), 152-8
   DOI 10.1097/FTD.0b013e3181d3f822, PubMed 20216113
3. Asberg A, Rollag H, Hartmann A (2010)
   Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients
   Expert Opin Pharmacother, 11 (7), 1159-66
   DOI 10.1517/14656561003742954, PubMed 20367273
4. Bergrem HA, Valderhaug TG, Hartmann A, Hjelmesaeth J, Leivestad T, Bergrem H, Jenssen T (2010)
   Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy
   Clin J Am Soc Nephrol, 5 (4), 616-22
   DOI 10.2215/CJN.07501009, PubMed 20133490
5. Bryhni B, Arnesen E, Jenssen TG (2010)
   Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study
   BMC Endocr Disord, 10, 21
   DOI 10.1186/1472-6823-10-21, PubMed 21162746
6. Dolgos S, Hartmann A, Isaksen GA, Simonsen S, Bjørtuft Ø, Boberg KM, Bollerslev J (2010)
   Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation - a population based study
   Clin Transplant, 24 (5), E145-52
   DOI 10.1111/j.1399-0012.2010.01231.x, PubMed 20236290
7. Elgstoen KB, Johnsen LF, Woldseth B, Morkrid L, Hartmann A (2010)
   Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria
   Nephrol Dial Transplant, 25 (7), 2341-5
   DOI 10.1093/ndt/gfq065, PubMed 20167571
8. Eriksen BO, Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I (2010)
   Cystatin C is not a better estimator of GFR than plasma creatinine in the general population
   Kidney Int, 78 (12), 1305-11
   DOI 10.1038/ki.2010.321, PubMed 20844470
9. Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Njølstad I, Schirmer H, Jorde R (2010)
   Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up
   Diabet Med, 27 (10), 1107-15
   DOI 10.1111/j.1464-5491.2010.03092.x, PubMed 20854377
10. Gude E, Andreassen AK, Arora S, Gullestad L, Grov I, Hartmann A, Leivestad T, Fiane AE, Geiran OR, Vardal M, Simonsen S (2010)
    Acute renal failure early after heart transplantation: risk factors and clinical consequences
    Clin Transplant, 24 (6), E207-13
    DOI 10.1111/j.1399-0012.2010.01225.x, PubMed 20184627
11. Gude E, Gullestad L, Arora S, Simonsen S, Hoel I, Hartmann A, Holdaas H, Fiane AE, Geiran OR, Andreassen AK (2010)
    Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation
    J Heart Lung Transplant, 29 (6), 641-7
    DOI 10.1016/j.healun.2010.01.005, PubMed 20304681
12. Guest JF, Jenssen T, Houge G, Aaseboe W, Tøndel C, Svarstad E (2010)
    Modelling the resource implications of managing adults with Fabry disease in Norway favours home infusion
    Eur J Clin Invest, 40 (12), 1104-12
    DOI 10.1111/j.1365-2362.2010.02363.x, PubMed 21070219
13. Hirsch HH, Hartmann A (2010)
    Immunotherapy for invasive fungal infections in transplant patients: back to the future?
    Am J Transplant, 10 (8), 1719-20
    DOI 10.1111/j.1600-6143.2010.03189.x, PubMed 20636453
14. Hjelmesæth J, Røislien J, Nordstrand N, Hofsø D, Hager H, Hartmann A (2010)
    Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study
    BMC Endocr Disord, 10, 6
    DOI 10.1186/1472-6823-10-6, PubMed 20398422
15. Hofsø D, Jenssen T, Bollerslev J, Ueland T, Godang K, Stumvoll M, Sandbu R, Røislien J, Hjelmesæth J (2010)
    Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
    Eur J Endocrinol, 164 (2), 231-8
    DOI 10.1530/EJE-10-0804, PubMed 21078684
16. Hofsø D, Nordstrand N, Johnson LK, Karlsen TI, Hager H, Jenssen T, Bollerslev J, Godang K, Sandbu R, Røislien J, Hjelmesaeth J (2010)
    Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
    Eur J Endocrinol, 163 (5), 735-45
    DOI 10.1530/EJE-10-0514, PubMed 20798226
17. Meen AJ, Øynebråten I, Reine TM, Duelli A, Svennevig K, Pejler G, Jenssen T, Kolset SO (2010)
    Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1
    J Biol Chem, 286 (4), 2636-47
    DOI 10.1074/jbc.M110.151944, PubMed 21075844
18. Mjoen G, Midtvedt K, Holme I, Øyen O, Fauchald P, Bergrem H, Holdaas H (2010)
    One- and five-year follow-ups on blood pressure and renal function in kidney donors
    Transpl Int, 24 (1), 73-7
    DOI 10.1111/j.1432-2277.2010.01148.x, PubMed 20723180
19. Mjøen G, Holdaas H, Pfeffer P, Line PD, Øyen O (2010)
    Minimally invasive living donor nephrectomy - introduction of hand-assistance
    Transpl Int, 23 (10), 1008-14
    DOI 10.1111/j.1432-2277.2010.01087.x, PubMed 20412538
20. Myhre HA, Øyen O, Kårbø Ø, Midtvedt K (2010)
    Successful treatment of spontaneous kidney graft decapsulation 18 years after renal transplantation: a case report
    NDT Plus, 3 (1), 100-2
    DOI 10.1093/ndtplus/sfp148, PubMed 25949418
21. NAVIGATOR Study Group, Holman RR, Haffner SM, McMurray JJ, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E et al. (2010)
    Effect of nateglinide on the incidence of diabetes and cardiovascular events
    N Engl J Med, 362 (16), 1463-76
    DOI 10.1056/NEJMoa1001122, PubMed 20228402
22. NAVIGATOR Study Group, McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E et al. (2010)
    Effect of valsartan on the incidence of diabetes and cardiovascular events
    N Engl J Med, 362 (16), 1477-90
    DOI 10.1056/NEJMoa1001121, PubMed 20228403
23. Norby GE, Lerang K, Holdaas H, Gran JT, Strøm EH, Draganov B, Os I, Hartmann A, Gilboe IM (2010)
    [Lupus-nephritis--diagnosis and treatment]
    Tidsskr Nor Laegeforen, 130 (11), 1140-4
    DOI 10.4045/tidsskr.09.0583, PubMed 20531500
24. Norby GE, Strøm EH, Midtvedt K, Hartmann A, Gilboe IM, Leivestad T, Stenstrøm J, Holdaas H (2010)
    Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study
    Ann Rheum Dis, 69 (8), 1484-7
    DOI 10.1136/ard.2009.122796, PubMed 20498208
25. Skottheim IB, Jakobsen GS, Stormark K, Christensen H, Hjelmesaeth J, Jenssen T, Asberg A, Sandbu R (2010)
    Significant increase in systemic exposure of atorvastatin after biliopancreatic diversion with duodenal switch
    Clin Pharmacol Ther, 87 (6), 699-705
    DOI 10.1038/clpt.2010.32, PubMed 20445535
26. Solli O, Jenssen T, Kristiansen IS (2010)
    Diabetes: cost of illness in Norway
    BMC Endocr Disord, 10, 15
    DOI 10.1186/1472-6823-10-15, PubMed 20854689
27. Strøm EH, Reinholt FP, Midtvedt K (2010)
    JC virus-associated nephropathy: lack of convincing documentation of the diagnosis
    Transpl Infect Dis, 13 (1), 93-4
    DOI 10.1111/j.1399-3062.2010.00594.x, PubMed 21299773
28. Syversveen T, Brabrand K, Midtvedt K, Strøm EH, Hartmann A, Jakobsen JA, Berstad AE (2010)
    Assessment of renal allograft fibrosis by acoustic radiation force impulse quantification--a pilot study
    Transpl Int, 24 (1), 100-5
    DOI 10.1111/j.1432-2277.2010.01165.x, PubMed 20819192
29. Tangeraas T, Midtvedt K, Fredriksen PM, Cvancarova M, Mørkrid L, Bjerre A (2010)
    Cardiorespiratory fitness is a marker of cardiovascular health in renal transplanted children
    Pediatr Nephrol, 25 (11), 2343-50
    DOI 10.1007/s00467-010-1596-9, PubMed 20676694
30. Aasebø W, Strøm EH, Hovig T, Undset LH, Heiberg A, Jenssen T (2010)
    Fabry disease in donor kidneys with 3- and 12-year follow-up after transplantation
    NDT Plus, 3 (3), 303-305
    DOI 10.1093/ndtplus/sfq036, PubMed 28657066

Publications 2009

1. Abedini S, Holme I, Fellström B, Jardine A, Cole E, Maes B, Holdaas H, ALERT Study Group (2009)
   Cerebrovascular events in renal transplant recipients
   Transplantation, 87 (1), 112-7
   DOI 10.1097/TP.0b013e31818bfce8, PubMed 19136900
2. Abedini S, Holme I, März W, Weihrauch G, Fellström B, Jardine A, Cole E, Maes B, Neumayer HH, Grønhagen-Riska C, Ambühl P, Holdaas H, ALERT study group (2009)
   Inflammation in renal transplantation
   Clin J Am Soc Nephrol, 4 (7), 1246-54
   DOI 10.2215/CJN.00930209, PubMed 19541816
3. Amundsen R, Asberg A, Robertsen I, Vethe NT, Bergan S, Hartmann A, Midtvedt K (2009)
   Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients
   Transplantation, 87 (8), 1221-4
   DOI 10.1097/TP.0b013e31819f1001, PubMed 19384170
4. Asberg A, Midtvedt K, Voytovich MH, Line PD, Narverud J, Reisaeter AV, Mørkrid L, Jenssen T, Hartmann A (2009)
   Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation
   Clin Transplant, 23 (4), 511-8
   DOI 10.1111/j.1399-0012.2009.00962.x, PubMed 19210527
5. Bergrem HA, Valderhaug TG, Hartmann A, Bergrem H, Hjelmesaeth J, Jenssen T (2009)
   Glucose tolerance before and after renal transplantation
   Nephrol Dial Transplant, 25 (3), 985-92
   DOI 10.1093/ndt/gfp566, PubMed 19854851
6. Boivin G, Goyette N, Rollag H, Jardine AG, Pescovitz MD, Asberg A, Ives J, Hartmann A, Humar A (2009)
   Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir
   Antivir Ther, 14 (5), 697-704
   PubMed 19704173
7. Bremer S, Vethe NT, Rootwelt H, Jørgensen PF, Stenstrøm J, Holdaas H, Midtvedt K, Bergan S (2009)
   Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study
   J Transl Med, 7, 64
   DOI 10.1186/1479-5876-7-64, PubMed 19635156
8. Dolgos S, Hartmann A, Bønsnes S, Isaksen GA, Godang K, Ueland T, Pfeffer P, Bollerslev J (2009)
   Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation
   Scand J Clin Lab Invest, 69 (2), 161-7
   DOI 10.1080/00365510802449634, PubMed 18972258
9. Dolgos S, Hartmann A, Jenssen T, Isaksen GA, Pfeffer P, Bollerslev J (2009)
   Determinants of short-term changes in body composition following renal transplantation
   Scand J Urol Nephrol, 43 (1), 76-83
   DOI 10.1080/00365590802273226, PubMed 18777442
10. Falck P, Midtvedt K, Vân Lê TT, Storehagen L, Holdaas H, Hartmann A, Asberg A (2009)
    A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients
    Clin Pharmacokinet, 48 (9), 615-23
    DOI 10.2165/11313380-000000000-00000, PubMed 19725595
11. Fellstrom B, Jardine A, Holdaas H, AURORA Executive Steering Comm (2009)
    Rosuvastatin in Patients Undergoing Hemodialysis REPLY
    N. Engl. J. Med., 361 (1), 94-95
12. Fellström B, Holdaas H, Jardine AG, Svensson MK, Gottlow M, Schmieder RE, Zannad F, AURORA Study Group (2009)
    Cardiovascular disease in patients with renal disease: the role of statins
    Curr Med Res Opin, 25 (1), 271-85
    DOI 10.1185/03007990802622064, PubMed 19210158
13. Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP et al. (2009)
    Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
    N Engl J Med, 360 (14), 1395-407
    DOI 10.1056/NEJMoa0810177, PubMed 19332456
14. Foss A, Heldal K, Scott H, Foss S, Leivestad T, Jørgensen PF, Scholz T, Midtvedt K (2009)
    Kidneys from deceased donors more than 75 years perform acceptably after transplantation
    Transplantation, 87 (10), 1437-41
    DOI 10.1097/TP.0b013e3181a4ebd2, PubMed 19461478
15. Heldal K, Hartmann A, Grootendorst DC, de Jager DJ, Leivestad T, Foss A, Midtvedt K (2009)
    Benefit of kidney transplantation beyond 70 years of age
    Nephrol Dial Transplant, 25 (5), 1680-7
    DOI 10.1093/ndt/gfp681, PubMed 20038521
16. Heldal K, Hartmann A, Leivestad T, Svendsen MV, Foss A, Lien B, Midtvedt K (2009)
    Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity
    Transplantation, 87 (7), 1045-51
    DOI 10.1097/TP.0b013e31819cdddd, PubMed 19352126
17. Hjelmesaeth J, Hofsø D, Aasheim ET, Jenssen T, Moan J, Hager H, Røislien J, Bollerslev J (2009)
    Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study
    Cardiovasc Diabetol, 8, 7
    DOI 10.1186/1475-2840-8-7, PubMed 19187564
18. Hofsø D, Jenssen T, Bollerslev J, Røislien J, Hager H, Hjelmesaeth J (2009)
    Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: a cross-sectional study
    Diabetes Res Clin Pract, 86 (1), e9-11
    DOI 10.1016/j.diabres.2009.06.016, PubMed 19608292
19. Hofsø D, Jenssen T, Hager H, Røislien J, Hjelmesaeth J (2009)
    Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects
    Obes Surg, 20 (3), 302-7
    DOI 10.1007/s11695-009-0022-5, PubMed 19949889
20. Hofsø D, Ueland T, Hager H, Jenssen T, Bollerslev J, Godang K, Aukrust P, Røislien J, Hjelmesaeth J (2009)
    Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose
    Eur J Endocrinol, 161 (3), 451-8
    DOI 10.1530/EJE-09-0421, PubMed 19542241
21. Holme I, Fayyad R, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Holdaas H, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
    Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial
    J Intern Med, 267 (6), 567-75
    DOI 10.1111/j.1365-2796.2009.02176.x, PubMed 20141566
22. Holme I, Fellstrom B, Jardine A, Holdaas H (2009)
    Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients
    Atherosclerosis, 208 (1), 234-9
    DOI 10.1016/j.atherosclerosis.2009.06.020, PubMed 19596331
23. Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A (2009)
    Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease
    Clin Infect Dis, 49 (8), 1160-6
    DOI 10.1086/605633, PubMed 19751151
24. Midtvedt K, Bitter J, Dørje C, Bjørneklett R, Holdaas H (2009)
    Belatacept as immunosuppression in patient with recurrence of hemolytic uremic syndrome after renal transplantation
    Transplantation, 87 (12), 1901-3
    DOI 10.1097/TP.0b013e3181a991ca, PubMed 19543075
25. Midtvedt K, Midtvedt T (2009)
    [Childhood diarrhea research in developing countries]
    Tidsskr Nor Laegeforen, 129 (15), 1484-5
    DOI 10.4045/tidsskr.09.0715, PubMed 19690601
26. Mjøen G, Øyen O, Holdaas H, Midtvedt K, Line PD (2009)
    Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry
    Transplantation, 88 (11), 1273-9
    DOI 10.1097/TP.0b013e3181bb44fd, PubMed 19996926
27. Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H, Assessment of Lescol in Renal Transplantation Study Group (2009)
    Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study
    Arthritis Rheum, 60 (4), 1060-4
    DOI 10.1002/art.24379, PubMed 19333947
28. Richard Hobbs FD, Gensini G, John Mancini GB, Manolis AJ, Bauer B, Genest J, Feldman RD, Harvey P, Jenssen TG, da Silva PM, JEWEL Study Group (2009)
    International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme
    Eur J Cardiovasc Prev Rehabil, 16 (4), 472-80
    DOI 10.1097/HJR.0b013e32832b63f5, PubMed 19407658
29. Skottheim IB, Stormark K, Christensen H, Jakobsen GS, Hjelmesaeth J, Jenssen T, Reubsaet JL, Sandbu R, Asberg A (2009)
    Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients
    Clin Pharmacol Ther, 86 (3), 311-8
    DOI 10.1038/clpt.2009.82, PubMed 19494810
30. Solbu MD, Jenssen TG, Eriksen BO, Toft I (2009)
    Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension--the impact of microalbuminuria: a 13-year follow-up study
    Metabolism, 58 (3), 408-15
    DOI 10.1016/j.metabol.2008.10.016, PubMed 19217459
31. Soveri I, Abedini S, Holdaas H, Jardine A, Eriksson N, Fellström B (2009)
    Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment
    Clin Transplant, 23 (6), 914-20
    DOI 10.1111/j.1399-0012.2009.01025.x, PubMed 19594771
32. Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J (2009)
    Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation
    Transplantation, 88 (3), 429-34
    DOI 10.1097/TP.0b013e3181af1f53, PubMed 19667949
33. Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, Midtvedt K, Bitter J, Hartmann A (2009)
    Experience from an active preemptive kidney transplantation program--809 cases revisited
    Transplantation, 88 (5), 672-7
    DOI 10.1097/TP.0b013e3181b27b7e, PubMed 19741464
34. Aasebø W (2009)
    ECG-voltage in alcoholics and non-alcoholics with acute alcohol intoxication
    J Forensic Leg Med, 16 (7), 381-4
    DOI 10.1016/j.jflm.2009.01.016, PubMed 19733325
35. Aasebø W, Hartmann A, Jenssen T (2009)
    Predictors of anemia in patients on hemodialysis
    Hemodial Int, 13 (3), 335-9
    DOI 10.1111/j.1542-4758.2009.00376.x, PubMed 19614760
36. Aasebø W, Midtvedt K, Valderhaug TG, Leivestad T, Hartmann A, Reisaeter AV, Jenssen T, Holdaas H (2009)
    Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
    Nephrol Dial Transplant, 25 (4), 1289-93
    DOI 10.1093/ndt/gfp617, PubMed 19934089

Publications 2008

1. Apeland T, Hartmann A (2008)
   Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation
   Nephrol Dial Transplant, 23 (6), 2091-4
   DOI 10.1093/ndt/gfn099, PubMed 18319357
2. Bergrem HA, Bergrem H, Hartmann A, Hjelmesaeth J, Jenssen T (2008)
   Role of prednisolone pharmacokinetics in postchallenge glycemia after renal transplantation
   Ther Drug Monit, 30 (5), 583-90
   DOI 10.1097/FTD.0b013e318187bb2f, PubMed 18728625
3. Bremer S, Mandla R, Vethe NT, Rasmussen I, Rootwelt H, Line PD, Midtvedt K, Bergan S (2008)
   Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression
   Transplantation, 85 (1), 55-61
   DOI 10.1097/01.tp.0000296854.68123.03, PubMed 18192912
4. Dolgos S, Hartmann A, Bønsnes S, Ueland T, Isaksen GA, Godang K, Pfeffer P, Bollerslev J (2008)
   Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation
   Clin Transplant, 22 (4), 462-8
   DOI 10.1111/j.1399-0012.2008.00810.x, PubMed 18318737
5. Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group (2008)
   The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study
   Clin Ther, 30 (3), 482-98
   DOI 10.1016/j.clinthera.2008.03.006, PubMed 18405787
6. Falck P, Asberg A, Byberg KT, Bremer S, Bergan S, Reubsaet JL, Midtvedt K (2008)
   Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients
   Transplantation, 86 (10), 1379-83
   DOI 10.1097/TP.0b013e31818aa4b6, PubMed 19034006
7. Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JL, Pfeffer P, Hartmann A, Midtvedt K (2008)
   Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients
   Transplantation, 85 (2), 179-84
   DOI 10.1097/TP.0b013e31815feede, PubMed 18212621
8. Foss A, Gunther A, Line PD, Brabrand K, Holdaas H, Hartmann A, Midtvedt K (2008)
   Long-term clinical outcome of paediatric kidneys transplanted to adults
   Nephrol Dial Transplant, 23 (2), 726-9
   DOI 10.1093/ndt/gfm826, PubMed 18198285
9. Gunther A, Foss A, Holdaas H, Brabrand K, Hartmann A, Line PD, Midtvedt K (2008)
   Increased peak systolic velocity in the renal artery of paediatric kidneys transplanted to adult recipients
   Nephrol Dial Transplant, 23 (12), 4041-3
   DOI 10.1093/ndt/gfn358, PubMed 18586763
10. Hesselink DA, van Schaik RH, van Agteren M, de Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DR, Pisarski P, Le Meur Y, Mamelok RD, van Gelder T (2008)
    CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients
    Pharmacogenet Genomics, 18 (4), 339-48
    DOI 10.1097/FPC.0b013e3282f75f88, PubMed 18334918
11. Holdaas H (2008)
    Statin therapy for prevention of coronary artery disease. The earlier the better or the longer the better?
    Eur Heart J, 29 (4), 425-6
    DOI 10.1093/eurheartj/ehm628, PubMed 18276612
12. Holdaas H, Bentdal O, Pfeffer P, Mjørnstedt L, Solbu D, Midtvedt K (2008)
    Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot study
    Clin Transplant, 22 (3), 366-71
    DOI 10.1111/j.1399-0012.2008.00795.x, PubMed 18279419
13. Jørgensen L, Heuch I, Jenssen T, Jacobsen BK (2008)
    Association of albuminuria and cancer incidence
    J Am Soc Nephrol, 19 (5), 992-8
    DOI 10.1681/ASN.2007060712, PubMed 18256361
14. Jørgensen L, Jenssen T, Heuch I, Jacobsen BK (2008)
    The combined effect of albuminuria and inflammation on all-cause and cardiovascular mortality in nondiabetic persons
    J Intern Med, 264 (5), 493-501
    DOI 10.1111/j.1365-2796.2008.01992.x, PubMed 18624904
15. Kronborg J, Solbu M, Njølstad I, Toft I, Eriksen BO, Jenssen T (2008)
    Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study
    Nephrol Dial Transplant, 23 (9), 2818-26
    DOI 10.1093/ndt/gfn148, PubMed 18400822
16. Reisaeter AV, Røislien J, Henriksen T, Irgens LM, Hartmann A (2008)
    Pregnancy and birth after kidney donation: the Norwegian experience
    Am J Transplant, 9 (4), 820-4
    DOI 10.1111/j.1600-6143.2008.02427.x, PubMed 18853953
17. Sagedal S, Thiel S, Hansen TK, Mollnes TE, Rollag H, Hartmann A (2008)
    Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation
    Nephrol Dial Transplant, 23 (12), 4054-60
    DOI 10.1093/ndt/gfn355, PubMed 18577532
18. Solbu MD, Kronborg J, Eriksen BO, Jenssen TG, Toft I (2008)
    Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: a gender-specific follow-up study
    Atherosclerosis, 201 (2), 398-406
    DOI 10.1016/j.atherosclerosis.2008.02.027, PubMed 18405901
19. Solbu MD, Kronborg J, Jenssen TG, Njølstad I, Løchen ML, Mathiesen EB, Wilsgaard T, Eriksen BO, Toft I (2008)
    Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events
    Atherosclerosis, 204 (2), 503-8
    DOI 10.1016/j.atherosclerosis.2008.11.002, PubMed 19091314
20. Tangeraas T, Bjerre A, Lien B, Kyte A, Monn E, Cvancarova M, Leivestad T, Reisaeter AV (2008)
    Long-term outcome of pediatric renal transplantation: the Norwegian experience in three eras 1970-2006
    Pediatr Transplant, 12 (7), 762-8
    DOI 10.1111/j.1399-3046.2007.00896.x, PubMed 18208441
21. van Agteren M, Armstrong VW, van Schaik RH, de Fijter H, Hartmann A, Zeier M, Budde K, Kuypers D, Pisarski P, Le Meur Y, van der Werf M, Mamelok RD, Oellerich M, van Gelder T (2008)
    AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism
    Ther Drug Monit, 30 (4), 439-44
    DOI 10.1097/FTD.0b013e318180c709, PubMed 18641546
22. van Gelder T, Silva HT, de Fijter JW, Budde K, Kuypers D, Tyden G, Lohmus A, Sommerer C, Hartmann A, Le Meur Y, Oellerich M, Holt DW, Tönshoff B, Keown P, Campbell S, Mamelok RD (2008)
    Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial
    Transplantation, 86 (8), 1043-51
    DOI 10.1097/TP.0b013e318186f98a, PubMed 18946341
23. Witczak BJ, Hartmann A, Geiran OR, Bugge JF (2008)
    Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine
    Eur J Anaesthesiol, 25 (4), 319-25
    DOI 10.1017/S0265021507003158, PubMed 18182121
24. Zwisler AD, Soja AM, Rasmussen S, Frederiksen M, Abedini S, Appel J, Rasmussen H, Gluud C, Iversen L, Sigurd B, Madsen M, Fischer-Hansen J, DANREHAB Group (2008)
    Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial
    Am Heart J, 155 (6), 1106-13
    DOI 10.1016/j.ahj.2007.12.033, PubMed 18513526
25. Aasebø W, Homb-Vesteraas NA, Hartmann A, Stavem K (2008)
    Life situation and quality of life in young adult kidney transplant recipients
    Nephrol Dial Transplant, 24 (1), 304-8
    DOI 10.1093/ndt/gfn537, PubMed 18840897

Publications 2007

1. Berdal M, Appelbom HI, Eikrem JH, Lund A, Zykova S, Busund LT, Seljelid R, Jenssen T (2007)
   Aminated beta-1,3-D-glucan improves wound healing in diabetic db/db mice
   Wound Repair Regen, 15 (6), 825-32
   DOI 10.1111/j.1524-475X.2007.00286.x, PubMed 18028130
2. Ekberg H, Kyllönen L, Madsen S, Grave G, Solbu D, Holdaas H (2007)
   Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients
   Transplantation, 83 (3), 282-9
   DOI 10.1097/01.tp.0000251923.14697.f5, PubMed 17297402
3. Ekberg H, Kyllönen L, Madsen S, Grave G, Solbu D, Holdaas H (2007)
   Clinicians underestimate gastrointestinal symptoms and overestimate quality of life in renal transplant recipients: a multinational survey of nephrologists
   Transplantation, 84 (8), 1052-4
   DOI 10.1097/01.tp.0000284983.89207.1a, PubMed 17989612
4. Falck P, Guldseth H, Asberg A, Midtvedt K, Reubsaet JL (2007)
   Determination of ciclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry
   J Chromatogr B Analyt Technol Biomed Life Sci, 852 (1-2), 345-52
   DOI 10.1016/j.jchromb.2007.01.039, PubMed 17301005
5. Falck P, Vethe NT, Asberg A, Midtvedt K, Bergan S, Reubsaet JL, Holdaas H (2007)
   Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients
   Nephrol Dial Transplant, 23 (3), 1048-53
   DOI 10.1093/ndt/gfm632, PubMed 17956893
6. Fellström B, Holdaas H, Jardine AG, Rose H, Schmieder R, Wilpshaar W, Zannad F, AURORA Study Group (2007)
   Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study
   Kidney Blood Press Res, 30 (5), 314-22
   DOI 10.1159/000106803, PubMed 17671394
7. Foss A, Line PD, Brabrand K, Midtvedt K, Hartmann A (2007)
   A prospective study on size and function of paediatric kidneys (<10 years) transplanted to adults
   Nephrol Dial Transplant, 22 (6), 1738-42
   DOI 10.1093/ndt/gfm080, PubMed 17384415
8. Heldal K, Leivestad T, Hartmann A, Svendsen MV, Lien BH, Midtvedt K (2007)
   Kidney transplantation in the elderly--the Norwegian experience
   Nephrol Dial Transplant, 23 (3), 1026-31
   DOI 10.1093/ndt/gfm719, PubMed 18079146
9. Hjelmesaeth J (2007)
   [Morbid obesity]
   Tidsskr Nor Laegeforen, 127 (1), 14
   PubMed 17205081
10. Hjelmesaeth J (2007)
    [Increased risk of myocardial infarction following rosiglitazone?]
    Tidsskr Nor Laegeforen, 127 (13), 1809
    PubMed 17599146
11. Hjelmesaeth J, Asberg A, Hartmann A, Jenssen T (2007)
    The effect of ciclosporin on insulin secretion and resistance - Reply
    Nephrol. Dial. Transplant., 22 (11), 3359
    DOI 10.1093/ndt/gfm526
12. Hjelmesaeth J, Hagen LT, Asberg A, Midtvedt K, Størset O, Halvorsen CE, Mørkrid L, Hartmann A, Jenssen T (2007)
    The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man
    Nephrol Dial Transplant, 22 (6), 1743-9
    DOI 10.1093/ndt/gfl820, PubMed 17299003
13. Hjelmesaeth J, Jenssen T, Hartmann A (2007)
    Ghrelin, atherosclerosis, and glucose: GAG or causal relationships?
    Transplantation, 84 (10), 1220-1
    DOI 10.1097/01.tp.0000287429.29273.ca, PubMed 18049105
14. Inan I, Gervaz P, Hagen M, Morel P (2007)
    Multimedia article. Laparoscopic repair of parastomal hernia using a porcine dermal collagen (Permacol) implant
    Dis Colon Rectum, 50 (9), 1465
    DOI 10.1007/s10350-007-0275-9, PubMed 17619220
15. Jørgensen L, Jenssen T, Ahmed L, Bjørnerem A, Joakimsen R, Jacobsen BK (2007)
    Albuminuria and risk of nonvertebral fractures
    Arch Intern Med, 167 (13), 1379-85
    DOI 10.1001/archinte.167.13.1379, PubMed 17620531
16. Kronborg J, Jenssen T, Njølstad I, Toft I, Eriksen BO (2007)
    Metabolic risk factors associated with serum creatinine in a non-diabetic population
    Eur J Epidemiol, 22 (10), 707-13
    DOI 10.1007/s10654-007-9164-8, PubMed 17653600
17. Kronborg J, Johnsen SH, Njølstad I, Toft I, Eriksen BO, Jenssen T (2007)
    Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromsø Study
    Diabetologia, 50 (8), 1607-14
    DOI 10.1007/s00125-007-0715-z, PubMed 17558484
18. Midtvedt K, Bjorang O, Letting AS (2007)
    Successful pregnancy in renal transplant recipient with previous known polyomavirus nephropathy
    Clin Transplant, 21 (4), 571-3
    DOI 10.1111/j.1399-0012.2007.00673.x, PubMed 17645722
19. Sagedal S, Rollag H, Hartmann A (2007)
    Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk
    Clin Transplant, 21 (3), 309-13
    DOI 10.1111/j.1399-0012.2006.00639.x, PubMed 17488378
20. Singer JB, Holdaas H, Jardine AG, Fellstrøm B, Os I, Bermann G, Meyer JM, Assessment of Lescol in Renal Transplantation (ALERT) Study Investigators (2007)
    Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients
    J Lipid Res, 48 (9), 2072-8
    DOI 10.1194/jlr.M700076-JLR200, PubMed 17563401
21. Valderhaug TG, Hjelmesaeth J, Rollag H, Leivestad T, Røislien J, Jenssen T, Hartmann A (2007)
    Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade
    Transplantation, 84 (9), 1125-30
    DOI 10.1097/01.tp.0000287191.45032.38, PubMed 17998867
22. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N, DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C Monitoring Versus Tacrolimus) Investigators (2007)
    Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus
    Am J Transplant, 7 (6), 1506-14
    DOI 10.1111/j.1600-6143.2007.01749.x, PubMed 17359512
23. Voytovich MH, Haukereid C, Hjelmesaeth J, Hartmann A, Løvik A, Jenssen T (2007)
    Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipients
    Clin Transplant, 21 (2), 246-51
    DOI 10.1111/j.1399-0012.2006.00634.x, PubMed 17425753
24. Witczak BJ, Jenssen T, Endresen K, Røislien J, Hartmann A (2007)
    Risk factors for mortality in diabetic nephropathy patients accepted for transplantation
    Transplantation, 84 (3), 356-61
    DOI 10.1097/01.tp.0000276935.31584.4c, PubMed 17700161
25. Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I (2007)
    Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes
    Transplantation, 83 (5), 600-6
    DOI 10.1097/01.tp.0000255583.34329.dd, PubMed 17353781

Publications 2006

1. Asberg A, Midtvedt K, Line PD, Narverud J, Holdaas H, Jenssen T, Reisaeter AV, Johnsen LF, Fauchald P, Hartmann A (2006)
   Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients
   Transplantation, 82 (1), 62-8
   DOI 10.1097/01.tp.0000225803.04995.2b, PubMed 16861943
2. Aune E, Hjelmesaeth J, Fox KA, Endresen K, Otterstad JE (2006)
   High mortality rates in conservatively managed patients with acute coronary syndrome
   Scand Cardiovasc J, 40 (3), 137-44
   DOI 10.1080/14017430600699889, PubMed 16798660
3. Boberg KM, Foss A, Midtvedt K, Schrumpf E (2006)
   ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody
   Clin Transplant, 20 (2), 265-8
   DOI 10.1111/j.1399-0012.2005.00470.x, PubMed 16640538
4. Bäckman L, Reisaeter AV, Wramner L, Ericzon BG, Salmela K, Brattström C (2006)
   Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus
   Clin Transplant, 20 (3), 336-9
   DOI 10.1111/j.1399-0012.2006.00489.x, PubMed 16824151
5. Fellström B, Abedini S, Holdaas H, Jardine AG, Staffler B, Gimpelewicz C, Assessment of Lescol in Renal Transplantation (ALERT) study group (2006)
   No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study
   Clin Transplant, 20 (6), 732-9
   DOI 10.1111/j.1399-0012.2006.00555.x, PubMed 17100723
6. Hartmann A (2006)
   [Hypercalcemia and proteinuria]
   Tidsskr Nor Laegeforen, 126 (20), 2668
   PubMed 17063596
7. Hartmann A, Holdaas H, Os I, Hunderi OH, Hallan S, Widerøe TE, Svarstad E, Selvig K, Skjønsberg H, Toft I (2006)
   [Staging and measurement of renal function in chronic renal conditions]
   Tidsskr Nor Laegeforen, 126 (9), 1198-200
   PubMed 16670740
8. Hartmann A, Sagedal S, Hjelmesaeth J (2006)
   The natural course of cytomegalovirus infection and disease in renal transplant recipients
   Transplantation, 82 (2 Suppl), S15-7
   DOI 10.1097/01.tp.0000230460.42558.b0, PubMed 16858268
9. Hjelmesaeth J, Flyvbjerg A, Jenssen T, Frystyk J, Ueland T, Hagen M, Hartmann A (2006)
   Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy
   Clin J Am Soc Nephrol, 1 (3), 575-82
   DOI 10.2215/CJN.01471005, PubMed 17699261
10. Hjelmesaeth J, Hartmann A, Leivestad T, Holdaas H, Sagedal S, Olstad M, Jenssen T (2006)
    The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events
    Kidney Int, 69 (3), 588-95
    DOI 10.1038/sj.ki.5000116, PubMed 16395250
11. Hjelmesaeth J, Ueland T, Flyvbjerg A, Bollerslev J, Leivestad T, Jenssen T, Hansen TK, Thiel S, Sagedal S, Røislien J, Hartmann A (2006)
    Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients
    J Am Soc Nephrol, 17 (6), 1746-54
    DOI 10.1681/ASN.2005121368, PubMed 16687626
12. Holdaas H, Hagen E, Asberg A, Lund K, Hartman A, Vaidyanathan S, Prasad P, He YL, Yeh CM, Bigler H, Rouilly M, Denouel J (2006)
    Evaluation of the pharmacokinetic interaction between fluvastatin XL and cyclosporine in renal transplant recipients
    Int J Clin Pharmacol Ther, 44 (4), 163-71
    DOI 10.5414/cpp44163, PubMed 16625985
13. Holdaas H, Singh D (2006)
    Fluvastatin may be similarly effective in older and younger people
    Evid Based Cardiovasc Med, 10 (1), 11-2
    DOI 10.1016/j.ebcm.2006.01.001, PubMed 16530657
14. Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J (2006)
    The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials
    Int J Cardiol, 117 (1), 64-74
    DOI 10.1016/j.ijcard.2006.06.003, PubMed 16889855
15. Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J (2006)
    The renal safety profile of fluvastatin: results of a pooled analysis
    Ren Fail, 28 (6), 487-92
    DOI 10.1080/08860220600781260, PubMed 16928618
16. Holdaas H, Westlie L (2006)
    [A renaissance for home hemodialysis?]
    Tidsskr Nor Laegeforen, 126 (21), 2785
    PubMed 17086216
17. Jenssen T (2006)
    The many faces of proinsulin
    Scand J Clin Lab Invest, 66 (1), 5-6
    DOI 10.1080/00365510500474512, PubMed 16464781
18. Jørgensen L, Jenssen T, Johnsen SH, Mathiesen EB, Heuch I, Joakimsen O, Fosse E, Jacobsen BK (2006)
    Albuminuria as risk factor for initiation and progression of carotid atherosclerosis in non-diabetic persons: the Tromsø Study
    Eur Heart J, 28 (3), 363-9
    DOI 10.1093/eurheartj/ehl394, PubMed 17132646
19. Kaindl AM, Asimiadou S, Manthey D, Hagen MV, Turski L, Ikonomidou C (2006)
    Antiepileptic drugs and the developing brain
    Cell Mol Life Sci, 63 (4), 399-413
    DOI 10.1007/s00018-005-5348-0, PubMed 16389461
20. Mandla R, Midtvedt K, Line PD, Hartmann A, Bergan S (2006)
    Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients
    Transpl Int, 19 (1), 44-53
    DOI 10.1111/j.1432-2277.2005.00228.x, PubMed 16359376
21. Midtvedt K, Brabrand K (2006)
    [Hemodynamic renal changes in right-sided heart failure]
    Tidsskr Nor Laegeforen, 126 (10), 1356; author reply 1356
    PubMed 16691279
22. Oien CM, Reisaeter AV, Os I, Jardine A, Fellström B, Holdaas H (2006)
    Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: post hoc analysis of the ALERT study
    Clin Transplant, 20 (3), 374-82
    DOI 10.1111/j.1399-0012.2006.00496.x, PubMed 16824157
23. Olsen GH, Andresen PA, Hilmarsen HT, Bjørang O, Scott H, Midtvedt K, Rinaldo CH (2006)
    Genetic variability in BK Virus regulatory regions in urine and kidney biopsies from renal-transplant patients
    J Med Virol, 78 (3), 384-93
    DOI 10.1002/jmv.20551, PubMed 16419108
24. Oyen O, Strøm EH, Midtvedt K, Bentdal O, Hartmann A, Bergan S, Pfeffer P, Brekke IB (2006)
    Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome
    Am J Transplant, 6 (2), 412-8
    DOI 10.1111/j.1600-6143.2005.01184.x, PubMed 16426329
25. Soveri I, Holdaas H, Jardine A, Gimpelewicz C, Staffler B, Fellström B (2006)
    Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality
    Nephrol Dial Transplant, 21 (8), 2282-9
    DOI 10.1093/ndt/gfl095, PubMed 16574686
26. Vethe NT, Mandla R, Line PD, Midtvedt K, Hartmann A, Bergan S (2006)
    Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment
    Scand J Clin Lab Invest, 66 (1), 31-44
    DOI 10.1080/00365510500420259, PubMed 16464785
27. Voytovich MH, Asberg A, Hjelmesaeth J, Jenssen T, Hartmann A (2006)
    Association between insulin resistance and endothelial dysfunction in renal transplant recipients
    Clin Transplant, 20 (2), 195-9
    DOI 10.1111/j.1399-0012.2005.00465.x, PubMed 16640526
28. Witczak BJ, Hartmann A, Jenssen T, Foss A, Endresen K (2006)
    Routine coronary angiography in diabetic nephropathy patients before transplantation
    Am J Transplant, 6 (10), 2403-8
    DOI 10.1111/j.1600-6143.2006.01491.x, PubMed 16952302

Publications 2005

1. Bryhni B, Jenssen TG, Olafsen K, Bendikssen A (2005)
   Oxidative and nonoxidative glucose disposal in elderly vs younger men with similar and smaller body mass indices and waist circumferences
   Metabolism, 54 (6), 748-55
   DOI 10.1016/j.metabol.2005.01.016, PubMed 15931609
2. Büchler M, Chadban S, Cole E, Midtvedt K, Thervet E, Prestele H, Keown P (2005)
   Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases
   Nephrol Dial Transplant, 21 (1), 197-202
   DOI 10.1093/ndt/gfi113, PubMed 16204301
3. Corsini A, Holdaas H (2005)
   Fluvastatin in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation
   Ren Fail, 27 (3), 259-73
   DOI 10.1081/JDI-200056623, PubMed 15957541
4. Fellström B, Holdaas H, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Staffler B, Pedersen TR, Assessment of Lescol in Renal Transplantation Study Investigators (2005)
   Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial
   Transplantation, 79 (2), 205-12
   DOI 10.1097/01.tp.0000147338.34323.12, PubMed 15665769
5. Fellström B, Jardine AG, Soveri I, Cole E, Grönhagen-Riska C, Neumayer HH, Maes B, Gimpelewicz C, Holdaas H, Assessment of Lescol in Renal Transplantation trial (2005)
   Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial
   Transplantation, 79 (9), 1160-3
   DOI 10.1097/01.tp.0000160764.35083.b8, PubMed 15880062
6. Fellström B, Jardine AG, Soveri I, Cole E, Neumayer HH, Maes B, Gimpelewicz C, Holdaas H, ALERT Study Group (2005)
   Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation
   Am J Transplant, 5 (8), 1986-91
   DOI 10.1111/j.1600-6143.2005.00983.x, PubMed 15996249
7. Fellström B, Zannad F, Schmieder R, Holdaas H, Jardine A, Rose H, Wilpshaar W, AURORA Study Group (2005)
   Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study
   Curr Control Trials Cardiovasc Med, 6 (1), 9
   DOI 10.1186/1468-6708-6-9, PubMed 15910680
8. Hermann M, Asberg A, Christensen H, Reubsaet JL, Holdaas H, Hartmann A (2005)
   Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients
   Eur J Clin Pharmacol, 61 (1), 59-62
   DOI 10.1007/s00228-004-0874-5, PubMed 15711834
9. Hjelmesaeth J, Asberg A, Müller F, Hartmann A, Jenssen T (2005)
   New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection
   Curr Diabetes Rev, 1 (1), 1-10
   DOI 10.2174/1573399052952604, PubMed 18220577
10. Hjelmesaeth J, Müller F, Jenssen T, Rollag H, Sagedal S, Hartmann A (2005)
    Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage
    Nephrol Dial Transplant, 20 (11), 2311-5
    DOI 10.1093/ndt/gfi033, PubMed 16046502
11. Hobbs FD, Gensini G, Mancini GB, Manolis AJ, Bauer B, Böhler S, Genest J, Feldman R, Harvey P, Jenssen TG, Metcalfe M, da Silva PM, JEWEL Study Group (2005)
    Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)
    Int J Cardiol, 110 (2), 242-50
    DOI 10.1016/j.ijcard.2005.10.017, PubMed 16338012
12. Holdaas H (2005)
    Preventing cardiovascular outcome in patients with renal impairment: is there a role for lipid-lowering therapy?
    Am J Cardiovasc Drugs, 5 (4), 255-69
    DOI 10.2165/00129784-200505040-00005, PubMed 15984908
13. Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, Madsen S, Grönhagen-Riska C, Neumayer HH, Maes B, Ambühl P, Hartmann A, Staffler B, Jardine AG, Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators (2005)
    Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study
    Am J Transplant, 5 (12), 2929-36
    DOI 10.1111/j.1600-6143.2005.01105.x, PubMed 16303007
14. Holdaas H, Fellström B, Jardine AG, ALERT Study Group (2005)
    Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: lessons to be learnt from the assessment of Lescol in renal transplantation (ALERT) trial
    Am J Transplant, 5 (6), 1574-5
    DOI 10.1111/j.1600-6143.2005.00909.x, PubMed 15888072
15. Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C, ALERT Study Group (2005)
    Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation
    Nephrol Dial Transplant, 20 (5), 974-80
    DOI 10.1093/ndt/gfh735, PubMed 15784644
16. Jardine AG, Fellström B, Logan JO, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Pedersen T, Holdaas H (2005)
    Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study
    Am J Kidney Dis, 46 (3), 529-36
    DOI 10.1053/j.ajkd.2005.05.014, PubMed 16129216
17. Jenssen T (2005)
    The issue of measuring microalbuminuria
    Scand J Clin Lab Invest, 65 (6), 437-8
    DOI 10.1080/00365510500208308, PubMed 16179275
18. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG (2005)
    Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment
    J Clin Endocrinol Metab, 91 (1), 145-53
    DOI 10.1210/jc.2005-1775, PubMed 16263815
19. Kvale EØ, Dalgaard J, Lund-Johansen F, Rollag H, Farkas L, Midtvedt K, Jahnsen FL, Brinchmann JE, Olweus J (2005)
    CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
    Blood, 107 (5), 2022-9
    DOI 10.1182/blood-2005-05-2016, PubMed 16269620
20. Lemahieu WP, Hermann M, Asberg A, Verbeke K, Holdaas H, Vanrenterghem Y, Maes BD (2005)
    Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus
    Am J Transplant, 5 (9), 2236-43
    DOI 10.1111/j.1600-6143.2005.01005.x, PubMed 16095503
21. Lindhardt TB, Abedini S, Olesen RM, Haunsø S, Gadsbøll N (2005)
    Effects of pharmacological modulation of the ATP-sensitive potassium channels on the development of warm-up angina pectoris
    Cardiology, 105 (1), 17-21
    DOI 10.1159/000088266, PubMed 16166774
22. Midtvedt K (2005)
    [Infections in immunosuppressed children]
    Tidsskr Nor Laegeforen, 125 (13), 1884; author reply 1884
    PubMed 16012580
23. Nashan B, Bock A, Bosmans JL, Budde K, Fijter H, Jaques B, Johnston A, Lück R, Midtvedt K, Pallardó LM, Ready A, Salamé E, Salizzoni M, Suarez F, Thervet E (2005)
    Use of Neoral C monitoring: a European consensus
    Transpl Int, 18 (7), 768-78
    DOI 10.1111/j.1432-2277.2005.00151.x, PubMed 15948854
24. Oberbauer R, Segoloni G, Campistol JM, Kreis H, Mota A, Lawen J, Russ G, Grinyó JM, Stallone G, Hartmann A, Pinto JR, Chapman J, Burke JT, Brault Y, Neylan JF, Rapamune Maintenance Regimen Study Group (2005)
    Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation
    Transpl Int, 18 (1), 22-8
    DOI 10.1111/j.1432-2277.2004.00052.x, PubMed 15612979
25. Russ G, Segoloni G, Oberbauer R, Legendre C, Mota A, Eris J, Grinyó JM, Friend P, Lawen J, Hartmann A, Schena FP, Lelong M, Burke JT, Neylan JF, Rapamune Maintenance Regimen Study Group (2005)
    Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function
    Transplantation, 80 (9), 1204-11
    DOI 10.1097/01.tp.0000178393.78084.9b, PubMed 16314787
26. Sagedal S, Hartmann A, Osnes K, Bjørnsen S, Torremocha J, Fauchald P, Kofstad J, Brosstad F (2005)
    Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin
    Nephrol Dial Transplant, 21 (2), 444-9
    DOI 10.1093/ndt/gfi203, PubMed 16234293
27. Toft I, Jenssen T (2005)
    Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production
    Scand J Clin Lab Invest, 65 (4), 307-20
    DOI 10.1080/00365510510025692, PubMed 16076686
28. Voytovich M, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmann A (2005)
    Short-term rosiglitazone treatment in renal transplant recipients - Reply
    Nephrol. Dial. Transplant., 20 (7), 1512
    DOI 10.1093/ndt/gfh815
29. Witczak B, Hartmann A, Svennevig JL (2005)
    Multiple risk assessment of cardiovascular surgery in chronic renal failure patients
    Ann Thorac Surg, 79 (4), 1297-302
    DOI 10.1016/j.athoracsur.2004.09.010, PubMed 15797066
30. Øien CM, Reisaeter AV, Leivestad T, Pfeffer P, Fauchald P, Os I (2005)
    Gender imbalance among donors in living kidney transplantation: the Norwegian experience
    Nephrol Dial Transplant, 20 (4), 783-9
    DOI 10.1093/ndt/gfh696, PubMed 15701672
31. Aasebø W, Midtvedt K, Hartmann A, Stavem K (2005)
    Predictors of health-related quality of life in hypertensive recipients following renal transplantation
    Clin Transplant, 19 (6), 756-62
    DOI 10.1111/j.1399-0012.2005.00416.x, PubMed 16313321

Publications 2004

1. Asberg A, Holdaas H (2004)
   Fluvastatin and fluvastatin extended release: a clinical and safety profile
   Expert Rev Cardiovasc Ther, 2 (5), 641-52
   DOI 10.1586/14779072.2.5.641, PubMed 15350166
2. Aune E, Steen-Hansen JE, Hjelmesaeth J, Otterstad JE (2004)
   [Prehospital diagnosis and treatment of acute myocardial infarction in Vestfold]
   Tidsskr Nor Laegeforen, 124 (23), 3058-60
   PubMed 15586187
3. Fellström B, Holdaas H, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Logan JO, Pedersen TR, Assessment of Lescol in Renal Transplantation Study Investigators (2004)
   Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial
   Kidney Int, 66 (4), 1549-55
   DOI 10.1111/j.1523-1755.2004.00919.x, PubMed 15458450
4. Hartmann A, Midtvedt K, Witczak B (2004)
   [Kidney injuries and kidney failure caused by drugs]
   Tidsskr Nor Laegeforen, 124 (21), 2765-6
   PubMed 15534671
5. Hermann M, Asberg A, Christensen H, Holdaas H, Hartmann A, Reubsaet JL (2004)
   Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients
   Clin Pharmacol Ther, 76 (4), 388-91
   DOI 10.1016/j.clpt.2004.07.008, PubMed 15470339
6. Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, Nordal KP, Jenssen T (2004)
   Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation
   Diabetologia, 47 (9), 1550-6
   DOI 10.1007/s00125-004-1499-z, PubMed 15338129
7. Hunderi OH, Hovda KE, Lie B, Listerud S, Hartmann A, Jacobsen D (2004)
   [Methanol poisoning in Norway 2002]
   Tidsskr Nor Laegeforen, 124 (24), 3199-202
   PubMed 15608765
8. Jardine AG, Holdaas H, Fellström B, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Holme I, Fauchald P, Gimpelwicz C, Pedersen TR, ALERT Study Investigators (2004)
   fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study
   Am J Transplant, 4 (6), 988-95
   DOI 10.1111/j.1600-6143.2004.00445.x, PubMed 15147434
9. Jørgensen L, Jenssen T, Joakimsen O, Heuch I, Ingebretsen OC, Jacobsen BK (2004)
   Glycated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: the Tromsø study
   Circulation, 110 (4), 466-70
   DOI 10.1161/01.CIR.0000136809.55141.3B, PubMed 15249512
10. Kahra T, Jenssen T, Løvik A (2004)
    Dietary intakes differ between renal transplant recipients living in patient hotels versus home
    J Ren Nutr, 14 (2), 101-8
    DOI 10.1053/j.jrn.2004.01.010, PubMed 15060875
11. Midtvedt K (2004)
    Therapeutic drug monitoring of cyclosporine
    Transplant Proc, 36 (2 Suppl), 430S-433S
    DOI 10.1016/j.transproceed.2004.01.025, PubMed 15041380
12. Midtvedt K, Hjelmesaeth J, Hartmann A, Lund K, Paulsen D, Egeland T, Jenssen T (2004)
    Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal
    J Am Soc Nephrol, 15 (12), 3233-9
    DOI 10.1097/01.ASN.0000145435.80005.1E, PubMed 15579527
13. Sagedal S, Hartmann A (2004)
    Low molecular weight heparins as thromboprophylaxis in patients undergoing hemodialysis/hemofiltration or continuous renal replacement therapies
    Eur J Med Res, 9 (3), 125-30
    PubMed 15096322
14. Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, Degré M, Fauchald P, Rollag H (2004)
    Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
    Kidney Int, 66 (1), 329-37
    DOI 10.1111/j.1523-1755.2004.00735.x, PubMed 15200441
15. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF (2004)
    Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease
    Eur Heart J, 25 (5), 363-70
    DOI 10.1016/j.ehj.2003.12.003, PubMed 15033247
16. Sund S, Grimm P, Reisaeter AV, Hovig T (2004)
    Computerized image analysis vs semiquantitative scoring in evaluation of kidney allograft fibrosis and prognosis
    Nephrol Dial Transplant, 19 (11), 2838-45
    DOI 10.1093/ndt/gfh490, PubMed 15385637
17. Sund S, Reisaeter AV, Scott H, Mollnes TE, Hovig T (2004)
    Glomerular monocyte/macrophage influx correlates strongly with complement activation in 1-week protocol kidney allograft biopsies
    Clin Nephrol, 62 (2), 121-30
    DOI 10.5414/cnp62121, PubMed 15356969
18. Svartberg J, Jenssen T, Sundsfjord J, Jorde R (2004)
    The associations of endogenous testosterone and sex hormone-binding globulin with glycosylated hemoglobin levels, in community dwelling men. The Tromsø Study
    Diabetes Metab, 30 (1), 29-34
    DOI 10.1016/s1262-3636(07)70086-1, PubMed 15029095
19. Voytovich MH, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmann A (2004)
    Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients
    Nephrol Dial Transplant, 20 (2), 413-8
    DOI 10.1093/ndt/gfh641, PubMed 15615809
20. Zykova SN, Svartberg J, Seljelid R, Iversen H, Lund A, Svistounov DN, Jenssen TG (2004)
    Release of TNF-alpha from in vitro-stimulated monocytes is negatively associated with serum levels of apolipoprotein B in patients with type 2 diabetes
    Scand J Immunol, 60 (5), 535-42
    DOI 10.1111/j.0300-9475.2004.01509.x, PubMed 15541048

Publications 2003

1. Asberg A, Holdaas H, Jardine AG, Edvardsen C, Hartmann A (2003)
   Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation
   Clin Transplant, 17 (4), 385-90
   DOI 10.1034/j.1399-0012.2003.00063.x, PubMed 12868997
2. Ballantyne CM, Corsini A, Davidson MH, Holdaas H, Jacobson TA, Leitersdorf E, März W, Reckless JP, Stein EA (2003)
   Risk for myopathy with statin therapy in high-risk patients
   Arch Intern Med, 163 (5), 553-64
   DOI 10.1001/archinte.163.5.553, PubMed 12622602
3. Bryhni B, Jenssen TG, Olafsen K, Eikrem JH (2003)
   Age or waist as determinant of insulin action?
   Metabolism, 52 (7), 850-7
   DOI 10.1016/s0026-0495(03)00100-8, PubMed 12870160
4. Fellström BC, Holdaas H, Jardine AG (2003)
   Why do we need a statin trial in hemodialysis patients?
   Kidney Int Suppl (84), S204-6
   DOI 10.1046/j.1523-1755.63.s84.10.x, PubMed 12694345
5. Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A (2003)
   A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients
   Nephrol Dial Transplant, 18 (10), 2154-9
   DOI 10.1093/ndt/gfg338, PubMed 13679495
6. Hartmann A, Fauchald P, Westlie L, Brekke IB, Holdaas H (2003)
   The risk of living kidney donation
   Nephrol Dial Transplant, 18 (5), 871-3
   DOI 10.1093/ndt/gfg069, PubMed 12686656
7. Hjelmesaeth J, Jenssen T, Hagen M, Egeland T, Hartmann A (2003)
   Determinants of insulin secretion after renal transplantation
   Metabolism, 52 (5), 573-8
   DOI 10.1053/meta.2003.50092, PubMed 12759886
8. Hjelmesaeth J, Jenssen T, Hartmann A (2003)
   Diagnosing PTDM
   Transplantation, 75 (10), 1761
   DOI 10.1097/01.TP.0000064543.07931.F6, PubMed 12777872
9. Holdaas H, Fellström B, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR, Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators (2003)
   Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
   Lancet, 361 (9374), 2024-31
   DOI 10.1016/S0140-6736(03)13638-0, PubMed 12814712
10. Holdaas H, Jardine A (2003)
    Acute renal allograft rejections, a role for statins?
    Minerva Urol Nefrol, 55 (2), 111-9
    PubMed 12847415
11. Jakobsen A, Holdaas H, Leivestad T (2003)
    Ethics and safety of living kidney donation
    Transplant Proc, 35 (3), 1177-8
    DOI 10.1016/s0041-1345(03)00136-2, PubMed 12947899
12. Mandla R, Line PD, Midtvedt K, Bergan S (2003)
    Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients
    Ther Drug Monit, 25 (3), 407-14
    DOI 10.1097/00007691-200306000-00025, PubMed 12766573
13. Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, Bergrem H, Eriksen BO, Pfeffer PF, Dalen I, Leivestad T (2003)
    C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
    Transplantation, 76 (8), 1236-8
    DOI 10.1097/01.TP.0000085046.39523.D5, PubMed 14578761
14. Midtvedt K, Fauchald P, Lien B, Hartmann A, Albrechtsen D, Bjerkely BL, Leivestad T, Brekke IB (2003)
    Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection
    Clin Transplant, 17 (1), 69-74
    DOI 10.1034/j.1399-0012.2003.02105.x, PubMed 12588325
15. Otterstad JE, Hjelmesaeth J, Hoffstad T (2003)
    [Percutaneous coronary intervention]
    Tidsskr Nor Laegeforen, 123 (5), 685
    PubMed 12683209
16. Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Asberg A, Degré M, Fauchald P, Rollag H (2003)
    Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study
    Nephrol Dial Transplant, 18 (9), 1899-908
    DOI 10.1093/ndt/gfg302, PubMed 12937241
17. Schramm W, Bergrem H, Cromme P, Feest T, Borch-Johnsen K, Feldt-Rasmussen B, Landgraf R (2003)
    First referral of diabetic patients to a nephrologist
    Diabet Med, 20 (8), 689-90
    DOI 10.1046/j.1464-5491.2003.09283.x, PubMed 12873302
18. Sund S, Hovig T, Reisaeter AV, Scott H, Bentdal Ø, Mollnes TE (2003)
    Complement activation in early protocol kidney graft biopsies after living-donor transplantation
    Transplantation, 75 (8), 1204-13
    DOI 10.1097/01.TP.0000062835.30165.2C, PubMed 12717204
19. Toft I, Lindal S, Bønaa KH, Jenssen T (2003)
    Quantitative measurement of muscle fiber composition in a normal population
    Muscle Nerve, 28 (1), 101-8
    DOI 10.1002/mus.10373, PubMed 12811780
20. Westlie L, Leivestad T, Holdaas H, Lien B, Hartmann A, Fauchald P (2003)
    [Is current practice concerning living donors in kidney transplantations acceptable?]
    Tidsskr Nor Laegeforen, 123 (8), 1063-5
    PubMed 12760222
21. Westlie L, Leivestad T, Holdaas H, Lien B, Meyer K, Fauchald P (2003)
    Report from the Norwegian National Hospitals Living Donor Registry: one-year data, January 1, 2002
    Transplant Proc, 35 (2), 777-8
    DOI 10.1016/s0041-1345(03)00039-3, PubMed 12644132
22. Westlie L, Leivestad T, Holdaas H, Lien B, Meyer K, Fauchald P (2003)
    [How are living kidney donors doing?]
    Tidsskr Nor Laegeforen, 123 (8), 1060-2
    PubMed 12760221
23. Witczak B, Hartmann A, Leivestad T, Øyen O, Svennevig J (2003)
    Cardiovascular surgery in renal failure patients with or without subsequent renal transplantation
    Transplant Proc, 35 (2), 798-800
    DOI 10.1016/s0041-1345(03)00075-7, PubMed 12644143

Publications 2002

1. Bjorang O, Tveitan H, Midtvedt K, Broch LU, Scott H, Andresen PA (2002)
   Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient
   Nephrol Dial Transplant, 17 (11), 2023-5
   DOI 10.1093/ndt/17.11.2023, PubMed 12401867
2. Cole E, Midtvedt K, Johnston A, Pattison J, O'Grady C (2002)
   Recommendations for the implementation of Neoral C(2) monitoring in clinical practice
   Transplantation, 73 (9 Suppl), S19-22
   DOI 10.1097/00007890-200205151-00004, PubMed 12023609
3. Hartmann A, Jenssen T, Midtvedt K, Reisaeter AV, Fauchald P, Henriksen T, Monn E, Christophersen B (2002)
   [Protein-creatinine ratio--a simple method for proteinuria assessment in clinical practice]
   Tidsskr Nor Laegeforen, 122 (22), 2180-3
   PubMed 12426892
4. Heldal K, Midtvedt K (2002)
   [Licorice--not just candy]
   Tidsskr Nor Laegeforen, 122 (8), 774-6
   PubMed 12092066
5. Hjelmesaeth J, Carlsson PO (2002)
   Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study
   Lancet, 359 (9324), 2201-2; author reply 2203-4
   DOI 10.1016/S0140-6736(02)09074-8, PubMed 12091007
6. Hjelmesaeth J, Hagen M, Hartmann A, Midtvedt K, Egeland T, Jenssen T (2002)
   The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation
   Clin Transplant, 16 (6), 389-96
   DOI 10.1034/j.1399-0012.2002.02059.x, PubMed 12437616
7. Hjelmesaeth J, Jenssen T, Egeland T, Hagen M, Hartmann A (2002)
   Response to Montori et al. Post-transplantation diabetes (PTD), risk factors for its development, prognostic implications, and optimal management of the disease
   Diabetes Care, 25 (9), 1667; discussion 1667-8
   DOI 10.2337/diacare.25.9.1667, PubMed 12196456
8. Hjelmesaeth J, Jenssen T, Hartmann A (2002)
   Diagnosing PTDM
   Transplantation, 74 (4), 579
   DOI 10.1097/00007890-200208270-00027, PubMed 12352924
9. Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A (2002)
   Insulin resistance after renal transplantation
   Diabetes Care, 25 (7), 1260-1261
   DOI 10.2337/diacare.25.7.1260
10. Holdaas H, Julian D (2002)
    The use of statins after solid organ transplantation
    Nephrol Dial Transplant, 17 (8), 1537
    DOI 10.1093/ndt/17.8.1537, PubMed 12147814
11. Midtvedt K, Hartmann A (2002)
    Hypertension after kidney transplantation: are treatment guidelines emerging?
    Nephrol Dial Transplant, 17 (7), 1166-9
    DOI 10.1093/ndt/17.7.1166, PubMed 12105236
12. Midtvedt K, Hartmann A (2002)
    Response to "Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared with lisinopril"
    Transplantation, 74 (1), UNSP 0041-1337/02/7401-139/0-140
    DOI 10.1097/00007890-200207150-00026
13. Os I, Stenehjem A, Høieggen A, Draganov B, Jenssen T, Holdaas H (2002)
    [Type 2 diabetes and nephropathy--new studies, new treatment strategies?]
    Tidsskr Nor Laegeforen, 122 (9), 918-20
    PubMed 12082835
14. Osterby R, Hartmann A, Nyengaard JR, Bangstad HJ (2002)
    Development of renal structural lesions in type-1 diabetic patients with microalbuminuria. Observations by light microscopy in 8-year follow-up biopsies
    Virchows Arch, 440 (1), 94-101
    DOI 10.1007/s004280100485, PubMed 11942582
15. Sagedal S, Nordal KP, Hartmann A, Sund S, Scott H, Degré M, Foss A, Leivestad T, Osnes K, Fauchald P, Rollag H (2002)
    The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
    Am J Transplant, 2 (9), 850-6
    DOI 10.1034/j.1600-6143.2002.20907.x, PubMed 12392291
16. Thorgersen EB, Øfsti AM, Nyheim T, Abedini S (2002)
    [Acute groin pain and femoral nerve deficit in a warfarin treated patient]
    Tidsskr Nor Laegeforen, 122 (24), 2360-1
    PubMed 12448249
17. Toft I, Bønaa KH, Eikrem J, Bendiksen AL, Iversen H, Jenssen T (2002)
    Microalbuminuria in hypertension is not a determinant of insulin resistance
    Kidney Int, 61 (4), 1445-52
    DOI 10.1046/j.1523-1755.2002.00286.x, PubMed 11918751
18. Toft I, Gerich JE, Jenssen T (2002)
    Autoregulation of endogenous glucose production during hyperglucagonemia
    Metabolism, 51 (9), 1128-34
    DOI 10.1053/meta.2002.34702, PubMed 12200756
19. van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE (2002)
    Disturbances in beta-cell function in impaired fasting glycemia
    Diabetes, 51 Suppl 1, S265-70
    DOI 10.2337/diabetes.51.2007.s265, PubMed 11815491

Publications 2001

1. Asberg A, Hartmann A, Fjeldså E, Bergan S, Holdaas H (2001)
   Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients
   Am J Transplant, 1 (4), 382-6
   DOI 10.1034/j.1600-6143.2001.10415.x, PubMed 12099384
2. Asberg A, Hartmann A, Fjeldså E, Holdaas H (2001)
   Atorvastatin improves endothelial function in renal-transplant recipients
   Nephrol Dial Transplant, 16 (9), 1920-4
   DOI 10.1093/ndt/16.9.1920, PubMed 11522880
3. Asberg A, Midtvedt K, Vassbotn T, Hartmann A (2001)
   Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients
   Nephrol Dial Transplant, 16 (7), 1465-70
   DOI 10.1093/ndt/16.7.1465, PubMed 11427642
4. Gøransson LG, Bergrem H (2001)
   Consequences of late referral of patients with end-stage renal disease
   J Intern Med, 250 (2), 154-9
   DOI 10.1046/j.1365-2796.2001.00869.x, PubMed 11489065
5. Hjelmesaeth J, Hartmann A, Kofstad J, Egeland T, Stenstrøm J, Fauchald P (2001)
   Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance
   Nephrol Dial Transplant, 16 (4), 829-35
   DOI 10.1093/ndt/16.4.829, PubMed 11274282
6. Hjelmesaeth J, Hartmann A, Midtvedt K, Aakhus S, Stenstrøm J, Mørkrid L, Egeland T, Tordarson H, Fauchald P (2001)
   Metabolic cardiovascular syndrome after renal transplantation
   Nephrol Dial Transplant, 16 (5), 1047-52
   DOI 10.1093/ndt/16.5.1047, PubMed 11328915
7. Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A (2001)
   Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy
   Diabetes Care, 24 (12), 2121-6
   DOI 10.2337/diacare.24.12.2121, PubMed 11723094
8. Holdaas H, Fellström B, Holme I, Nyberg G, Fauchald P, Jardine A, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Weinreich T, Olsson AG, Pedersen TR, Benghozi R, Hartmann A, ALERT Study Group. Assessment of Lescol in Renal Transplantation (2001)
   Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data
   J Cardiovasc Risk, 8 (2), 63-71
   DOI 10.1177/174182670100800202, PubMed 11324372
9. Holdaas H, Jardine AG, Wheeler DC, Brekke IB, Conlon PJ, Fellstrøm B, Hammad A, Holme I, Isoniemi H, Moore R, Rowe PA, Sweny P, Talbot DA, Wadstrøm J, Østraat Ø (2001)
   Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial
   Kidney Int, 60 (5), 1990-7
   DOI 10.1046/j.1523-1755.2001.00010.x, PubMed 11703619
10. Jenssen T (2001)
    [Revised national budget and peritoneal dialysis--all that glitters is not gold]
    Tidsskr Nor Laegeforen, 121 (17), 2094
    PubMed 11875911
11. Kolstad O, Jenssen TG, Ingebretsen OC, Vinnars E, Revhaug A (2001)
    Combination of recombinant human growth hormone and glutamine-enriched total parenteral nutrition to surgical patients: effects on circulating amino acids
    Clin Nutr, 20 (6), 503-10
    DOI 10.1054/clnu.2001.0478, PubMed 11883998
12. Linde T, Ekberg H, Forslund T, Furuland H, Holdaas H, Nyberg G, Tydén G, Wahlberg J, Danielson BG (2001)
    The use of pretransplant erythropoietin to normalize hemoglobin levels has no deleterious effects on renal transplantation outcome
    Transplantation, 71 (1), 79-82
    DOI 10.1097/00007890-200101150-00013, PubMed 11211199
13. Midtvedt K, Hartmann A, Foss A, Fauchald P, Nordal KP, Rootwelt K, Holdaas H (2001)
    Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril
    Transplantation, 72 (11), 1787-92
    DOI 10.1097/00007890-200112150-00013, PubMed 11740389
14. Midtvedt K, Hartmann A, Holdaas H, Fauchald P (2001)
    Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial
    Clin Transplant, 15 (6), 426-31
    DOI 10.1034/j.1399-0012.2001.150611.x, PubMed 11737121
15. Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, Fauchald P, Holdaas H (2001)
    Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study
    Transplantation, 72 (1), 107-11
    DOI 10.1097/00007890-200107150-00021, PubMed 11468543
16. Reisaeter AV, Hartmann A (2001)
    Risk factors and incidence of posttransplant diabetes mellitus
    Transplant Proc, 33 (5A Suppl), 8S-18S
    DOI 10.1016/s0041-1345(01)02229-1, PubMed 11498199
17. Witczak BJ, Asberg A, Hartmann A (2001)
    [Acute dialysis-dependent renal failure at the Rikshospital in 1998]
    Tidsskr Nor Laegeforen, 121 (10), 1216-9
    PubMed 11402747

Publications 2000

1. Birkeland KI, Claudi T, Hansteen V, Hanssen KF, Hjermann I, Jenssen T, Jervell J, Os I (2000)
   [Prevention of cardiovascular disease in type 2 diabetes]
   Tidsskr Nor Laegeforen, 120 (21), 2554-9
   PubMed 11070996
2. Grill V, Claudi T, Følling I, Jenssen T, Hanssen K, Jervell J (2000)
   [New diagnostic criteria for diabetes mellitus--why?]
   Tidsskr Nor Laegeforen, 120 (16), 1876-7
   PubMed 10925616
3. Hartmann A, Halvorsen CE, Jenssen T, Bjørneklett A, Brekke IB, Bakke SJ, Hirschberg H, Tønjum T, Gaustad P (2000)
   Intracerebral abscess caused by Nocardia otitidiscaviarum in a renal transplant patient--cured by evacuation plus antibiotic therapy
   Nephron, 86 (1), 79-83
   DOI 10.1159/000045716, PubMed 10971157
4. Hjalmarsen A, Viitanen M, Jenssen T, Jorde R, Johansen O (2000)
   Plasma beta-endorphin concentrations are increased in chronic obstructive pulmonary disease patients
   Scand J Clin Lab Invest, 60 (6), 501-6
   DOI 10.1080/003655100448482, PubMed 11129066
5. Hjelmesaeth J (2000)
   [New diagnostic criteria for diabetes mellitus]
   Tidsskr Nor Laegeforen, 120 (18), 2193
   PubMed 11006749
6. Hjelmesaeth J, Hartmann A (2000)
   Risk for posttransplant diabetes mellitus with current immunosuppressive medications
   Am J Kidney Dis, 35 (3), 562
   DOI 10.1016/s0272-6386(00)70217-4, PubMed 10692289
7. Jindal RM, Hjelmesaeth J (2000)
   Impact and management of posttransplant diabetes mellitus
   Transplantation, 70 (11 Suppl), SS58-63
   PubMed 11152233
8. Midtvedt K, Neumayer HH (2000)
   Management strategies for posttransplant hypertension
   Transplantation, 70 (11 Suppl), SS64-9
   PubMed 11152234
9. Skeie S, Bergrem H (2000)
   [Use of information technology in quality development of diabetic care]
   Tidsskr Nor Laegeforen, 120 (16), 1899-902
   PubMed 10925622
10. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Häring H, Fritsche A, Gerich J (2000)
    Assessment of insulin secretion from the oral glucose tolerance test in white patients with type 2 diabetes
    Diabetes Care, 23 (9), 1440-1
    DOI 10.2337/diacare.23.9.1440, PubMed 10977054
11. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Renn W, Gerich J (2000)
    Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity
    Diabetes Care, 23 (3), 295-301
    DOI 10.2337/diacare.23.3.295, PubMed 10868854
12. van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE (2000)
    Relative conributions of beta-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia
    Metabolism, 49 (10), 1318-25
    DOI 10.1053/meta.2000.9526, PubMed 11079822
13. Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R, Seljelid R (2000)
    Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice
    Diabetes, 49 (9), 1451-8
    DOI 10.2337/diabetes.49.9.1451, PubMed 10969828

Publications 1999

1. Asberg A, Attramadal H, Midtvedt K, Sund S, Hartmann A, Berg KJ (1999)
   Gene expression of the renal endothelin system in renal transplant recipients on cyclosporine A based immunosuppression
   Transplantation, 67 (7), 1056-60
   DOI 10.1097/00007890-199904150-00020, PubMed 10221493
2. Halvorsen CE, Hartmann A, Jenssen T, Fauchald P, Brekke IB, Jakobsen JA (1999)
   Salvage of a renal graft by percutaneous transluminal angioplasty of the occluding transplant artery
   Nephrol Dial Transplant, 14 (9), 2231-3
   DOI 10.1093/ndt/14.9.2231, PubMed 10489241
3. Hjelmesaeth J, Hartmann A (1999)
   Insulin resistance in patients with adult polycystic kidney disease
   Nephrol Dial Transplant, 14 (10), 2521-2
   DOI 10.1093/ndt/14.10.2521, PubMed 10528694
4. Hjelmesaeth J, Midtvedt K, Aakhus S, Hartmann A (1999)
   [Cardiovascular disease after kidney transplantation]
   Tidsskr Nor Laegeforen, 119 (25), 3784-8
   PubMed 10574058
5. Jardine A, Holdaas H (1999)
   Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience
   J Clin Pharm Ther, 24 (6), 397-408
   DOI 10.1046/j.1365-2710.1999.00252.x, PubMed 10651972
6. Leivestad T, Reisaeter AV, Brekke IB, Vartdal F, Thorsby E (1999)
   The role of HLA matching in renal transplantation: experience from one center
   Rev Immunogenet, 1 (3), 343-50
   PubMed 11256425
7. Midtvedt K (1999)
   [Infections in renal transplant recipients in Norway]
   Tidsskr Nor Laegeforen, 119 (24), 3621-3
   PubMed 10563182
8. Reisaeter AV (1999)
   [Kidney transplantation in Norway--a historical perspective]
   Tidsskr Nor Laegeforen, 119 (21), 3163-6
   PubMed 10522485
9. Sund S, Reisaeter AV, Fauchald P, Bentdal O, Hall KS, Hovig T (1999)
   Living donor kidney transplants: a biopsy study 1 year after transplantation, compared with baseline changes and correlation to kidney function at 1 and 3 years
   Nephrol Dial Transplant, 14 (10), 2445-54
   DOI 10.1093/ndt/14.10.2445, PubMed 10528671
10. Toft I, Bønaa KH, Lindal S, Berg TJ, Jenssen T (1999)
    Population-based study of the relationship among muscle morphology, insulin action, and hypertension
    Am J Hypertens, 12 (12 Pt 1-2), 1209-16
    DOI 10.1016/s0895-7061(99)00157-0, PubMed 10619584

Publications 1998

1. Balteskard L, Unneberg K, Mjaaland M, Jenssen TG, Revhaug A (1998)
   Growth hormone and insulinlike growth factor 1 promote intestinal uptake and hepatic release of glutamine in sepsis
   Ann Surg, 228 (1), 131-9
   DOI 10.1097/00000658-199807000-00019, PubMed 9671077
2. Balteskard L, Unneberg K, Mjaaland M, Sager G, Jenssen TG, Revhaug A (1998)
   Treatment with growth hormone and insulin-like growth factor-1 in septicemia: effects on carbohydrate metabolism
   Eur Surg Res, 30 (2), 79-94
   DOI 10.1159/000008562, PubMed 9565741
3. Hjelmesaeth J, Hartmann A (1998)
   [Diabetic care in general practice]
   Tidsskr Nor Laegeforen, 118 (2), 278
   PubMed 9485629
4. Holdaas H, Hartmann A, Berg KJ, Lund K, Fauchald P (1998)
   Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy
   Nephrol Dial Transplant, 13 (12), 3096-102
   DOI 10.1093/ndt/13.12.3096, PubMed 9870472
5. Lehne G, Nordal KP, Midtvedt K, Goggin T, Brosstad F (1998)
   Increased potency and decreased elimination of lamifiban, a GPIIb-IIIa antagonist, in patients with severe renal dysfunction
   Thromb Haemost, 79 (6), 1119-25
   PubMed 9657435
6. Midtvedt K (1998)
   [Clostridium difficile-associated diarrhea treated with homologous feces]
   Tidsskr Nor Laegeforen, 118 (11), 1758
   PubMed 9621767
7. Midtvedt K, Hartmann A, Hjelmesaeth J, Lund K, Bjerkely BL (1998)
   Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients
   Nephrol Dial Transplant, 13 (2), 427-31
   DOI 10.1093/oxfordjournals.ndt.a027841, PubMed 9509457
8. Midtvedt K, Hartmann A, Midtvedt T, Brekke IB (1998)
   Routine perioperative antibiotic prophylaxis in renal transplantation
   Nephrol Dial Transplant, 13 (7), 1637-41
   DOI 10.1093/ndt/13.7.1637, PubMed 9681704
9. Midtvedt K, Hartmann A, Sund S (1998)
   Can a diagnosis of renal allograft rejection be based on histology alone?
   Clin Transplant, 12 (4), 300-2
   PubMed 9686323
10. Reisaeter AV, Leivestad T, Vartdal F, Spurkland A, Fauchald P, Brekke IB, Thorsby E (1998)
    A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients
    Transplantation, 66 (4), 523-8
    DOI 10.1097/00007890-199808270-00018, PubMed 9734498
11. Reisaeter AV, Thorsby E, Brinchmann JE (1998)
    Allospecific helper T-lymphocyte repertoire in monozygotic twins
    Scand J Immunol, 47 (4), 381-7
    DOI 10.1046/j.1365-3083.1998.00308.x, PubMed 9600321
12. Sund S, Reisaeter AV, Scott H, Fauchald P, Bentdal O, Sødal G, Hovig T (1998)
    Morphological studies of baseline needle biopsies from living donor kidneys: light microscopic, immunohistochemical and ultrastructural findings
    APMIS, 106 (11), 1017-34
    DOI 10.1111/j.1699-0463.1998.tb00254.x, PubMed 9890263
13. Toft I, Bønaa KH, Jenssen T (1998)
    Insulin resistance in hypertension is associated with body fat rather than blood pressure
    Hypertension, 32 (1), 115-22
    DOI 10.1161/01.hyp.32.1.115, PubMed 9674647
14. Toft I, Bønaa KH, Lindal S, Jenssen T (1998)
    Insulin kinetics, insulin action, and muscle morphology in lean or slightly overweight persons with impaired glucose tolerance
    Metabolism, 47 (7), 848-54
    DOI 10.1016/s0026-0495(98)90125-1, PubMed 9667234

Publications 1997

1. Hjelmesaeth J, Hartmann A, Kofstad J, Stenstrøm J, Leivestad T, Egeland T, Fauchald P (1997)
   Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age
   Transplantation, 64 (7), 979-83
   DOI 10.1097/00007890-199710150-00008, PubMed 9381545
2. Midtvedt K, Hartmann A, Brekke IB, Lyngdal PT, Bentdal O, Haugen G (1997)
   Successful pregnancies in a combined pancreas and renal allograft recipient and in a renal graft recipient on tacrolimus treatment
   Nephrol Dial Transplant, 12 (12), 2764-5
   DOI 10.1093/ndt/12.12.2764, PubMed 9430893
3. Perriello G, Nurjhan N, Stumvoll M, Bucci A, Welle S, Dailey G, Bier DM, Toft I, Jenssen TG, Gerich JE (1997)
   Regulation of gluconeogenesis by glutamine in normal postabsorptive humans
   Am J Physiol, 272 (3 Pt 1), E437-45
   DOI 10.1152/ajpendo.1997.272.3.E437, PubMed 9124550
4. Reisaeter AV, Leivestad T, Fauchald P, Brekke I, Thorsby E (1997)
   Influence of matching for HLA-DR in first cadaveric renal transplantation in nonsensitized recipients
   Transplant Proc, 29 (7), 3099-100
   DOI 10.1016/s0041-1345(97)00798-7, PubMed 9365682
5. Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Birkeland KI, Jenssen T (1997)
   Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension
   Arterioscler Thromb Vasc Biol, 17 (3), 553-9
   DOI 10.1161/01.atv.17.3.553, PubMed 9102176
6. Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Jenssen T (1997)
   Fibrinolytic function after dietary supplementation with omega3 polyunsaturated fatty acids
   Arterioscler Thromb Vasc Biol, 17 (5), 814-9
   DOI 10.1161/01.atv.17.5.814, PubMed 9157942
7. Unneberg K, Mjaaland M, Balteskard L, Jenssen TG, Bjøro T, Revhaug A (1997)
   Both growth hormone and exogenous glutamine increase gastrointestinal glutamine uptake in trauma
   Ann Surg, 225 (1), 97-102
   DOI 10.1097/00000658-199701000-00011, PubMed 8998125

Publications 1996

1. Hapnes R, Bergrem H (1996)
   Diabetic eye complications in a medium sized municipality in southwest Norway
   Acta Ophthalmol Scand, 74 (5), 497-500
   DOI 10.1111/j.1600-0420.1996.tb00607.x, PubMed 8950402
2. Hartmann A, Andereassen AK, Holdaas H, Simonsen S, Geiran O, Berg KJ (1996)
   Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients
   J Heart Lung Transplant, 15 (10), 972-9
   PubMed 8913913
3. Midtvedt K, Hartmann A, Bentdal O, Brekke IB, Fauchald P (1996)
   Bilateral nephrectomy simultaneously with renal allografting does not alleviate hypertension 3 months following living-donor transplantation
   Nephrol Dial Transplant, 11 (10), 2045-9
   DOI 10.1093/oxfordjournals.ndt.a027094, PubMed 8918720
4. Midtvedt K, Stokke ES, Hartmann A (1996)
   Successful long-term treatment of post-transplant erythrocytosis with losartan
   Nephrol Dial Transplant, 11 (12), 2495-7
   DOI 10.1093/oxfordjournals.ndt.a027224, PubMed 9017632
5. Midtvedt K, Tafjord AB, Hartmann A, Eide TC, Holdaas H, Nordal KP, Draganov B, Sødal G, Leivestad T, Fauchald P (1996)
   Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection
   Transplantation, 62 (1), 38-42
   DOI 10.1097/00007890-199607150-00008, PubMed 8693541
6. Nyberg G, Holdaas H, Brekke IB, Hartmenn A, Norden G, Olausson M, Osterby R (1996)
   Glomerular ultrastructure in kidneys transplanted simultaneously with a segmental pancreas to patients with type 1 diabetes
   Nephrol Dial Transplant, 11 (6), 1029-33
   PubMed 8671964
7. Reisaeter AV, Brinchmann JE, Lundin KE, Thorsby E (1996)
   Monozygotic twins display differences in their allospecific cytotoxic T-cell repertoire
   Scand J Immunol, 44 (6), 638-42
   DOI 10.1046/j.1365-3083.1996.d01-357.x, PubMed 8972747
8. Reisaeter AV, Thorsby E, Brinchmann JE (1996)
   Analysis of alloreactive helper T lymphocyte precursor frequencies. Influence of interleukin-2 produced by the stimulating cells
   J Immunol Methods, 189 (1), 65-72
   DOI 10.1016/0022-1759(95)00230-8, PubMed 8576581
9. Reseland JE, Holm H, Jacobsen MB, Jenssen TG, Hanssen LE (1996)
   Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretion
   J Nutr, 126 (3), 634-42
   DOI 10.1093/jn/126.3.634, PubMed 8598548
10. Stumvoll M, Perriello G, Nurjhan N, Bucci A, Welle S, Jansson PA, Dailey G, Bier D, Jenssen T, Gerich J (1996)
    Glutamine and alanine metabolism in NIDDM
    Diabetes, 45 (7), 863-8
    DOI 10.2337/diab.45.7.863, PubMed 8666134
11. Unneberg K, Mjaaland M, Balteskard L, Jenssen TG, Revhaug A (1996)
    Growth hormone pre-treatment combined with exogenous glutamine induced a postoperative shift from glucose to glutamine consumption in the gastrointestinal tract
    Clin Nutr, 15 (4), 165-70
    DOI 10.1016/s0261-5614(96)80235-4, PubMed 16844028

Publications 1995

1. Bergrem H, Johansen KS (1995)
   Targets for glycated haemoglobin. Targets set reference points for clinic comparisons
   BMJ, 311 (6998), 189-90
   DOI 10.1136/bmj.311.6998.189c, PubMed 7613443
2. Brekke IB, Bentdal O, Pfeffer P, Lien B, Sødal G, Holdaas H, Fauchald P, Jervell J (1995)
   [Pancreas transplantation. A 10-year material]
   Tidsskr Nor Laegeforen, 115 (6), 703-5
   PubMed 7900130
3. Holdaas H, Hartmann A, Berg KJ, Langberg H, Blystad L, Fauchald P (1995)
   Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy
   J Intern Med, 237 (1), 63-71
   DOI 10.1111/j.1365-2796.1995.tb01141.x, PubMed 7830033
4. Holdaas H, Hartmann A, Stenstrøm J, Dahl KJ, Borge M, Pfister P (1995)
   Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine
   Am J Cardiol, 76 (2), 102A-106A
   DOI 10.1016/s0002-9149(05)80028-1, PubMed 7604781
5. JENSSEN T (1995)
   METHODOLOGICAL PROBLEMS IN EVALUATION OF SOCIAL REFORMS - EXEMPLIFIED BY DEINSTITUTIONALIZATION OF THE MENTALLY-RETARDED IN NORWAY
   Psychol. Rec., 45 (4), 535-563
6. Johansen O, Jorde R, Tønnesen T, Jenssen T, Burhol PG, Reikerås O (1995)
   Effects of naloxone on glucagon and insulin concentrations after injection of endotoxin in rats
   Eur J Surg, 161 (9), 635-8
   PubMed 8541421
7. Mjaaland M, Unneberg K, Jenssen TG, Bjøro T, Lindal S, Revhaug A (1995)
   Metabolic effects of two regimens of growth hormone given before operation in piglets
   Eur J Surg, 161 (9), 639-46
   PubMed 8541422
8. Mjaaland M, Unneberg K, Jenssen TG, Revhaug A (1995)
   Experimental study to show that growth hormone treatment before trauma increases glutamine uptake in the intestinal tract
   Br J Surg, 82 (8), 1076-9
   DOI 10.1002/bjs.1800820823, PubMed 7648157
9. Nurjhan N, Bucci A, Perriello G, Stumvoll M, Dailey G, Bier DM, Toft I, Jenssen TG, Gerich JE (1995)
   Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man
   J Clin Invest, 95 (1), 272-7
   DOI 10.1172/JCI117651, PubMed 7814625
10. Perriello G, Jorde R, Nurjhan N, Stumvoll M, Dailey G, Jenssen T, Bier DM, Gerich JE (1995)
    Estimation of glucose-alanine-lactate-glutamine cycles in postabsorptive humans: role of skeletal muscle
    Am J Physiol, 269 (3 Pt 1), E443-50
    DOI 10.1152/ajpendo.1995.269.3.E443, PubMed 7573421
11. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J (1995)
    Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative
    JAMA, 273 (23), 1855-61
    DOI 10.1001/jama.273.23.1855, PubMed 7776502
12. Reisaeter AV, Leivestad T, Albrechtsen D, Holdaas H, Hartmann A, Sødal G, Flatmark A, Fauchald P (1995)
    Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients
    Transplantation, 60 (3), 242-8
    DOI 10.1097/00007890-199508000-00006, PubMed 7645036
13. Reseland JE, Holm H, Jenssen T, Jacobsen MB, Hanssen LE (1995)
    Inhibitor-stimulated non-parallel pancreatic secretion in man: hormonal and neural regulation?
    Scand J Gastroenterol, 30 (1), 72-80
    DOI 10.3109/00365529509093239, PubMed 7701255
14. Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Jenssen T (1995)
    Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial
    Ann Intern Med, 123 (12), 911-8
    DOI 10.7326/0003-4819-123-12-199512150-00003, PubMed 7486485
15. Tonstad S, Holdaas H, Gørbitz C, Ose L (1995)
    Is dietary intervention effective in post-transplant hyperlipidaemia?
    Nephrol Dial Transplant, 10 (1), 82-5
    PubMed 7724035

Publications 1994

1. Bentdal OH, Brekke IB, Lien B, Pfeffer PF, Sødal G, Hartmann A, Holdaas H, Nordal KP, Fauchald P (1994)
   Rapid development of cancer in both kidney grafts after transplantation from a donor with undiagnosed malignant disease
   Transplant Proc, 26 (3), 1763
   PubMed 8030123
2. Cooper JG, Bergrem H, Lassen J (1994)
   [Hemolytic-uremic syndrome caused by verotoxin-producing Escherichia coli intestinal infection]
   Tidsskr Nor Laegeforen, 114 (27), 3179-81
   PubMed 7809868
3. Gullestad L, Midtvedt K, Dolva LO, Norseth J, Kjekshus J (1994)
   The magnesium loading test: reference values in healthy subjects
   Scand J Clin Lab Invest, 54 (1), 23-31
   DOI 10.3109/00365519409086506, PubMed 8171268
4. Gullestad L, Nes M, Rønneberg R, Midtvedt K, Falch D, Kjekshus J (1994)
   Magnesium status in healthy free-living elderly Norwegians
   J Am Coll Nutr, 13 (1), 45-50
   DOI 10.1080/07315724.1994.10718370, PubMed 8157853
5. Hartmann A, Lund K, Holdaas H, Fauchald P, Reisaeter A, Berg KJ (1994)
   Contrasting short-term effects of nifedipine on glomerular and tubular functions in glomerulonephritic patients
   J Am Soc Nephrol, 5 (6), 1385-90
   DOI 10.1681/ASN.V561385, PubMed 7534496
6. Hartmann A, Reisaeter A, Holdaas H, Rolfsen B, Fauchald P (1994)
   Accidental metabolic acidosis during hemodialysis
   Artif Organs, 18 (3), 214-7
   DOI 10.1111/j.1525-1594.1994.tb02178.x, PubMed 8185487
7. Holdaas H, Andersson R, Fauchald P, Albrechtsen D (1994)
   [Infection in patients with organ transplants]
   Nord Med, 109 (6-7), 194-6
   PubMed 8015915
8. JENSSEN T, NURJHAN N, PERRIELLO G, BUCCI A, TOFT I, GERICH J (1994)
   DETERMINATION OF [C-14] GLUTAMINE SPECIFIC ACTIVITY IN PLASMA
   J. Liq. Chromatogr., 17 (6), 1337-1348
   DOI 10.1080/10826079408013767
9. Reisaeter AV, Fauchald P, Leivestad T, Holdaas H, Hartmann A, Pfeffer P, Sødal G (1994)
   Plasma exchange in highly sensitized patients as induction therapy after renal transplantation
   Transplant Proc, 26 (3), 1758
   PubMed 8030121

Publications 1993

1. Hjelmesaeth J, Rynning S, Halvorsen E, Otterstad JE, Vatne K, Nitter-Hauge S (1993)
   [Are the results of thallium scintigraphy and coronary angiography equivalent? An evaluation of thallium scintigraphies performed at Vestfold Central Hospital]
   Tidsskr Nor Laegeforen, 113 (27), 3342-5
   PubMed 8273057
2. Midtvedt K (1993)
   [Urinary tract infections]
   Tidsskr Nor Laegeforen, 113 (5), 618-9
   PubMed 7794286
3. Omdal R, Gøransson L, Bergrem H (1993)
   Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritis
   Clin Rheumatol, 12 (2), 283-4
   DOI 10.1007/BF02231548, PubMed 8358998

Publications 1992

1. Apeland T, Bergrem H, Berget M (1992)
   [Pregnant diabetics. A retrospective study of pregnancy and labor in women with type 1 diabetes in Sør-Rogaland 1982-90]
   Tidsskr Nor Laegeforen, 112 (19), 2520-3
   PubMed 1412260
2. Fauchald P, Vatne K, Paulsen D, Brodahl U, Sødal G, Holdaas H, Berg KJ, Flatmark A (1992)
   Long-term clinical results of percutaneous transluminal angioplasty in transplant renal artery stenosis
   Nephrol Dial Transplant, 7 (3), 256-9
   DOI 10.1093/oxfordjournals.ndt.a092116, PubMed 1315000
3. Hanssen KF, Jenssen T (1992)
   [Treatment of non-insulin dependent diabetes (type 2 diabetes mellitus)]
   Tidsskr Nor Laegeforen, 112 (7), 912-4
   PubMed 1557762
4. Hartmann A, Holdaas H, Fauchald P, Nordal KP, Berg KJ, Talseth T, Leivestad T, Brekke IB, Flatmark A (1992)
   Fifteen years' experience with renal transplantation in systemic amyloidosis
   Transpl Int, 5 (1), 15-8
   DOI 10.1007/BF00337183, PubMed 1580980
5. HAUGSTVEDT TK, VISTE A, EIDE GE, MAARTMANNMOE H, MYKING A, SOREIDE O, HANSEN O, ANDENAES K, SKJELDAL S, WESSELHOLST C, SOLHEIM K, OMLAND E, BERGAN A, GERNER T, STADAAS J, HARBITZ TB, LIAVAAG I, HOGNESTAD J, HAVIG O, LEIDAL O, UGGERUD R, NORBYE B, AASEN S, SVANE S, HOLME P et al. (1992)
   IS LAUREN HISTOPATHOLOGICAL CLASSIFICATION OF IMPORTANCE IN PATIENTS WITH STOMACH-CANCER - A NATIONAL EXPERIENCE
   Eur. J. Surg. Oncol., 18 (2), 124-130
6. Holst N, Jenssen TG, Burhol PG (1992)
   Plasma concentrations of motilin and somatostatin are increased in late pregnancy and postpartum
   Br J Obstet Gynaecol, 99 (4), 338-41
   DOI 10.1111/j.1471-0528.1992.tb13735.x, PubMed 1349818
7. Mitrakou A, Mokan M, Bolli G, Veneman T, Jenssen T, Cryer P, Gerich J (1992)
   Evidence against the hypothesis that hyperinsulinemia increases sympathetic nervous system activity in man
   Metabolism, 41 (2), 198-200
   DOI 10.1016/0026-0495(92)90153-2, PubMed 1736043
8. Mitrakou A, Vuorinen-Markkola H, Raptis G, Toft I, Mokan M, Strumph P, Pimenta W, Veneman T, Jenssen T, Bolli G (1992)
   Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp
   J Clin Endocrinol Metab, 75 (2), 379-82
   DOI 10.1210/jcem.75.2.1639939, PubMed 1639939
9. Uhlving S, Bergrem H, Gabrielsen K (1992)
   [Prevalence of diabetes in a 5-year material of amputations in Sør-Rogaland]
   Tidsskr Nor Laegeforen, 112 (3), 328-30
   PubMed 1553666

Publications 1991

1. Bentdal OH, Fauchald P, Brekke IB, Holdaas H, Hartmann A (1991)
   Rehabilitation and quality of life in diabetic patients after successful pancreas-kidney transplantation
   Diabetologia, 34 Suppl 1, S158-9
   DOI 10.1007/BF00587645, PubMed 1936685
2. Berg KJ, Holdaas H, Endresen L, Fauchald P, Hartmann A, Pran T, Solbu D (1991)
   Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients
   Nephrol Dial Transplant, 6 (10), 725-30
   DOI 10.1093/ndt/6.10.725, PubMed 1836548
3. Durrant JD, Gerich JE, Mitrakou A, Jenssen T, Hyre RJ (1991)
   Changes in BAEP under hypoglycemia: temperature-related?
   Electroencephalogr Clin Neurophysiol, 80 (6), 547-50
   DOI 10.1016/0168-5597(91)90137-m, PubMed 1720731
4. Endresen L, Bergan S, Holdaas H, Pran T, Sinding-Larsen B, Berg KJ (1991)
   Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients
   Ther Drug Monit, 13 (6), 490-5
   DOI 10.1097/00007691-199111000-00004, PubMed 1837629
5. Hartmann A, Charania B, Sund S, Holdaas H, Fauchald P, Flatmark A (1991)
   Interstitial nephritis with extensive calcium deposits as a cause of renal allograft failure
   Nephrol Dial Transplant, 6 (12), 984-8
   DOI 10.1093/ndt/6.12.984, PubMed 1798600
6. Hartmann A, Holdaas H (1991)
   [Therapeutic principles in hyperkalemia]
   Tidsskr Nor Laegeforen, 111 (18), 2275-7
   PubMed 1896986
7. Holdaas H, Brekke IB, Hartmann A, Fauchald P, Bentdal O, Søodal G, Jervell J, Flatmark A (1991)
   Long-term glucose control following combined kidney and pancreatic transplantation
   Transplant Proc, 23 (1 Pt 2), 1656-7
   PubMed 1989322
8. Holdaas H, Hartmann A, Lien MG, Nilsen L, Jervell J, Fauchald P, Endresen L, Djøseland O, Berg KJ (1991)
   Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy
   J Intern Med, 229 (2), 163-70
   DOI 10.1111/j.1365-2796.1991.tb00325.x, PubMed 1847721
9. Holst N, Jenssen TG, Burhol PG, Haug E (1991)
   Prolactin response to secretin during the spontaneous menstrual cycle in women
   Gynecol Obstet Invest, 31 (1), 37-41
   DOI 10.1159/000293097, PubMed 1672662
10. Holst N, Oian P, Aune B, Jenssen TG, Burhol PG (1991)
    Increased plasma levels of vasoactive intestinal polypeptide in pre-eclampsia
    Br J Obstet Gynaecol, 98 (8), 803-6
    DOI 10.1111/j.1471-0528.1991.tb13486.x, PubMed 1911589
11. Midtvedt K (1991)
    [Measurement of C-reactive protein gives valuable information on patients with various types of inflammation]
    Tidsskr Nor Laegeforen, 111 (13), 1660-1
    PubMed 2063373
12. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J (1991)
    Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction
    Am J Physiol, 260 (1 Pt 1), E67-74
    DOI 10.1152/ajpendo.1991.260.1.E67, PubMed 1987794

Publications 1990

1. Bernersen B, Johnsen R, Straume B, Burhol PG, Jenssen TG, Stakkevold PA (1990)
   Towards a true prevalence of peptic ulcer: the Sørreisa gastrointestinal disorder study
   Gut, 31 (9), 989-92
   DOI 10.1136/gut.31.9.989, PubMed 2210467
2. Brekke IB, Holdaas H, Albrechtsen D, Fauchald P, Flatmark A (1990)
   Combined pancreatic and renal transplantation: improved survival of uremic diabetic patients and renal grafts
   Transplant Proc, 22 (4), 1580
   PubMed 2389410
3. Dahl O, Horn A, Morild I, Halvorsen JF, Odland G, Reinertsen S, Reisaeter A, Kavli H, Thunold J (1990)
   Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway
   Cancer, 66 (11), 2286-94
   DOI 10.1002/1097-0142(19901201)66:11<2286::aid-cncr2820661106>3.0.co;2-t, PubMed 2245382
4. Gerich JE, Mitrakou A, Kelley D, Mandarino L, Nurjhan N, Reilly J, Jenssen T, Veneman T, Consoli A (1990)
   Contribution of impaired muscle glucose clearance to reduced postabsorptive systemic glucose clearance in NIDDM
   Diabetes, 39 (2), 211-6
   DOI 10.2337/diab.39.2.211, PubMed 2227129
5. Holdaas H, Brekke IB, Hartmann A, Fauchald P, Berg KJ, Sødal G, Jervell J, Flatmark A (1990)
   Metabolic control in recipients of duct-occluded segmental pancreatic grafts: a four-year follow-up
   Transplant Proc, 22 (2), 655-6
   PubMed 2327010
6. Holdaas H, Hartmann A, Talseth T, Fauchald P, Sødal G, Brekke IB, Berg KJ (1990)
   Change in intrarenal sodium reabsorption following donor nephrectomy
   Transplant Proc, 22 (1), 246
   PubMed 2309323
7. Holst N, Jenssen TG, Burhol PG (1990)
   A characterization of immunoreactive somatostatin in human milk
   J Pediatr Gastroenterol Nutr, 10 (1), 47-52
   DOI 10.1097/00005176-199001000-00010, PubMed 1969941
8. Holst N, Jenssen TG, Burhol PG, Haug E (1990)
   The effects of secretin on prolactin, estradiol, vasoactive intestinal polypeptide, and somatostatin levels in women
   Acta Endocrinol (Copenh), 122 (3), 313-8
   DOI 10.1530/acta.0.1220313, PubMed 1970210
9. Madsen S, Midtvedt K (1990)
   [Penicillin in clinical use--50 years]
   Tidsskr Nor Laegeforen, 110 (30), 3884-7
   PubMed 2281453
10. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, Gerich J (1990)
    Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM
    Diabetes, 39 (11), 1381-90
    DOI 10.2337/diab.39.11.1381, PubMed 2121568
11. Norstein J, Brekke IB, Holdaas H, Vatne K (1990)
    Arterial stenoses in duct occluded segmental pancreatic grafts treated with percutaneous transluminal angioplasty
    Transplant Proc, 22 (2), 599-601
    PubMed 2139263

Publications 1989

1. Berg KJ, Gjellestad A, Nordby G, Rootwelt K, Djøseland O, Fauchald P, Mehl A, Narverud J, Talseth T (1989)
   Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients
   Nephron, 53 (3), 218-22
   DOI 10.1159/000185747, PubMed 2677807
2. Holdaas H, Brekke IB, Hartmann A, Talseth T, Sødal G, Jervell J, Flatmark A (1989)
   Long-term metabolic control in recipients of duct-occluded segmental pancreatic grafts
   Transplant Proc, 21 (1 Pt 3), 2854-5
   PubMed 2650384
3. Holst N, Jenssen TG, Burhol PG, Haug E, Forsdahl F (1989)
   Plasma gastrointestinal hormones during spontaneous and induced menstrual cycles
   J Clin Endocrinol Metab, 68 (6), 1160-6
   DOI 10.1210/jcem-68-6-1160, PubMed 2498386
4. Holst N, Jenssen TG, Burhol PG, Maltau JM (1989)
   Plasma secretin concentrations during normal human pregnancy, delivery, and postpartum
   Br J Obstet Gynaecol, 96 (4), 424-7
   DOI 10.1111/j.1471-0528.1989.tb02416.x, PubMed 2751955
5. Hvidsten D, Lindsetmo RO, Røkke O, Jenssen TG, Burhol PG, Revhaug A (1989)
   Clearance of vasoactive intestinal polypeptide (VIP) in the porcine pulmonary circulation
   Regul Pept, 26 (3), 267-75
   DOI 10.1016/0167-0115(89)90194-8, PubMed 2623191
6. Johannessen JO, Bergrem H (1989)
   [Neuroleptic malignant syndrome]
   Tidsskr Nor Laegeforen, 109 (6), 696-7
   PubMed 2922736
7. Tydén G, Brattström C, Bolinder J, Bohman SO, Groth CG, Brekke IB, Holdaas H, Flatmark A (1989)
   Long-term metabolic control in recipients of segmental-pancreas grafts with pancreaticoenterostomy or duct obstruction
   Diabetes, 38 Suppl 1, 94-6
   DOI 10.2337/diab.38.1.s94, PubMed 2642864

Publications 1988

1. Almdahl SM, Jenssen TG, Samdal FA, Burhol PG (1988)
   The effect of pancreatectomy and gastroenterectomy on the release of somatostatin and vasoactive intestinal polypeptide in experimental fecal peritonitis
   Scand J Gastroenterol, 23 (1), 31-4
   DOI 10.3109/00365528809093843, PubMed 2894071
2. Hartmann A, Holdaas H (1988)
   [Emergency treatment of serious hypertension]
   Tidsskr Nor Laegeforen, 108 (33), 3108-10
   PubMed 3206505
3. Holdaas H, Hartmann A, Talseth T, Berg KJ, Fauchald P, Stenstrøm J, Djøseland O, Nordal KP, Brodwall E (1988)
   Short-term changes in renal function of the remaining kidney after donor nephrectomy
   Transplant Proc, 20 (3), 434-5
   PubMed 3381255
4. Holdaas H, Talseth T, Berg KJ, Fauchald P, Nordal KP, Hartmann A (1988)
   Diagnostic value of peripheral plasma renin response to a single dose of captopril in suspected renal transplant artery stenosis
   Transplant Proc, 20 (3), 423-4
   PubMed 3289174
5. Holst N, Jenssen TG, Burhol PG, Jorde R (1988)
   Gastrointestinal regulatory peptides during oxytocin infusion in post-term pregnancies
   Acta Physiol Scand, 132 (1), 23-7
   DOI 10.1111/j.1748-1716.1988.tb08293.x, PubMed 2906209
6. Revhaug A, Lygren I, Jenssen TG, Giercksky KE, Burhol PG (1988)
   Vasoactive intestinal peptide in sepsis and shock
   Ann N Y Acad Sci, 527, 536-45
   DOI 10.1111/j.1749-6632.1988.tb27007.x, PubMed 3291700
7. Talseth T, Holdaas H, Albrechtsen D, Berg KJ, Fauchald P, Naalsund A, Nordal KP, Skar AG, Sødal G, Flatmark A (1988)
   Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients
   Transplant Proc, 20 (3), 400-1
   PubMed 3289169

Publications 1987

1. Burhol PG, Jenssen TG, Florholmen J, Jorde R (1987)
   [Apudomas of the gastrointestinal tract and pancreas]
   Tidsskr Nor Laegeforen, 107 (7), 652-3, 672
   PubMed 3576560

Publications 1986

1. Almdahl SM, Jenssen TG, Burhol PG, Giercksky KE (1986)
   Vasoactive intestinal polypeptide and somatostatin in experimental endogenous gram-negative peritonitis
   Acta Chir Scand, 152, 135-8
   PubMed 2869631
2. Hartmann A, Langberg H, Holdaas H, Kiil F (1986)
   Glomerulotubular balance during renal sympathetic stimulation
   Acta Physiol Scand, 127 (2), 187-95
   DOI 10.1111/j.1748-1716.1986.tb07893.x, PubMed 2873711
3. Holst N, Jenssen TG, Burhol PG, Jorde R, Maltau JM (1986)
   Plasma vasoactive intestinal polypeptide, insulin, gastric inhibitory polypeptide, and blood glucose in late pregnancy and during and after delivery
   Am J Obstet Gynecol, 155 (1), 126-31
   DOI 10.1016/0002-9378(86)90094-3, PubMed 3524233
4. Holst N, Jenssen TG, Burhol PG, Jorde R, Maltau JM, Haug E (1986)
   Gut peptides in lactation
   Br J Obstet Gynaecol, 93 (2), 188-93
   DOI 10.1111/j.1471-0528.1986.tb07885.x, PubMed 2868752
5. Hvidsten D, Jenssen TG, Bolle R, Burhol PG (1986)
   Plasma gastrointestinal regulatory peptides in exercise-induced asthma
   Eur J Respir Dis, 68 (5), 326-31
   PubMed 2874049
6. Jenssen TG, Haukland HH, Florholmen J, Jorde R, Burhol PG (1986)
   Evidence of somatostatin as a humoral modulator of motilin release in man. A study of plasma motilin and somatostatin during intravenous infusion of somatostatin, secretin, cholecystokinin, and gastric inhibitory polypeptide
   Scand J Gastroenterol, 21 (3), 273-80
   DOI 10.3109/00365528609003076, PubMed 2872717
7. Jenssen TG, Holst N, Burhol PG, Jorde R, Maltau JM, Vonen B (1986)
   Plasma concentrations of motilin, somatostatin and pancreatic polypeptide before, during and after parturition
   Acta Obstet Gynecol Scand, 65 (2), 153-6
   DOI 10.3109/00016348609158371, PubMed 2873707
8. Jenssen TG, Revhaug A, Burhol PG, Giercksky KE, Vonen B (1986)
   Effect of haemorrhagic shock and duodenal instillation of blood on the plasma profiles of somatostatin and motilin in pigs. A study of molecular plasma components
   Scand J Gastroenterol, 21 (3), 281-90
   DOI 10.3109/00365528609003077, PubMed 2872718
9. Riepl R, Jenssen TG, Revhaug A, Burhol PG, Gierchksky KE, Lehnert P (1986)
   [Increase of plasma cholecystokinin by Escherichia coli endotoxin-induced shock in swine]
   Z Gastroenterol, 24 (11), 691-9
   PubMed 3544541

Publications 1985

1. Bergrem H, Jervell J, Flatmark A (1985)
   Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients
   Kidney Int, 27 (2), 459-64
   DOI 10.1038/ki.1985.31, PubMed 3887001
2. Burhol PG, Jenssen TG, Florholmen J, Jorde R (1985)
   Protein-binding of secretin in human plasma
   Acta Physiol Scand, 123 (3), 339-47
   DOI 10.1111/j.1748-1716.1985.tb07598.x, PubMed 4061116
3. Burhol PG, Jenssen TG, Schulz TB, Lygren I, Jorde R (1985)
   Production and evaluation of rabbit cholecystokinin (CCK)
   Mater Med Pol, 17 (1), 34-8
   PubMed 4033220
4. Burhol PG, Jorde R, Florholmen J, Jenssen TG, Vonen B (1985)
   A systematic approach to the preparation of 125I-labeled gastrointestinal regulatory peptides with high specific radioactivities
   Scand J Gastroenterol, 20 (4), 466-9
   DOI 10.3109/00365528509089682, PubMed 2862690
5. Burhol PG, Lygren I, Jenssen TG, Jorde R (1985)
   Diurnal profiles of plasma cholecystokinin (CCK) and vasoactive intestinal polypeptide (VIP) in man
   Mater Med Pol, 17 (1), 30-3
   PubMed 4040993
6. Florholmen J, Burhol PG, Jenssen TG, Jorde R (1985)
   Pharmacological effects of gastric inhibitory polypeptide, cholecystokinin, and somatostatin on the serum levels of cationic trypsin-like immunoreactivity in man
   Scand J Gastroenterol, 20 (7), 829-34
   DOI 10.3109/00365528509088830, PubMed 2864738
7. Holdaas H, Kopp UC, DiBona GF (1985)
   Modulation of reflex renal vasoconstriction by increased endogenous renal prostaglandin synthesis
   J Pharmacol Exp Ther, 232 (3), 725-31
   PubMed 3973825
8. Jenssen TG, Burhol PG, Jorde R (1985)
   Release of gastrointestinal regulatory peptides after a soap enema
   Scand J Gastroenterol, 20 (6), 762-6
   DOI 10.3109/00365528509089210, PubMed 2863869
9. Jenssen TG, Revhaug A, Burhol PG, Giercksky KE, Lygren I (1985)
   The origin and fall of plasma motilin during Escherichia coli endotoxin shock in pigs
   Acta Physiol Scand, 123 (4), 399-404
   DOI 10.1111/j.1748-1716.1985.tb07606.x, PubMed 3887842
10. Midtvedt K, Midtvedt T (1985)
    Rapid determination of antibiotic susceptibility by a disc diffusion test for urgent clinical situations
    Scand J Infect Dis, 17 (1), 131-2
    DOI 10.3109/00365548509070435, PubMed 3992201
11. Vikse A, Holdaas H, Sejersted OM, Kiil F (1985)
    Haemodynamic conditions for renal PGE2 and renin release during alpha- and beta-adrenergic stimulation in dogs
    Acta Physiol Scand, 124 (2), 163-72
    DOI 10.1111/j.1748-1716.1985.tb07648.x, PubMed 2861715

Publications 1984

1. Burhol PG, Jenssen TG, Jorde R, Lygren I, Johnson JA (1984)
   Plasma cholecystokinin (CCK) before and after a jejunoileal bypass operation in obese patients with reference to appetite regulation
   Int J Obes, 8 (3), 233-6
   PubMed 6746190
2. Burhol PG, Jorde R, Jenssen TG, Lygren I, Florholmen J (1984)
   Diurnal profile of plasma somatostatin in man
   Acta Physiol Scand, 120 (1), 67-70
   DOI 10.1111/j.1748-1716.1984.tb07374.x, PubMed 6144239
3. Burhol PG, Lygren I, Jenssen TG, Florholmen J, Jorde R (1984)
   Somatostatin release and plasma molecular somatostatin components in man
   Acta Physiol Scand, 121 (3), 223-8
   DOI 10.1111/j.1748-1716.1984.tb07450.x, PubMed 6433648
4. Hartmann A, Holdaas H, Steen PA, Kiil F (1984)
   Evidence for bicarbonate-dependent lithium reabsorption in dog kidneys
   Acta Physiol Scand, 120 (2), 257-64
   DOI 10.1111/j.1748-1716.1984.tb00132.x, PubMed 6231805
5. Hartmann A, Langberg H, Holdaas H, Kiil F (1984)
   Glomerular filtration rate and PCO2 as determinants of lithium reabsorption
   Acta Physiol Scand, 121 (3), 283-90
   DOI 10.1111/j.1748-1716.1984.tb07458.x, PubMed 6089506
6. Holdaas H, DiBona GF (1984)
   Stimulatory and inhibitory reflexes from somatic receptors: effect on renin release
   Am J Physiol, 246 (6 Pt 2), R1005-10
   DOI 10.1152/ajpregu.1984.246.6.R1005, PubMed 6377915
7. Holdaas H, DiBona GF (1984)
   On the existence of renal vasodilator nerves
   Proc Soc Exp Biol Med, 176 (4), 426-33
   DOI 10.3181/00379727-176-41893, PubMed 6463053
8. Jenssen TG, Burhol PG, Jorde R, Florholmen J, Lygren I (1984)
   Radioimmunoassayable plasma motilin in man. Secretagogues, insulin-induced suppression, renal removal, and plasma components
   Scand J Gastroenterol, 19 (6), 717-23
   DOI 10.1080/00365521.1984.12005799, PubMed 6393315
9. Langberg H, Hartmann A, Holdaas H, Kiil F (1984)
   Site and magnitude of the tubular inhibitory effect of expanding the extracellular volume in dogs
   Acta Physiol Scand, 122 (3), 285-98
   DOI 10.1111/j.1748-1716.1984.tb07512.x, PubMed 6516881
10. Langård O, Holdaas H, Vikse A, Sejersted OM, Eide I (1984)
    Ouabain inhibits renin release by a direct renal haemodynamic effect
    Scand J Clin Lab Invest, 44 (6), 557-63
    DOI 10.1080/00365518409083611, PubMed 6148785
11. Lygren I, Revhaug A, Burhol PG, Giercksky KE, Jenssen TG (1984)
    Vasoactive intestinal polypeptide and somatostatin in leucocytes
    Scand J Clin Lab Invest, 44 (4), 347-51
    DOI 10.3109/00365518409083818, PubMed 6147010
12. Vikse A, Holdaas H, Sejersted OM, Kiil F (1984)
    Relationship between PGE2 and renin release in dog kidneys. Effects of afferent arteriolar dilation and adrenergic stimulation
    Acta Physiol Scand, 121 (3), 261-8
    DOI 10.1111/j.1748-1716.1984.tb07455.x, PubMed 6382924

Publications 1983

1. Bergrem H, Grøttum P, Rugstad HE (1983)
   Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration
   Eur J Clin Pharmacol, 24 (3), 415-9
   DOI 10.1007/BF00610064, PubMed 6861855
2. Bergrem H, Jervell J, Flatmark A (1983)
   Different prednisolone pharmacokinetics in Cushingoid and non-Cushingoid kidney transplant patients
   Proc Eur Dial Transplant Assoc, 20, 286-90
   PubMed 6361740
3. BERGREM H, JERVELL J, FLATMARK A (1983)
   DIFFERENT PREDNISOLONE PHARMACOKINETICS IN CUSHINGOID AND NON-CUSHINGOID KIDNEY-TRANSPLANT PATIENTS
   P EUR DIAL TRANS, 20, 286-290
4. Bergrem H, Opedal I (1983)
   Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein-binding
   Scand J Gastroenterol, 18 (4), 545-9
   DOI 10.3109/00365528309181635, PubMed 6669930
5. Bergrem H, Refvem OK (1983)
   Changes in prednisolone pharmacokinetics and protein binding during treatment with rifampicin
   Proc Eur Dial Transplant Assoc, 19, 552-7
   PubMed 6878255
6. Bergrem H, Refvem OK (1983)
   Altered prednisolone pharmacokinetics in patients treated with rifampicin
   Acta Med Scand, 213 (5), 339-43
   DOI 10.1111/j.0954-6820.1983.tb03748.x, PubMed 6880856
7. Bergrem H, Ritland S, Opedal I, Bergan A (1983)
   Prednisolone pharmacokinetics and protein-binding in patients with portosystemic shunt
   Scand J Gastroenterol, 18 (2), 273-6
   DOI 10.3109/00365528309181594, PubMed 6673058
8. Holdaas H (1983)
   Adrenergic control of renin release
   J Oslo City Hosp, 33 (10-11), 111-27
   PubMed 6315904
9. Langård O, Holdaas H, Eide I, Kiil F (1983)
   Conditions for augmentation of renin release by theophylline
   Scand J Clin Lab Invest, 43 (1), 9-14
   PubMed 6312554
10. Osborn JL, Holdaas H, Thames MD, DiBona GF (1983)
    Renal adrenoceptor mediation of antinatriuretic and renin secretion responses to low frequency renal nerve stimulation in the dog
    Circ Res, 53 (3), 298-305
    DOI 10.1161/01.res.53.3.298, PubMed 6349846
11. Vikse A, Holdaas H, Hartmann A, Kiil F (1983)
    Segmental distribution of vascular resistances during ureteral occlusion. The vasoconstrictive effects of angiotensin and CaCl2 differ from those of catecholamines and renal nerve stimulation
    Acta Physiol Scand, 119 (2), 147-58
    DOI 10.1111/j.1748-1716.1983.tb07320.x, PubMed 6140816
12. Vikse A, Holdaas H, Sejersted OM, Eide I, Kiil F (1983)
    Prostaglandin E2 and renin release response to dilation of afferent arterioles and during alpha- and beta-adrenergic stimulation
    Acta Med Scand Suppl, 677, 44-7
    DOI 10.1111/j.0954-6820.1984.tb08627.x, PubMed 6322531

Publications 1982

1. Bergrem H, Jervell J, Solheim DM, Flatmark A (1982)
   Prognostic value of renal vein renin determination in suspected renovascular hypertension
   Acta Med Scand, 211 (5), 387-91
   DOI 10.1111/j.0954-6820.1982.tb01967.x, PubMed 6126071
2. BERGREM H, REFVEM OK (1982)
   CHANGES IN PREDNISOLONE PHARMACOKINETICS AND PROTEIN-BINDING DURING TREATMENT WITH RIFAMPICIN
   P EUR DIAL TRANS, 19, 552-557
3. Burhol PG, Jenssen TG, Lygren I, Schulz TB, Jorde R, Waldum HL (1982)
   Iodination with Iodo-gen and radioimmunoassay of cholecystokinin (CCK) in acidified plasma, CCK release, and molecular CCK components in man
   Digestion, 23 (3), 156-68
   DOI 10.1159/000198723, PubMed 7106417
4. Holdaas H, Langaard O, Eide I, Kiil F (1982)
   Conditions for enhancement of renin release by isoproterenol, dopamine, and glucagon
   Am J Physiol, 242 (3), F267-73
   DOI 10.1152/ajprenal.1982.242.3.F267, PubMed 7039349
5. Midtvedt T, Midtvedt K (1982)
   Sport and infection
   Scand J Soc Med Suppl, 29, 241-4
   PubMed 6958046
6. MIDTVEDT T, MIDTVEDT K (1982)
   SPORT AND INFECTION
   Scand. J. Soc. Med. (29), 241-244

Publications 1981

1. BERGREM H, DJOSELAND O, JERVELL J, RUGSTAD HE (1981)
   ABSORPTION OF PREDNISOLONE .1. THE EFFECT OF FASTING, FOOD, AND FOOD COMBINED WITH ANTACIDS
   Scand. J. Urol. Nephrol. (64), 167-173
2. Bergrem H, Djøseland O, Jervell J, Rugstad HE (1981)
   Immunosuppressive treatment policies. A) Glucocorticoids: absorption of prednisolone. I. The effect of fasting, food, and food combined with antacids
   Scand J Urol Nephrol Suppl, 64, 167-73
   PubMed 6959258
3. Bergrem H, Jakobsen A, Flatmark A (1981)
   Prednisolone in renal transplantation: a comparison between two dosage regimes
   Scand J Urol Nephrol Suppl, 64, 174-8
   PubMed 6755677
4. BERGREM H, JAKOBSEN A, FLATMARK A (1981)
   PREDNISOLONE IN RENAL-TRANSPLANTATION - A COMPARISON BETWEEN 2 DOSAGE REGIMES
   Scand. J. Urol. Nephrol. (64), 174-178
5. Holdaas H, DiBona GF, Kiil F (1981)
   Effect of low-level renal nerve stimulation on renin release from nonfiltering kidneys
   Am J Physiol, 241 (2), F156-61
   DOI 10.1152/ajprenal.1981.241.2.F156, PubMed 7023249
6. Holdaas H, Langård O, Eide I, Kiil F (1981)
   Mechanism of renin release during renal nerve stimulation in dogs
   Scand J Clin Lab Invest, 41 (7), 617-25
   DOI 10.3109/00365518109090506, PubMed 7041238
7. Jenssen TG, Waldum HL, Burhol PG, Straume BK (1981)
   [The diagnosis of peptic ulcer and gastric cancer in gastroscopy case material]
   Tidsskr Nor Laegeforen, 101 (12), 706-9
   PubMed 7245155
8. Jorde R, Burhol PG, Schulz TB, Waldum HL, Lygren I, Jenssen T, Myhre ES (1981)
   The effect of a 34-h fast on the meal-induced rises in plasma GIP, serum insulin, and blood glucose in man
   Scand J Gastroenterol, 16 (1), 109-12
   PubMed 7015476
9. Jorde R, Waldum HL, Burhol PG, Lygren I, Schulz TB, Florholmen J, Jenssen TG (1981)
   The effect of somatostatin on fasting and postprandial plasma GIP, serum insulin, and blood glucose in man
   Scand J Gastroenterol, 16 (1), 113-9
   PubMed 6112787
10. Langberg H, Mathisen O, Holdaas H, Kiil F (1981)
    Filtered bicarbonate and plasma pH as determinants of renal bicarbonate reabsorption
    Kidney Int, 20 (6), 780-8
    DOI 10.1038/ki.1981.211, PubMed 6801371
11. Langård O, Holdaas H, Eide I, Kiil F (1981)
    Conditions for humoral alpha-adrenoceptor stimulation of renin release in anaesthetized dogs
    Scand J Clin Lab Invest, 41 (6), 527-34
    DOI 10.3109/00365518109090494, PubMed 6278576
12. Langård O, Holdaas H, Eide I, Kiil F (1981)
    Conditions for stimulation of renin release by cyclic AMP in anaesthetized dogs
    Scand J Clin Lab Invest, 41 (6), 535-42
    DOI 10.3109/00365518109090495, PubMed 6278577
13. PAPE J, JERVELL J, ANKER E, BERGREM H, DAHLE K, LEIVESTAD T, MYRSETH L, THAULOW E, URVING H, VANDERLIPPE A (1981)
    BLOOD-PRESSURE AND PULSE RESPONSE TO INSULIN-INDUCED HYPOGLYCEMIA DURING NON-SELECTIVE AND SELECTIVE BETA-BLOCKADE
    Acta Med. Scand. (645), 105-108
14. Pape J, Jervell J, Anker E, Bergrem H, Dahle K, Leivestad T, vd Lippe A, Myrseth L, Thaulow E, Urving H (1981)
    Blood pressure and pulse response to insulin-induced hypoglycemia during non-selective and selective beta-blockade
    Acta Med Scand Suppl, 645, 105-8
    DOI 10.1111/j.0954-6820.1981.tb02608.x, PubMed 6112844

Publications 1980

1. Bergrem H, Jervell J, Brodwall EK, Flatmark A, Mellbye O (1980)
   Goodpasture's syndrome. A report of seven patients including long-term follow-up of three who received a kidney transplant
   Am J Med, 68 (1), 54-8
   DOI 10.1016/0002-9343(80)90165-5, PubMed 6985766
2. Midtvedt T, Midtvedt K (1980)
   [Athletics and infections]
   Tidsskr Nor Laegeforen, 100 (12B), 859-62
   PubMed 7404535
3. Røyset PM, Jenssen TG, Burhol PG (1980)
   [Crohn's disease. Tromsø-material from the period 1974-1978]
   Tidsskr Nor Laegeforen, 100 (16), 1068-70
   PubMed 7414587

Publications 1979

1. Jenssen TG, Røyset P, Burhol P (1979)
   [Ulcerative colitis. A Tromsø series, 1974-1977]
   Tidsskr Nor Laegeforen, 99 (3), 149-52
   PubMed 419493
2. Mathisen O, Holdaas H, Kiil F (1979)
   Re-examination of the dose-reponse relationship for the renal effect of acetozolamide
   Scand J Clin Lab Invest, 39 (4), 297-301
   DOI 10.3109/00365517909106112, PubMed 523981
3. Mathisen O, Monclair T, Holdaas H, Kiil F (1979)
   To what extent does acetazolamide inhibit renal bicarbonate reabsorption?
   Scand J Clin Lab Invest, 39 (4), 293-5
   DOI 10.3109/00365517909106111, PubMed 118512

Publications 1978

1. Bergrem H, Flatmark A, Simonsen S (1978)
   Dialysis fistulas and cardiac failure
   Acta Med Scand, 204 (3), 191-3
   DOI 10.1111/j.0954-6820.1978.tb08423.x, PubMed 696419
2. Bergrem H, Leivestad T (1978)
   Dialysis death and increased free fatty acids
   Lancet, 2 (8100), 1160
   DOI 10.1016/s0140-6736(78)92328-0, PubMed 82729
3. Bohmer T, Bergrem H, Eiklid K (1978)
   Carnitine deficiency induced during intermittent haemodialysis for renal failure
   Lancet, 1 (8056), 126-8
   DOI 10.1016/s0140-6736(78)90422-1, PubMed 87556
4. Mathisen O, Monclair T, Holdaas H, Kiil F (1978)
   Bicarbonate as mediator of proximal tubular NaCl reabsorption and glomerulotubular balance
   Scand J Clin Lab Invest, 38 (1), 7-17
   DOI 10.3109/00365517809108396, PubMed 415348
5. Sejersted OM, Holdaas H, Monclair T (1978)
   Functional differences of ouabain and ethacrynic acid on renal potassium metabolism in dogs
   Scand J Clin Lab Invest, 38 (7), 603-14
   DOI 10.3109/00365517809102426, PubMed 152453